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1. INTRODUCTION 
“Be fruitful and increase in number”this was the first blessing given by the Lord to 
the mankind.
1 
Ever since the commencement of documentation of history, the human has 
positioned a great importance on fertility.
2
 Reproduction, continuity, maintenance through the 
descendants and the desire for self protection forms the fundamental need of family unit. 
Infertility represents a severe emotional and common problem in the social order where 
importance is emotionally involved to have offspring.
3 
50 to 80 million general populations 
suffer due to infertility on world level. The World Health Organization (WHO) has estimated 
about 8 to 10% of couples goes through this problem.
4
 Male part is exclusively accountable 
with reference to 20 % of unfruitful couples and contributory factor in 30 – 40%.5 50% 
couple infertity, is due to Oligospermia a male medical condition.
6 
In the year 1981 Indian 
census estimated around 4 to 6% infertility. Survey on southern part of India as on 1993- 
2005 showed deterioration in sperm conut, motility and morphology.
4 
Infertility is defined as 
the inability of a sexually active, non-contracepting couple to achieve spontaneous pregnancy 
in one year”.7 WHO guiding principle reports, “Count less than 15million/ml is defined as 
oligozoospermia”.8 
 
Selection of the disease 
In the present days male infertility is increasing due to factors like environment, 
alcoholism and smoking which lead to poor semen quality.
9
 Carlsen et al. observed 
considerable decline in the mean value of sperm count from 113 million per ml (1940) to 66 
million per ml (1990) and a drop of 0.94 million per ml for every year.
10
 Infertility is usually 
the presenting illness and investigations might lead to the finding of oligozoospermia, 
asthenozoospermia, teratozoospermia and azoospermia. In medical practice, oligozoospermia 
is considered single most common cause for male infertility.
11
 Investigator preferred in spot 
lighting male infertility however such an extensive issue cannot be studied in limited time 
and hence the study was limitied to be focused on Oligozoospermia. 
 
Causes for Oligozoospermia  
 Pretesticular cause which includes hypogonadism, smoking, drugs, alcohol, 
medication and strenuous riding.  
 Testicular causes which include genetic defect, age, neoplasm, varicocele, hydrocele, 
cryptoorchidism, mumps, malaria and trauma.  
2 
 
 Post testicular causes which include lack/obstuction of vas deferens, obstruction of 
ejaculatory duct, genetic markers for cystic fibrosis and infections.
12
 
 Obesity has been proposed to affect male fertility both directly and indirectly by 
inducing alteration in sleep, sexual behavior, hormonal profiles and scrotal 
temperature.
13
 
 Environmental toxins like insecticides, pesticides and heavy metals highly afffect 
reproductive organs.
14
 
 Since past decades distorted lifestyle, chemical based foods, lack of nutrition, 
pollution, tight clothing, deskbound work and stress have reduced fertility.
4
 
Siddha Background 
1, 15
 
Siddha system of Medicine [SSM] is started off from Tamil Nadu, south state of 
India. Practiced generally in and around the areas of its foundation. The drug resources of 
SSM have been classified into three main groups, plant resources, inorganic resources and 
animal resources which are described by means of suvai (taste), gunam (quality), veeriyam 
(potency), pirivu (post-digestive taste) and prabhavam (specific action). Diagnosis of disease 
in Siddha system is based on the assessment of envagi thaervu (eight fold examination) 
which are tongue, colour of the body, voice, eyes, stools, urine, touch and pulse. Most 
prominent procedures used for diagnosis and prognosis of diseases are neerkuri, neikuri 
(urine examination) and naadi (pulse examination). Siddha system had already gained an 
insight in individualistic management through thega ilakkanam ( biotype - characterization of 
an individuals ) which reduces the possibility of misdiagnosis / incorrect treatments, which 
now contemporary research is testing to achieve through pharmacogenetics and 
pharmacogenomics. In Siddha science, 96 thathuvam (principles) deals with the basic 
components of human body which include intellectual, physiological, physical and 
psychological components of the individual.  
 
SSM describes the human body is made of five primordial basic elements like space, 
air, fire, water and earth which are the building blocks of physical and subtle bodies. Siddha 
scientific principles, has been already present in the universe. The Lord God formed the man 
of dust [earth element] from the ground and breathed into his nostrils the breath of life [air-
vatham] and the man became a living creature. According to Siddha medical science the 
element earth gives fine shape to the body, including bones, tissues, muscles, skin and hair. 
The physiological function in the human system is mediated by uyir thathukkal (functional 
3 
 
constitution of the body) i) vatham - air (bio energy movement) ii) pitham-bile (bio energy 
fire) iii) Iyyam-phlegm (bio energy water) which is formed by the combination of the five 
primordial basic elements. Saaram (chyle), senneer (blood), oon (muscle), kozhupu 
(cholesterol), enbu (bone), moolai (bone marrow), sukkilam/suronitham ( semen/ovum) are 
udal thathukkal (physical constituents) which are identical to the various types of tissues. 
SSM defines disease as the signs and symptoms resulting from vitiation of intrinsic factors i.e 
three humors and seven physical constituents due to changes in extrinsic factors such as diet 
and activities. Drugs of SSM are used separately or in combination for maintaining the three 
humours 
 
 
Siddha ethical guidelines and preventive measures for diseases 
15
 
Indications for Preliminary treatments  
Diseases are determined with the help of pulse reading. Clinical condition of the 
patients like diet habits, sleeping pattern, urine, motion and five sense organs should be 
assessed.  
People more prone to the incidence of disease 
People who are on irregular diet, sendentary life; consuming food without proper 
mastication; devoid of exposure to first sun light (morning ), consuming food which make 
worse the kabam, impure water, inhaling the air from graveyards, intercourse with elder 
women, are more prone to the incidence of disease. 
Preventive measures 
Consuming nutritious food, inhaling pure air, drinking pure water, doing physical 
exercise, intercourse with younger women during night, not suppressing the natural urges (14 
reflexes). Regular practicing of all these behavior can lead to a blissful life. 
 
Comparison of Thathu nashtam to Oligozoospermia 
According to Siddha Scholar Yugi muni symptoms like semen
 
showing lack of 
sweetness, floating on water, absence of vitality & frothy micturation indicates Aan maladu 
[male infertility].
16
 In Siddha, Thathu nashtam [Oligozoospermia] has not been described as a 
separate disease entity. There is no direct reference for the comparison of Thathu nashtam to  
oligozoospermia however its feature can be understood on the basis of the indirect references 
available in the Siddha literatures. The various nomenclature used in siddha texts in relation 
with Sukkilam the seventh udal thathu [physical constituent] can be compared to sperm and 
not semen  alone since its function is reproducion. The term Thathu Rogam [vinthu vai patria 
4 
 
noi]  denotes disease relating to sperm and Thathu kuraivu / Thathu pushti kuraivu  denotes 
Oligozoospermia
17 
and  hence the term Thathu nashtam can be compared to oligozoospermia 
of contemporary science as both are similar in terminology [oligo-low; zoospermia- 
spermatozoa in semen ; thathu –sperm; nashtam-lack, be deficient in]. 
 
The empirical therapies 
Male infertility is evaluated through investigation of semen and hormonal analysis 
(testosterone, follicle stimulating harmone and lutenizing harmone).
18
The empirical therapies 
in treating oligozoospermia includes androgens, gonadotropins and antiestrogens. Majority of 
these treatment put importance on the stimulatory effect of testosterone in spermatogenesis.
19
 
Fertility depends on synchronized functions of reproductive tract axis-hypothalamus, 
pituitary and gonads.
20 
Alteration in life style, intake of balanced nutritional diet and 
supplements may increase sperm count and motility. Among micro nutrients Vit B12, Vit C, 
Vit E, carnitine, arginine, selenium and zinc play significant function in increasing sperm 
count and motility and each has definite role in increasing sperm count and improve its 
function.
14
 Antioxidants may protect sperm DNA from oxidants/free radicals and may 
increase stability of blood testis barrier.
21
 Intracytoplasmic sperm injection, ever since from 
its introduction (1992), has revolutionized the male infertility treatment.
20
 In vitro 
fertilization and intracytoplasmic sperm injection provide symptomatic managements and the 
cause of the limited success may be the requirement of methods to identify ART (Assisted 
reproductive technology ) type providing the most possible chances of pregnancy in a 
couple.
22
 
 
Need of the hour 
Inspite of revolutionary progression in treatment of infertility in the most recent 
decade through drugs, diagnostic procedures, and assisted reproductive technologies, the 
expenditure of ARTs is still extremely high and beyond the reach. Most part of infertile men 
do not need expensive and advanced trial.
3,23
 In most of the times invasive technology (ART) 
creates economical and emotional stress and may not assure success. Alternative therapies 
(Siddha) should be developed to guarantee the wish of the infertile males to give forth to 
bilogical offspring in a natural way. Conversely scientific perspective documentation through 
clinical trials are required to assure the safety and efficacy of the drugs.
24 
 
 
5 
 
Choice of the drug 
 Siddha sastric herbomineral formulation Chandrakanthi Chooranam (CKC) consist of 
twenty five ingredients and is indicated for the treatment of oligozoospermia, vaginal 
diseases, veneral diseases, polyuria and in all biliousness
.25
 
 Traditional utilization of the ingredients of CKC claims its function in treating male 
infertility, oligozoospermia, impotency, nocturnal emission, premature ejaculation, 
spermatorrhoea, high and low viscous semen, male gonorrhoea, testicle swelling and 
prostate enlargement.
24
 
 Some ingredients in CKC act as an aphrodisiac drug, testosterone booster and also 
counteract alcohol intoxication.
24
 
 In general, mineral medicines progress semen immediately. Spermatogenic activity of 
Shilajit (mineral) is reported in rats and in clinical trial of patients with 
oligozoospermia and there was significant improvement in the semen quality.
24
 
 The composition in CKC is specifically judged and thus motivated the investigator to 
select it as the study drug to provide treatment for oligozoospermic patients.  
Siddha claim in treatment of Oligozoospermia 
 
 Synergistic features are exceptional to phytotherapy and the part of the ingredients in 
this combination contributes both to efficacy and safety 
 
 Shilajit is referred to thathuras (body tissue) and it is the rasayana that tonifies the 
action of the saptha thathus (seven body constituents) that is chyle, blood, muscle, fat, 
bone, bone marrow and reproductory fluids of the body (semen) 
 
 Shilajit augments the bioavailability of the herbs in the body.  
 
In this study the investigator have intended to establish both the safety and efficacy of the 
siddha herbo-mineral formulation Chandrakanthi chooranam to be proved in clinical and 
preclinical studies and to provide it as a standard treatment for oligozoospermic patients by 
improving sperm parameters. 
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2. AIM  
 
 To evaluate the safety and efficacy of Siddha herbo mineral formulation 
Chandrakanthi  chooranam  through preclinical  and clinial studies 
 
OBJECTIVES 
 
I ] Preclinical 
 
a) Standardisation of Chandrakanthi chooranam 
 Identification and authentication of the herbal and mineral constituents 
 Pharmacognostical study for the selected herbal constituents 
 Preparation of the study drug 
 Analytical specifications of Chandrakanthi chooranam  (PLIM guidelines) 
 Thermo gravimetric analysis (TGA)  
 ICP-OES elemental analysis 
 
b) Animal studies 
 
i) Toxicity study (Safety study) 
 Acute and long term toxicity studies to evaluate the safety of the study drug 
 
ii) Pharmacological study ( Efficacy study) 
 Evaluation of spermatogenic activity of the study drug in ethanol induced sperm 
reduction in wistar rats. 
 
2] Clinical Trial 
 
A) Pilot study 
 To assess the feasibility, safety and tolerability of administration of the study drug in 
Oligospermic patients prior to conducting phase II main clinical trial 
 
B) Main clinical Trial 
 To evaluate the changes in the sperm concentration, percentage of total  and  
progressive motility and the percentage of normal forms of sperm per milliliter of 
seminal fluid  
 To estimate the changes in serum Testosterone, FSH and LH harmones  
 To assess the clinical safety parameters  
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3. LITERATURE REVIEW  
 
3.1. SIDDHA LITERATURE REVIEW 
 
DEFINITION 
17
 
                                  Table 3.1.1: Siddha Definitions 
Maladu  (Infertility) A disease by which men/woman are rendered incapable of 
producing child by reason of defective semen or menses in them is 
termed as Maladu 
Aanmaladu (Male Infertility) Want of fertility or fecundation in a man’s semen  
Sukilam  ( Semen ) Semen is formed by the essential parts of bone marrow the sixth 
constiuent of the body mixed with blood. It is the support of the 
body and the root of pregnacy. 
Vinthu  ( Sperm / Masculine 
embodiment ) 
A term to denote the male reproductive cell / gamete / characters 
 
Etymology for Sukilam 
26
 
Derived from tamil word, Sukilathuvam - venmai; Sukilam - venmai (white / purity)  
 
Anatomical  [ Angadhi padham ] and Physiological [ Sukaranam ] terms 
17,27 
 
             Table 3.1.2: Anatomical and Physiolgical terms in Siddha 
Bijam, Lingam, Andam, Vithai 
(Seed) 
This has the capacity to give rise to new offspring  
Vinthu  (sperm) Sukila kirumi (spermatozoan); Sukilathathu - vinthu; Sukilam - 
vinthu  
Sukila Vasayam Repository [Testes and ovaries] for reproductive tissue 
Manomaya kosam  (Mental 
system / psychic system ) 
Constituted by the mind and the five organs of perception  
Niyana Inthiriyam:   Action of genital organ 
Mulatharam (Neuro endocrinal 
centres)  
Located between the rectal and external genitalia [inside the 
perineum] at the base of the spinal column. Resting place of 
serpent power / rectal plexus 
Swathittanam (Neuro 
endocrinal centres) 
It is situated two finger breadths above the moolatharam. It is a 
constituent of earth element 
Thi Mantalam ( Fire Zone )   This is found two finger breadths above the moolatharam  
Thinkal Manadalam (Lunar 
zone) 
Lies in the centre of the eyebrows from where emerges brightness 
like that of millions of moons and stars 
Kuntalini A form of energy located in the moolatharam   
Abana vayu Component of vatham-downward air 
Theka Ilakkanam (Bio Type) The nature of an individual including structural, functional 
characteristics, adaptability, a relatively stable and genetically 
predetermined which is classified into four main types namely Vali/ 
Azhal/Iyyam/ Thontham  
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Synonyms for Oligozoospermia 
 
 Thathu Rogam (Vinthu vai patria noi): Disease relating to sperm 17 
 Thathu kuraivu / Thathu pushti kuraivu: Oligospermia 17 
 Vinthu kuraivu: Oligospermia 28  
 Vinthu anu kuraivu: Oligospermia 29 
 Sheena vinthu:  Oligospermia 17 
Other related terms 
 Sukila nattam:  spermatorrhoea 17 
 Vinthu nashtam: spermatorrhoea 17 
Epidemiology 
 
Elavenil [Early summer] aggravates the disease 
30 
 
Siddha philosophy and physiology of sperm  
 
Fertility period (Ovulation days) 
31
 
As per saint Agathiyar, on the first day of women menstrual cycle her genitals bloom 
like a lotus having fourteen to sixteen petals. From the first day onwards till the fourteenth or 
sixteenth day each petal closes one by one  every day; within these days if the vindhu [sperm] 
which is chiefly constituted by the fire and air elements, enters with the natham [ovum], then 
all the petals will immediatey closes. Thus if a man and woman copulates within the first 
fourteen or sixteen days of the menstrual period it is easy for formation of zygote to evolve 
stay in the uterus. 
 
Acrosomal reaction of sperm and embryogenesis in Siddha 
17, 32, 33 
“Natha vintu vilungum vayu” For gestation in union of the male and female fluid 
vayu (pranan) is needed. The simile of mixing together of thaneer (water) and sunnabu 
(calcium) is mentioned to explain the fusion of the ovum and sperm to develop into an 
embryo. This can be explained through the following research work done in sea urchin. The 
increase in intracellular Ca (calcium) will cause water to enter the cell, and will increase the 
hydrostatic pressure. This will support the extension of acrosomal reaction (calcium 
dependent reaction ) of the sperm. Then the acrosome fuses with egg's plasma membrane 
(beneath the vitelline layer). The sperm head will now have the access to the cytoplasm. 
Sperm alone are not required for activation of the egg and the calcium can induce egg 
activation. 
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Elemental composition and three humour in human embryology 
31
 
The natham (ovum) consists of the element earth, whereas the vinthu (sperm) consist 
of fire and air. The uterine wall which nourishes it has water element and the uterine cavity is 
of the element space. Therefore in the formation of foetus all the five elements combine and 
create it. As per saint Dhanvantari, when the sperm and ovum combines on the very day 
three kinds of humor’s spring forth. 
 
Microscopic nature of sperm 
32
 
Vinthu and natham are parama anu. Saint Yugi says, munai arugu nuni pani pol 
suronethathil sernthu thakavey. The sperm and the ovum are very microscopic the invisible 
base of aggregate bodies, they are like a dew on the sharp tip of a grass which means the 
semen and ovum merges and that the sperms in the semen moves in utmost swiftness and 
joins.  
 
Morphology of sperm 
31 
As per saint Thirumoolar, the semen containing innumerable spermatazoa passes very 
swiftly (motility) in to the uterus with rapid vibration of their tail. It is understood that the 
sperm has tail. 
 
Sperm Motility 
32 
From the poems, vayu odu vinthu senru malarkul sernthal; pinumam sukilathil 
piranavayu than selum and vinthu anga oorum pothu, it is explained that with the help of 
vayu (kinetic force- pranan ) sperm move in to uterus and fuse with ovum. 
 
Functional sperm 
32
 
As per saint Yugi, Vinthu thayin karbathil vegu thanthiramaga selum, Oru pani thuli 
alavey nilaithu nirkum. These lines denotes that only one functional sperm is necessary for 
fertilization. 
 
Preventing polspermy 
32 
From the poem, Vayu odu vinthu senru malarkul sernthal, malar ethel-yelam moodi 
kolum and Veli pol valinthu kakum vinthu udan prana vayu, it is explained that abana stays 
outside and the pranan goes along with the spermatazoa and bisects the size of the zygote. 
Just as the fence guards the garden the air surrounds the thiranda suronitham (zygote) and 
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guards it and prevents other sperms entering it. (preventing polyspermy). Although many 
sperm attach to the coats surrounding the egg, it is important that only one sperm fuses with 
the egg plasma membrane and delivers its nucleus into the egg.  
 
Aperture 
32
 
Saint Yugi says, munai arugu nuni pani pol suronethathil serunthu thakavey and 
vaithya saaram says, paintha veli thamar pol. The spermatozoa enters by penetrating the wall 
of the ovum by penetrating it and where the sperm enters in to the ovum is perforated with 
apertures.  
 
Sex determination 
31, 32 
As per Athuva Thathuvam, the fusion of the sukkilam and suronitham constitutes the 
human body. The variations can lead to deformities. Depends upon the dominance of 
sukkilam or suronitham the male or female birth take place. At the time of copulation if the 
male dominates then it is male and if the female dominates then it is a female. If the male and 
female are equal then the child will be neutral gender or a eunch. Here male indicates the 
vindhu and the female indicates nadham. 
 
Formation of the semen/sperm 
 
i)   Formed from Saaram 
ii)  Formed from Moolai Thathu 
iii) Formed out of Water eleme 
           
Figure  3.1.1: Formation of the semen/sperm 
                               
Saram 
Moolai 
Water 
   SEMEN/ SPERM 
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Formed from Saaram (Chyle) 
32
 
According to saint Theraiyar the concentrate of the food becomes, saaram (chyle) the 
same day; Senneer (blood) the second day; Oon (muscle) the third day;  Kozhupu 
(cholesterol) the fourth day; Enbu (bone) the fifth day; Moolai (bone marrow) the sixth day 
and Sukilam/Suronitha (sperm/ovum) the seventh day. From chyle the essentials were taken 
up to semen and were produced. Saaram (chyle), senner (blood) and venneer (sukilam) one 
day fuse to form vinthu (sperm) 
 
Formed from Moolai thathu (bone marrow) 
34 
Modern research showed early stage sperm cells had been created from bone marrow 
(moolai). Stem cells were isolated from bone marrow of donors (male) and.then cultured and 
identified in the laboratory. Some were induced to grow into spermatological cells, which 
generally become sperm cells. Transplantation of cells inside the testis was carried out in 
mice. 
 
Formed out of water element 
31
 
The physical component of the water element are blood, fat, semen, urine and brain. 
Iyyam (bio energy water) one of the three humour is condensed from the elements water and 
earth and it lies in sperm, fat, blood, bone and bone marrow. Measurement of semen (water 
component of the body) is ½ anjali (two palms held together to shape a bowel like structure 
and its capacity is called one anjali) 
 
Spermatogenesis 
35 
                                      Table 3.1.3: Spermatogenesis in Siddha 
 
 
 
 
 
Spermiogenesis 
35
 
Saaram (chyle), senner (blood) and venneer (sukilam) one day fuse to form vinthu 
(sperm) which grows in body for 21 days (yel mundru thenam) which can be correlated to the 
differentiation of spermatids to mature sperms 
 
80 drops of blood makes 1 drop of semen 
80 drops of semen makes 1 sperm 
6400 drops of blood makes 1 sperm 
1000 drops of blood + 3000 drops of blood and semen makes 1 sperm 
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Nutrition 
32, 27 
Vani (fire) gives nutrition to sperm. For processing saram to sukilam agni (basal 
metabolic heat-samakini) is needed. Testosterone, FSH and LH and are responsible for 
stimulation of spermatogenesis process. Stimulation also needs agni. Agni ( Vani, Azhal) is 
formed from the element fire and is the principle of transformation energy and governs heat 
and metabolism in the body and is concerned with the digestive, enzymatic and endocrine 
systems.  
 
Sukila Gunam ( Physical Characteristics ) 
32,16,36
 
                                           Table 3.1.4: Sukila Gunam 
 
 
 
 
 
 
 
Saint Sivavakiyar says, Unmayana sukila ubayama erunthathum, venmayagi 
neeriley virainthu neera thanathum. Semen ejaculated is milky white in appearance due to 
prostatic secretion. Immediately after ejaculation, sperm remains immotile for the reason it is 
viscous due to coagulation and becomes highly motile as the coagulation dissolves. 
 
The characters relating to sukilam will be comparatively better in iyya thegi individual 
due to similarities of gunam. 
 
Function of the Sukilam 
32
 
Responsible for reproduction. 
 
Harmone 
36
 
Saint Thiruvalluvar gana vettiyan says, Vinthu kudi iruntha thirunattai vitaen, 
marukinra kathirikol pattathanil, vinthunindru vilangunathi mayathuley, vilangu 
swathittanam veliyilethan. Swathittanam can be correlated to adrenal gland that secretes 
testosterone.  
 
State Water  
Colour White and butter –Excellent 
White and curd -Very Good 
White and milk- Good 
Specific gravity Should sink in water 
Taste Innipu (Fructose) 
Chief elemental composition Fire and water 
Predominant humour Aiyam  
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Siddha Physiology 
32, 36
  
Secretion of semen may be controlled by moolatharam (resting place of serpent 
power/rectal plexus), manomaya kosam (pschyic system), swathithanam (psycho physical 
center above moolatahram) and iyyam (water).  
 
As per saint Thirumoolar, uthayathil vinthuvil ongum kuntalium. Kuntalini (serpent 
form of energy) facilitate the act of emission of semen. Ejaculation is also controlled by 
kanma-inthiriyam (motor organs), abana vayu (downward air) and sadhaka pitham 
(accomplishment fire) 
 
Uyir thathukal  (Bio energetic principle) 
27, 32, 37
  
 
Vali  ( Bio energy air ) 
It is located in idakalai, abanan, kama kodi (spermatic cord). Vali is the principle of 
kinetic energy in the body and is concerned with the nervous system and with circulation. It 
activates  andcoordinates the seven udal kattugal (physical constituents). Abanan one of the 
component of vatham is the downward air responsible for excretion of semen  
 
Azhal  ( Bio energy fire )  
The heat of azhal is responsible for many actions. Azhal lies in blood and chyle. 
Sadhaka Pitham seems to have the psycho-somatic role in the formation of semen and human 
desires. Azhal is the principle of transformation [conversion] energy and governs heat and 
metabolism and is concerned with the digestive, enzymatic and endocrine systems. 
 
Iyyam  ( Bio energy water )   
It lies in semen, fat, blood, bone and bone marrow. Iyyam is the principle of stablizing 
energy and governs growth in the body and is concerned with structure, stability, lubrication 
and fluid balance. Tarpaka Kabam [CSF fluid] has important role in production of sukilam. 
Major component of human semen is cerebro spinal fluid. 
 
Noy Muthanatal (Aetilogy)  
 
Genetic cause: Theka Ilakkanam (Bio Type) 
32, 36
 
 Vali ( ectomorphic constitution) - Thatu nashtam (Oligozoospermia)  
 Pitham ( mesomorphic constitution) - Arpa sukilam (Oligozoospermia)  
 Aiya ( endomorphic constitution) - Inthriya kuraivu (Oligozoospermia)  
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Infections 
17, 32
  
 As per saint Thirumoolar, Varaiyana garbathil malatu pulu pugil, viraiyana 
vinthuvai virainthun didumel. Sperm is eaten up by maltu pulu (may be antisperm 
antibodies) in uterus.  
 Sukila piramium/megam (male gonorrhoea) 
 Koruku noi (Syphilis) 
Testicular cause 
32, 36
  
 Beeja Thamba Vatham / Neerandam ( Hydrocele ) 
 Asuva vatham (Crypto orchidism)  
 Vithai Vatham (Orchitis)  
 Sukila Pitham (Varicocele)  
As per Dhanvantari vaithiyam, Thakathan karbam thanai thavirthidum, kanavu thanil 
sakidium sukilathai sukila nalam kanthum, mika sukilam polneeril vellaiyum kannum kandal, 
sukila pitham menrai solinar sruthivallor. Here sukila nalam kanthum refers to burning 
sensation in ejaculatory ducts. 
 
Traumatic causes 
38 
 Surgery or accident sometimes leads to varmam ( vital points / subtle energy station)  
 Kallitaikkalam / Vithu  Varmam  
 Beeja kaalam- Testis will be found ascended through the inguinal canal 
 
Psychiatric disease 
38 
In Mathazhivu / Mathathiam udal thathus (physical constituents) including sukilam 
will be affected.  
 
Taste 
39
 
                                  Table 3.1.5- Consequences of affected Taste 
 
 
 
 
 
Increased Pulipu (sour) Weakness of genital organ 
Increased kaippu ( bitter) Abnorml change in semen qualities 
Increasedkarppu ( pungent) Oligozoospermia 
Decreased innipu (sweet) Lack of maintainence of seven body tissues 
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Dietary factors 
30, 40
  
Macrotyloma uniflorum, yam (karunai kizhangu), mango (unripe), bitter gourd, 
sesban leaves, lily pond water and red water. 
 
Life style 
30, 35, 36 
Intercourse with elder female, restraining ejaculation (one of the 14 functional natural 
urge) wearing slippers made of Acacia catechu (karungali), Cedrus deodara (devadaru), 
Wrightia tinctoria (vetpalai), Morinda citrifolia (nuna) and Ficus religiosa (aal) 
 
Gonado toxic drugs 
40
 
Nicotiana tabacum  
 
Diurnal factors 
36
 
Intercourse during digestion of food, intercourse in day time [intercourse at improper 
time] and intercourse during sunset 
Oligozoospermia coexpress with the following diseases 
41 
                            Table 3.1.6: Diseases that coexpress with Oligozoospermia  
Perumanjal kaamalai (Jaundice) 
Eraippu (Bronchial asthma) 
Vinthu Suram and vali azhal suram ( Fever ) 
Aiya Pandu (Anaemia) 
Mukutra  Kalladaippu (Urolithiasis)  
Vali Neer kiricharam (Urinary tract infection) 
Neerazhivu avathai (Diabetic complication) – In second stage sukilam ketu (sperm 
destruction) and oli kunrum and fifth stage will cause vinthu nashtam (Oligospermia). 
Elaippu Noi (Pulmonary Tuberculosis) 
Eruvaaimulai Noi (Haemorrhoids) 
Karumpa nasai ammai (Measles) - Affect semen and can make the patient maladu. 
 
Pathalogical state of semen 
 
            Table 3.1.7:  Signs of semen in Male Infertility as per saint Yugi 
16, 42, 43
  
Devoid of sweetness  
[Absence of fructose] 
Normal value of seminal fructose is  > 13 μmol/ejaculate (WHO 2010) 
Floating on water  
[decreased semen 
specific gravity]  
Normal specific gravity of semen is between 1.020 and 1.040 which is 
higher than that of water and when it reduces its floats which is the sign 
of infertlity 
Absence of live sperms  
[ Absence of vitality] 
Normal value of live spermatozoa is 58% (WHO 2010) 
Foamy urine  Foamy urine is most likely to appear in case of urinary tract infections 
and retrograde ejaculation, a condition in which the sperm reaches the 
urinary bladder 
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 Increased sukkilam causes increased lust, libido and urinary calculi.27 
 Decreased sukkilam causes failure in reproduction, pain in genitalia, dropy ejaculation 
of semen/ or blood during copulation, pricking pain in the testis, inflammation and 
blackening of genitalia.
27
 
 
  Semen if restrained results in fever, retention of urine, joints pain, heaviness of the 
body, heart diseases and white discharge. 
27 
 
Pathogenesis 
27, 30, 32, 39, 40, 41, 44  
 
 Three humours play a major role in the initiation of the disease. Vitiated vatham, 
pitham and iyyam thodam consecutively vitiate sukilam (semen/sperm) and decreases 
it either quantitatively or qualitatively  
 
 Mental stress and strain reduces sperm count in which vatham and saram is deranged 
(air element has the property of mental agony, saram gives mental and physical 
perseverance)  
 
 In repeated intercourse since fire element is affected, sperm production is decreased. 
(fire element has the property of sexual intercourse) 
 
 In excessive sexual abstinence, the activity of vayu is dreanged and sperm motility is 
affected.( vali is the principle of kinetic energy) 
 
 Even if saaram is well nourished and absorbed normally, it should be available up to 
sukilam. In excessive physical strains, most of the saaram is utilized and does not 
reaches till sukilam. 
 
 Intercourse with elder female causes iyyam derangement 
 
 In Testicular atrophy vali is deranged (abnormal functions of deranged vali is 
weakness of functional organs) and decreases spermatogenesis.  
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 In inflammations (orchitis,prostatis), mumps, jaundice, urinary tract infection, seminal 
infections and fever pitham is deranged. 
 
 The maturation arrest in spermatogenesis can also be considered as pitham 
derangement since azhal is the principle of transformation [conversion] energy. 
 
 In crypto orchidism pitham is deranged which affects (temperature difference) the 
testis. 
 
 Obstructive pathology (ejaculatory duct) can be considered as iyyam derangment  
(due to properties of solidity, nature of immobility]  
 . 
 Alcohol is thamo gunam (vatha) food articles and hence derangment of vali causes 
weakness of functional organs. 
  
 Nicotiana tabacum (Tobacco,smoking) affects pitham and destroys sperm 
(vinthualikum) 
                       Table 3.1.8: Deranged three humours and affected semen quality  
 
 Frothy micturation urationis due to iyyam derangement ( iyyam  is eliminated    
through urine 
 
 Floating on water is due to vatham derangement which has the property of lightness. 
 
 
Sperm production (Oligozoospermia) is affected by kabam derangment ( iyyam lies in semen) 
Sperm motility (Asthenozoospermia) is affeted due to vatha derangement ( kinetic force ) 
Sperm morphology (Teratozoospermia) is affected due to iyyam derangment (governs growth, 
concerned with structure ).  
Azoospermia (Obstructive pathalogy) shows absence of fructose (innipu taste) in semen due to iyyam 
derangement ( innipu -  water + earth = kabam) 
In Necrospermia vatham ( kinetic energy) is decreased, iyyam (immobility) is increased 
Low viscosity is due to vatham derangment (dryness) and high viscosity is due to iyyam derangment  
( solidity, fluid balance is the property of iyyam) 
Semen liquification is affected due to iyyam derangement ( fluid balance ).  
Semen volume is affected due to iyyam derangment ( iyyam - water and earth element) 
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 Uyirupu illathathu (Necrospermia- absence of live spermatozoa) due to vatham 
(kinetic force) and iyyam ( immobility) derangment. 
 
 Pungent ( karpu - air and fire)  and bitter ( kaipu- air and space ) taste causes sukila 
kedu (destruction of sperm production) due to derangment of pitham (fire) and vatham 
(air)  
 
 Saaram is impaired due to deekshagni- (fiery digestion) in which due to increased 
digestive fire food gets digested along with essence and manthagni in which food is 
digested delayed. The affected saaram affects sukilam.  
 
 When pitham (transformation energy) is affected, spermatogenesis (primary 
spermatocytes to immature sperm) and spermiogenesis (immature to mature sperm) 
will be affected  
 
 Iyyam derangement increases viscosity of semen which indicates infection in the 
genital tract or the presence of antisperm antibodies. Viscous interfer’s with 
determination of motility and antibody coating of spermatozoa.Vitiated iyyam 
condensed with the element earth, has the propety of conglomeration, solidity and 
viscuous which leads to the formation of agglutination of sperms due to inceased 
viscosity of semen, which hampers the motility of sperms and results in 
asthenozoospermia  
 
 As moolatharam is in the akkini mandalam, any pathological condition here can harm 
the moolakini and eventually derange the pitha humour. Symptoms are produced 
when deranged pitham affect the seven thathus. 
 
 The disturbances in seeva agni / pitham [basal metabolic heat] due to food articles and 
behaviour like sour, pungent, salt taste; unboiled food; sorrow; hot temperature, 
angry, insomnia and excessive coitus leads to vishamagni (toxic digestive fire).In 
which digestion is delayed due to deranged and displaced samanan (digestive air) 
which leads to toxic digestion and which will produce amam (indigested food toxin). 
Amam is the toxic material produced from undigested food and is a disease connected 
with the mucous (viscuos fluid-iyyam) in the intestines. Iyyam gets vitiated by amam [ 
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free radicals, reactive oxygen species] which is responsible for improper production 
of rasa thatu which finally results in improper nourishment of sukila thatu  
 
Associated symptoms 
32, 41
  
Ejaculatory dysfunction - Vali (abanan) is deranged in ejaculatory dysfunction. It is the 
downward air and responsible for excretion of semen. 
 
Erectyle dysfunction - Vali is deranged in erectyle dysfunction. Vali is concerned with the 
nervous system and with circulation.  
 
Nocturnal emmision - Pitham is deranged in nocturnal emmision. One of the symptoms of 
sukila pitham is, kanavu thanil sakidium sukilathai. 
 
Noi kanippu vivaadham  ( Differential diagnosis )  
32,41
  
 
 Sukila vatham (Asthenozoospermia)  
 Sukila Megam ( Pitham type of  Neerizhivu (diabetes) ) 
 Sukila piramiyam / premegam (Veneral disease)  
Siddha maruthuva noi  kanippu muraigal (Diagnostic methodology) 
27, 32, 16
  
 
 Neykkuri (Oil on urine sign)- Slow dispersal/formation of sieve/ flower/ animal/ 
irregular margin 
 Nadi (Pulse) -  vali naadi, vali azhal naadi, azhal vali naadi, pithathil vayu 
 Manikadai  (wrist circumference sign) -  8 ½ inch  
 Sukila thervu (Semen Analysis) 
                          Figure  3.1.2: Sukila thervu in Aan maladu 
 
 
 
 
 
 
 
 
 
 Devoid of sweetness   
 
 Buoyancy on water 
Absence of live sperms  
 
   Frothy micturation 
20 
 
Noi nidhanam (Prognosis) 
32,45
  
  Table 3.1.9: Indication of Semen colour in Prognosis 
                         
 
 
 
 
 
 
Excellent, very good, good –can be controlled through medicine. Other types are difficult but 
can be normalized by medicine that increases the quality of semen 
 Neikuri – Saladai kan (sieve) - Curable as per saint Theriyaar and intractable as per 
saint Gowthamar. 
 Manikadai- 8 ½ -curable  
Treatment 
Karpa marunthu (Rejuvenation) 
27, 38
  
 Karpa Yogam: Vajira asana, Pranayamam, Yoga muthirai, Sarvaangaasana  
 Thathu karpam- Poorna Chandrothayam 
 Seeva Karpam- Inthira Koba poochi 
 Siddha Panacea –Muppu [Supreme Salt]- Normalize the body constituents 
Medicinal Water 
30, 31
  
Thathuundakum (Spermatogenesis)  
Jambolana treee roots soaked water, cooked rice water kept over night, hot water kept 
in a gold pitcher and in iron pitcher, rain water before it falls down on earth and hot water 
drink. 
Thathu nattam (Oligozoospermia) 
Yamuna river water, thungabhadra river water, sindhu river water and vaigai river 
water 
 
Herbs and Animal Product 
30, 40  
Greens of drumstick, climbing brinjal, spinash, Amaranthus tritis, wheat; plantain 
flower; coriander leaf, black plum; pomegranate; mango fruit, black grapes, cashew, almond 
and walnut, elephant milk; fresh milk (cow’s milk) for 3 ¾ naligai (5hrs), milk skin or 
Colour Prognosis 
White and butter like Excellent 
White and curd like Very Good 
White and milk like Good  
White and akin to buttermilk Fair 
Akin to the honey in colour and consistency Average 
Akin to the ghee in colour and weight Poor 
Akin to the toddy in colour thickness Very poor 
Akin to the water Bad 
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lactoderm; mixed ghee (bufallo, goat and cow); thamboolam (conventional betel chewing), 
meat of domestic pig (Oor  panri); black bug stag (Kalai man); meat of duck (Vathu); white 
breasted kingfisher (Vichuli); Ruddy Shelduck (Thara kari); spotted dove (Mani pura); goat 
meat (Velladu), Sea fish like emperor (Valai), eel (Vilangu) and ray fish (Thiru kai), 
 
Season 
6
 
Pinpanikalam ( late winter season) induces spermatogensis 
 
Noi anuga vithi olukkam  ( Preventive Techniques ) 
27, 36, 41
  
 Pariyanga yogam (Spermatoschesis): Siddha art of sexual intercourse in which the 
kama vayu (Pranan) does not act and does not emmit semen. Bogam [sexual desire] 
was prefered in Thi Mantalam but the act was performed in Thinkal Manadalam. 
 Coitus during day time is not advised.   
 Avoid  sexual act with elder lady ( increases iyyam ) 
 Ideal time interval for coitus is once in a month  
 The coitus performed during the time of digestion (after a full meal) should be 
avoided . Saram may not be completely nourished.  
 During Sunset avoid coitus 
 
Duration of treatment 
31
 
Every disease has a fixed period of treatment for complete recovery. For oligo 
spermia ( Thathu nattam), the duration of treatment is one year. 
 
Physician’s Fees Prescribed 31 
The fees are also prescribed for diseases and it is clearly mentioned that treatment 
should not be given for ailments unless the fees is paid. The patient is morally obliged to pay 
the physician whatever he asks as his fees according to the set of the norms of the noble 
profession and for Thathu nattam (Oligospermia) it is 10 gold coins. 
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3.2. DISEASE REVIEW 
 
DEFINITION 
46,47,48
  
 
 Infertility (clinical definition): “A disease of the reproductive system defined by the 
failure to achieve a clinical pregnancy after 12 months or more of regular unprotected 
sexual intercourse.”  
 “Infertility is regarded as ‘male factor’ when an alteration in sperm concentration 
and/or motility and/or morphology is present in at least one sample of two sperm 
analyses, which comply with the World Health Organization (WHO) 1999 guidelines, 
collected between one to four weeks apart.”  
 “A male who do not have biological offspring and presents for reproductive 
evaluation is labeled as "primary infertility," and one who is incapable to 
impregnate his partner but already has biological children is defined as "secondary 
infertility"  
                        Table 3.2.1.Nomenclature related to semen quality 
49 
 
 
ANATOMY AND PHYSIOLOGY 
Reproductive organs 
3
 
The principal reproductive organs / gonads of the males are the testis, which produce 
sperm and as well secrete testosterone the male sex hormone. Prostate gland, seminal vesicles 
and bulbourethral glands are the accessory secretory glands which are involved in the 
secretion of seminal fluid.   
 
Spermatozoa 
3
  
Spermatozoa are formed in the seminiferous tubules of the testis. Seminiferous 
tubules have many germ cells - spermatogenic cells and majority are in various stage of 
division. The outer most layer of spermatogenesis is in contact with the membrane which 
Oligozoospermia Total number of sperm below 15 ×10
6 
million / ml  
Asthenozoospermia Percentage of PR (progressively motile) sperm below 32 ml 
Teratozoospermia Percentage of normal morphological sperm below 4%  
Aspermia No semen ( or retrograde ejaculation) 
Azoospermia No sperm in the ejaculate  
Cryptozoospermia Sperm absent in fresh preparations however observed in centrifuged pellet 
Haemospermia Presence of erythrocyte in ejaculate 
Leukospermia Presence of leukocyte in ejaculate beyond the threshold value 
Necrozoospermia Low percentage of live and high percentage of immotile sperm  
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surrounds each seminiferous tubule and these are termed as spermatogonia ( undifferentiated 
germ cells ) which divides mitotically and provides source of germ cells constantly. 
Spermatogonia that move about from the membrane will increase distinctly in size. These 
large cells are termed as primary spermatocyte which undergoes meiotic division and form 2 
secondary spermatocytes, which consecutively divide in to 2 spermatids. Spermatids 
ultimately transform into spermatozoa (sperm). Semen in general contains about hundred 
million sperms per milliliters, even if it takes one sperm only to fertilize an ovum. Length of 
the normal spermatozoa is about 50-70 μm. Head being oval shape with acrosomal cap which 
measures about 3 to 5 × 2 to 3 μm, a middle piece (short) and a thin long tail ( length which is 
about 45 μm ).  
 
Semen 
3
 
 
Semen is composed of fluids from the seminal vesicles, vas deferens, prostate gland 
and bulbourethral glands ( mucous glands ). Major bulk of the fluid is from seminal vesicle 
(60 %) which is last to ejaculate and also serves to wash the spermatozoa out of the 
ejaculatory duct and urethra. The protein concentration in seminal plasma is 35 to 55 mg/ml. 
 
Sperm Quality and Semen Quality 
50  
Sperms go throughout the ejaculatory ducts and mix with the fluids. Fructose secreted 
by the seminal vesicle is specially rich in semen and provide nutritonal energy to the 
spermatozoa. Seminal plasma is fundamental since it provides protective and nutritive 
environment for sperm to survive, mainly during the passage through the reproductive tract of 
female which direct to the fertilization. Most mammalian seminal plasma and sperm are 
greatly rich in zinc which is derived from the prostate. In addition to fructose, semen contains 
high level of Ca (calcium), Mg (magnesium), and Cu (copper) and they are bounded in ionic 
form.  
To take in to concern six main criteria (Sperm volume, concentration, vitality, 
motility, morphology, and pH) as defined by WHO (world health organization – 2010) in 
grouping a  semen into normal /  subnormal.  
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Table 3.2.2: Lower reference limits for normal semen (fifth centiles and 95% confidence 
intervals ) 
49 
 
Volume   1.5 ml 
Concentration  >39million sperms/ejaculate   
> 15 million/ ml of semen 
Vitality > 58 %   
Progressive motility  
Total motility  
> 32% 
> 40% 
Morphologically normal forms  > 4% 
pH  > 7.2 
Peroxidase positive leukocytes  (106/ mL) < 1.0 
MAR test (motile spermatozoa with bound particles < 50 % 
Immunobead test (motile spermatozoa with bound beads  < 50 % 
Zinc  > 2.4 (μmol per ejaculate) 
Fructose > 13 (μmol per ejaculate) 
Neutral glucosidase > 20 (mU per ejaculate) 
 
Endocrine Interplay 
18 
 
The complete and successful germ cell (male) growth depends on the balanced endocrine 
interaction of hypothalamus – pituitary - testis. Hypothalmus secretes gonadotropin releasing 
hormone (Gnrh) and bring forth the release of gonadotrophins FSH and LH from pituitary 
gland.  
 FSH bind with receptors present in sertoli cells and will stimulate spermatogenesis.  
 LH will stimulate the steroidogenesis ( testosterone production ) in leydig cells which 
will act on sertoli cells and peritubular cells in seminiferous tubules and will stimulate 
spermatogenesis. 
 Failure of pituitary in secreting FSH and LH may result in disturbance in testicle 
function which will lead to infertility.  
 Testosterone, inhibin and estradiol will control the gonadotrophins secretion through 
feedback mechanism.  
 
Primary hypogonadism is the disorder which directly affects the gonads. Secondary 
hypogonadism is due to defective secretion of pituitary gonadotropin. Testosterone, FSH and 
LH are the principal regulators of germ cell growth. Quantitative production of sperm 
generally needs the presence of these principal regulators. FSH directly acts on the 
seminiferous tubules while LH indirectly stimulate spermatogenesis via testosterone.  
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FSH acts a key role in the stimulation of meiotic and mitotic DNA production in 
spermatogonia. Androgen receptors are sited on sertoli cells and peritubular myoid cells. The 
signal has to be transduced by these cells, mainly in sertoli cells, since these receptors are not 
expressed on germ cells. 
 
Spermatogenesis 
50 
 
Spermatogenesis is exactly an organized development by which diploid cells transform 
into spermatozoa which take place inside the seminiferous tubules. Three distinctive phases 
may be divided in the development of spermatogenesis and they are  
 
 Profileration     - Increase in diploid spermatogonia;  
 Meiosis             -  Spermatocytes into haploid spermatids 
 Differentiation - Round haploid spermatids are differentiated into elongated sperm 
with mid piece and tail at final stage of spermiogenesis 
                         Table  3.2.3. Micronutrients function during Spermatogenesis 
50
  
 
 
                         Table 3.2.4. Functions of Vitamins during Spermatogenesis 
50
  
 
 
T
a
b 
 
 
Calcium  Its important in sperm motility, acrosomal reaction and metabolism   
Magnesium   Found in high concentration in the prostrate and is necessary for correct ejaculation 
Potassiumand 
sodium 
Have great role in acrosome reactions  
Zinc Involves in the ribonuclease activity and is highly active in the mitosis of 
spermatogonia and in meiosis of spermatocytes 
Selenium 
[Antioxidant] 
The high Selenium concentration in spermatogenesis is linked to its protective 
properties and to its related enzymes, like mitochondrial capsule protein in 
spermatozoa. If the Selenium content in seleno-proteins is low it likely decreases 
the chance of fertilization.  
Folate  Folate has the antioxidant property which possibly inhibit apoptosis that results 
after DNA oxidative damage  in spermatozoa 
Nickel Deficiency reduces the production of sperm in testis, count in epididymis and 
motility  
Manganese  Manganese is suggested as the stimulator of pubertal growth 
Vit B12 Involves in DNA and RNA synthesis and will promote healthy development of 
seminiferous tubule 
Vit B9 Promotes healthy spermatozoa and seminiferous tubule growth 
Vit A Differentiation of spermatogonia and in spermatid regulation 
Vit C Protects spermatozoa from the oxidative stress 
Vit E Improves the mitochondrial function 
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 3.2.5. Biomolecules in Sperm Function 
50, 51
 
 
Functions of Sertoli Cells and Leydig Cells 
50 
 
Sertoli cells, specifically nurse cell, lines the inner walls of the tubules and participate 
partially in the differentiation process and provide nutritional and structural support for 
developing germinative cells. Secretion of the sertoli cells facilitates the transportation of 
non-motile sperm from testis in to the efferent duct. Leydig cells (interstitial cells) are 
interspersed within the seminiferous tubule which is the main site of steriodogenesis that 
produce testosterone in testes and also play vital role in the maturation of sperm. 
 
Capacitation and Fertilization 
50 
 
Spermatozoa have to be activated priorly to obtain the competence to fertilize the 
oocyte and this process of activation is defined as capacitation. The eventual organization of 
capacitation is within sperm membrane. Glycocalyx the outer surface of the membrane 
undergoes various biochemical alterations.Preprogrammed cellular derepression takes place 
which hyperactivate the sperm. The alterations include modifications in lipid and protein 
composition. Oviduct the microenvironment provides higher levels of bicarbonate than the 
epididymis and permits sperm capacitation. The capacitation needs electrolytes, metabolic 
energy sources (Ca2+) and protein sources like BSA (bovine serum albumin). To achieve 
fertilization perfectly and efficiently, it is essential for sperm to be progressive motile and the 
membranes should be intact. 
 
 
 
Lipids                                     Maintains sperm maturity, viability, function and fertility  
Arginine 
 
Precursor in the production of spermine, spermidine, putrescine and necessary in 
sperm motility  
L-carnitine Progression of sperm development, maturation and the maintenance of the quality  
Tyrosine Scavanges free radicals and improve the motility   
Hyaluronan 
 
Its the main protein derivative found to be in reproductive fluids  and is involved in 
sperm motility and penetration   
HSP-A1/A2 & A3                                               Concerned in the management of sperm motility and in sperm-oocyte binding  
 MCP- CD46 It is the complement regulatory protein and have role  in protecting sperm from lysis 
in female reproductive tract and in interaction of sperm and oocyte  
Neurotrophins 
( group of protein)       
Plays role in the spermatogenesis and in the post- ejaculatory functions like motility, 
capacitation and acrosomal-exocytosis 
Cholesterol 
 
Secreted from the prostrate gland and is important in the protection of  the sperm 
membrane integrity from environmental shocks by the chemicals/pollutants  
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AETIOLOGY 
Y-chromosome micro-deletions 
51
  
Microdeletions in long arm of Y chromosome leads in to failure of spermatogenesis 
and ejaculation.Paternal lineage Y chromosome are related with low count and motility. 
Deletions of the regions that underline the heterochromatin in Y chromosome lead to the 
morphological abnormalities. 
 
Chromosomal abnormalities 
51 
 
Klinfelter’s Syndrome is the common genetic abnormality found to be in 5% to 10% 
oligozoospermia peoples and is associated with failure of testicle and low count. 
 
Anti-sperm antibodies (ASA) 
51
  
Anti-Sperm Antibodies are small proteins identified to deteriorate the fertility and 
semen quality through reducing acrosomal reaction, sperm motility, lysis of sperm, inhibiting 
the sperm penetration in to the cervical mucus and its capacitation. 
 
Hormonal Disruption and Hormonal Imbalance 
4
   
 
 Testicular dysgenesis syndrome (TDS) - Congenital derangement in seminiferous 
tubulule structure and its function inextricably associated to inappropriate 
concentration of hormones (sex) at various stages of the life cycle which leads to male 
infertility.  
 
 Testosterone deficiency will lead to the clinical condition hypogonadism. 
Abnormalities like reduced production of sperm and inhibition in the capability in 
fertilization take place in the male reproductive structure due to unbalanced action of 
the androgen during maturity.  
 
 Copious amount of the circulating estrogens will suppress spermatogenesis and will 
adversely have an effect on male fertility. 
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      Table  3.2.6.  Anatomical Abnormalities in male reproductive system 
4, 52
  
 
Cryptorchidism The testicles fails to descend into the scrotal sacs prior to 
birth.Abdominal testicles are not capable to maintain 
spermatogenesis since it needs the temperature less (2ºC)  than 
the normal temperature of human for maturation of the 
spermatozoa to be functional, viable and fertilizable. 
Varicocele Collection of unusually swelled, dilated spermatic veins which 
drains the testicle. It may arise on both the side and most 
frequently on the left side. Varicocele will lower sperm quantity 
and quality and even shrinkage of the  testicles. 
Congenital 
anomalies 
May be either rare with the localized defect in the vas deferens ( 
proximal part ) or with an complete abnormal growth 
Epispadias It is a congenital defect with abnormal curvature, shorter and 
wider size (penis) which will make the intercourse difficult. 
Anomalies of the 
seminal vesicles 
Abnormalities in number (fusion and agenesis), maturation ( 
hypoplasia ) and canalization ( cyst )  
Hypospadias Uro-genital birth defect with abnormal urethral opening and it’s 
the part of TDS which includes male infertility. 
 
Alcoholism, Smoking 
4 
 
Heavy and chronic alcohol toxication will have slow and progressive harmful impact. 
Will lead to moderate teratozoospermia which will be followed by the 
oligoasthenoteratospermia (OATS),  then severe cryptozoospermia and finally azoospermia.  
Smoking and the passive inhalation of cigarette smoking will reduce the spermatozoa count, 
morphology, motility, viability and fertilizing capacity by increasing the seminal-oxidative 
stress and DNA damage. Nicotine, the major constituent in smoke has the considerable 
impact on morphology and count. Burning up of more than twenty cigarettes per day showed 
elevation in seminal Cd (cadmium) level in smokers.  
 
Club Drug 
4 
 
MDMA (Ecasty), GHB (gamma-hydroxybutyrate), methamphetamine, ketamine, 
morphine, heroin, marijuana, rohypnol, caffeine, cocaine and poppers. These addictions are 
accountable for the deleterious effect on complete sperm structure. Chronic addiction to 
cocaine has deleterious impact on spermatogenesis and eventually fertility.  
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Lifestyle 
4, 53, 54
  
Decline in fertility with the age is related with a decrease in the testicular weight, 
spermatozoa production and level of testosterone. Obesity and overweight will end in 
hypogonadism, higher scrotal temperature, defective spermatogenesis, decline in sperm 
concentration and motility and increased DNA damage of sperm. Mild to severe 
psychological stress and psycho pharmacological agents will decrease the testosterone and 
probably disrupt the spermatogenesis.  
                                     
                                  Table 3.2.7. Pollution and Radiation 
4 
 
 
Diseases 
4
  
Mumps, sexually transmitted diseases, tuberculosis and febrile illness will cause 
temporary sperm decline. 
 
                                    Table 3.2.8.Antispermatogenic Plants 
4, 55
  
 
Infections 
3, 55, 56
  
Antisperm antibodies presence is regarded as the indicator of chronic infections. 
Chlamydia trachomatis is the general cause of prostatitis and epididymitis. E.coli in the 
semen lowers the motilty of the sperm. Candida albicans exert its inhibition in sperm 
motility. Ureaplasma urealyticum have a negative effect on male fertility. Mycoplasma 
hominis will cause sperm tail abnormalities. 
                               
 
 
Air pollution Reduces sperm motility. 
Textile dye Decrease the weight of the reproductive organ  
Pulp/paper-mill Reduces testis weight, count, motility and testosterone. 
Ozone (Oxidant) Reduce the sperm density by means of oxidative damage 
pathway. 
Radio-frequency electromagnetic  
waves (RF-EMW) 
Leads to oxidative stress in semen that negatively affects 
sperm and impairs fertility. 
Chemotherapies and radiation Utilized in the cancer treatment will severely affect sperm 
production  
Azadirachta indica Leaves are powerful spermicide 
Carica papaya Seeds affect cauda epididymis sperm motility, count and viability  
Momordica charantia Seeds have antisteroidogenic, antispermatogenicand androgenic properties 
Embelia ribes Spermicidal anti- androgenic activites. 
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                                    Table 3.2.9. Occupation and chemicals 
4, 55, 57, 58
  
 
 
                                       Table 3.2.10 Diet Factors 
4, 55
  
 
Gossypol 
 
The toxic residue in cotton seeds inhibits sperm function and being 
examined as male birth control pill. 
Estrogen and diethyl-
stilbestrol 
 
Broadly used in poultry, livestock and dairy industries.Increased 
exposure is responsible for prenatal testicular damage, post-natal 
testicular function depression and spermatogenesis.  
Soyabeans-(isoflavone-
phytoestrogens) 
Long term use willl have adverse effect on the growth and function of 
male reproductive system will result in decrease count and fertility   
 
Scrotal temperature 
55
  
Sperm needs temperature for about 3 to 4°C less than the normal temperature of the 
body for active production. This aspect is supported by the decrease sperm count in the 
pathologies like cryptorchidism, varicocele, patients constrained to wheel chair as in 
paralysis, drivers and in prolonged sauna exposure. 
 
     
Table 3.2.11 Therapeutic drugs 
4, 55
  
Lead workers Showed  decreased spermatozoa count and decreased motility 
Welders Exposed to chromium and will have reduced sperm quality. 
Exposure to copper Associated to oligo/terato/ astheno- zoospermia  
Professional drivers Impairment of spermatogenesis  
Pesticide/agricultural workers  1-2-dibromo-3-chloropropane and nematocide may affect 
spermatogenesis. 
Formaldehyde Leads to male sterility  
Boric acid Reproductive toxicant that reduces the testosterone  
Aluminium Reduces the weight of the reproductive organs and will impair 
fertility  
Ammonium metavanadate Toxic effect on reproduction  
Antineoplastic agents Chlorambucil cyclophosphamide, busulphan and methotrexate 
Drugs-Schizophrenia 
 
Phenothiazines like thioridazine and chlorpromazine causes  
hypospermatogenesis,  hyperprolactinaemia and impotence  
Anti-bacterial drugs 
 
                                            
 
Furacin and nitro furantoin significantly affect the spermatogenesis. 
Sulfasalazine causes oligozoospermia and reduced sperm motility  
Tetracycline derivatives will cause decrease sperm index 
Macrolide group – Neomycin, erythromycin and spiramycin affect fertility 
Penicillin group- Ampicillin, penicillin-G and dicloxacillin causes 
spermatogenic arrest.  
Aminoglycosides (gentamycin and neomycin) will alter the testicular 
functions.. 
Anti-malaria drugs 
 
 
 
Quinine, chloroquine and quinacrine will inhibit leydig cell and 
steroidogenesis. Chloroquine will reduce the sperm motility.  
Pyrimethamine (prophylactic drug) causes spermatogenic arrest.  
Quinine causes morphological change in the testis and will suppress the 
spermatogenesis. 
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Oxidative stress 
59, 60, 61
  
 Among various causes, oxidative stress (OS) has been attributed to have an effect on 
the fertility status and physiology of spermatozoa.  
 Many pathological conditions such as cryptorchidism, infections in the male 
reproductive tract, varicocele, exposure to drugs, environmental factors, aging and 
smoking have oxidative stress as a common component.  
 The time durability of spermatozoa in epididymis is longer in oligozoospermia which 
results in higher exposure to reactive oxygen species. 
 
Pathogenesis 
51,4,55,54,62
  
 
 Condensation of sperm chromatin may be changed by exposure to the OP 
(organophosphorus) with higher susceptibility to denaturation of DNA and will affect 
the reproductive system adversely through protein phosphorylation mechanism. 
 
 Klinefelter’s syndrome (47 XXY) is the common chromosomal disorder that affects 
the growth of the testicle. Chromosomal abnormalities may interrupt cell division and 
the sperm production. 
 
 Spermatogenic break-down will result due to Y chromosome (related to 
spermatogenesis) microdeletion. Genes required for the process of spermatogenesis 
are situated in azoospermia factor (AZF) region of Y chromosome. In azoosperimia 
deletion are related to the six azoospermia factor regions. In oligozoospermia 
deletions doesn’t takes place inside AZF region and it takes place outside the region 
of deletion. 
 
 Robertsonian translocations the major sex chromosomal aberration affects the 
structure and count in the semen and also several degrees of variation in the sperm. 
This take place when the two chromosome (acronetic) mingle together to form single 
High blood pressure  
monitoring drugs 
CCB (calcium channel blockers ) and CNS depressant drugs will suppress 
the spermatogenesis 
Drugs-Gastric 
problems 
Will interfere in the production sperm and ejaculation  
Chemotherapeutic 
agents 
Will causes oligozoospermia and even will lead to azoospermia 
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chromosome. This will result in the abnormal dicentric chromosome formation which 
will modulate the count, motility and morphology. 
 
 Reciprocal translocations are a mutual exchange of information between the two 
chromosomes. This leads to the unbalanced sperm and their morphology. This results 
in severe oligozoospermia and azoosperimia in males.  
 
 Mast cells release inflammatory mediators which directly inhibit sperm motility in 
potential reversible mode.  
 
 Excess sugar in the blood will affect the quality of sperms directly and will gradually 
cause male infertility. In chronic diabetes, autonomous nervous system function gets 
damage which will result in the problems related to ejaculation and erection. It will 
directly effect fertility by causing sperm DNA damage 
 
 Germ cell tumors will produce β-HCG (β–human chorionic gonadotropin) and AFP 
(α-fetoprotein). The increased β-HCG of the intra-testicular production of estradiol 
decreases/ inhibits spermatogenesis in contra-lateral testis and increased AFP will 
cause oligozoospermia 
 
 Mumps, TB (tuberculosis) and STD (sexually transmitted diseases) may affect 
production of sperm through inflammation and male genital tract obstruction.  
 
 Chlamydial infection may damage sperm parameters, acrosome reaction capacity and 
proportion of the DNA fragmentation, which will affect male fertility adversely.  
 
  ASA (anti sperm antibodies) will impair fertility and quality of semen through 
impairing acrosomal reaction, the complement cascade will be invoked which will 
result in sperm lysis, motility inhibition, inhibits sperm penetration and capacitation. 
Sperm antibodies will impede the reproductive function and depends on where the 
antibodies are found as well as where the corresponding antigen located on sperm 
surface  
 
33 
 
 Lead and cadmium are considered to decrease the gonadotrophin binding which 
diminish the hormone secretion and will reduce the quality of the semen. 
 
 Bisphenol A (BPA) the toxicant released in the environment in the period of 
industrialization affected the spermatogenesis by modifying the gene expression that 
is predient to the formation of sperm and also affects steroidogenesis by changing the 
effect of the epigenetic.  
 
 Estrogen, its derivatives and diethylstilbestrol (synthetic analogs)) are responsible for 
depression of spermatogenesis. Exogenous estrogens have impact on fetal growth  by 
inhibiting the sertoli cell development which will determine the life long capability 
for sperm production 
 
 Smoking has negative correlation with cadmium in the blood and density of sperm. 
Smokers show the presence of elevated estradiol in serum, more leucocytes in semen, 
low sperm density, higher DNA fragmentation in sperm and decrease sperm 
penetration. 
 
 Nicotine modifies the hypothalamic pituitary axis function which will affect the 
growth hormone, vasopressin, cortisol, oxytocin release then inhibits the luteinizing 
hormone and prolactin release which have negative impact on spermatogenesis.  
 
 The testis is extremely susceptible to ethanol since it crosses the blood testis barrier 
and will depress the spermatogenesis 
 
 Cocaine will induce injury in the testicle which could be associated to apoptosis and 
will involve the mitochondria-associated pathway or fasmediated pathway. Cocaine 
exposure will cuase the cytochrome release from mitochondria and following 
activation of caspase 9 and 3 in the testes and will play a important role in the cocaine 
induced germ cell loss or apoptosis in the testicle. 
 
 There will be  increase in the DFI (sperm DNA fragmentation index) with age 
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 In obesity SHBG (sex hormone binding globulin) will be decreased and free 
testosterone will be increased and results in the conversion of testosterone to estradiol 
in the adipose tissue. Decrease in the testosterone estradiol ratio will contribute to the 
spermatogenesis impairment. 
 
 HPA (hypothalamus-pituitary-adrenal) axis controls spermatogenesis and reported to 
be involved in stress which raises the cortisol hormone levels and which will result in 
the involution of the testicle followed by fall in the testosterone. Stress is related to 
enhance ROS generation  
 
Oxidative Stress as a common component of pathophysiological mechanisms 
47, 59
  
 
 Imbalance between the reactive oxygen species production and ability of the 
biological system to detoxify/repair the damage due to the reactive intermediates is 
known as oxidative stress.  
 
 The production of reactive oxygen species by sperm is the normal physiological 
process. The imbalance between this ROS production and the scavenging activity is 
unfavorable to the sperm and is related with male infertility. 
 
 The main source of production of ROS in semen is immature sperms and leukocytes. 
Spermatids and matured sperm are considered to be extremely sensitive to reactive 
oxygen species because sperm membranes are chiefly rich in the poly-unsaturated 
lipids.  
 
 Inhibition in spermatogenesis will lead to abnormal sperm and give way to more ROS 
and which may overpower and reduce the antioxidant defense mechanism and end in 
oxidative stress  
 
 Overload in free radical generation will frequently cause an error in the 
spermiogenesis which results in release of sperm from germinal epithelium with 
abnormal high level of the cytoplasmic retention: 
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 ROS alters the membrane integrity and will harm sperm morphology and motility and 
will lead in sperm death.  
 
 The concentration of the marker lipid peroxidation MDA (malondialdehyde) was 
found to be twice as high in spermtozoa pellet suspension in asthenozoospermic and 
oligoasthenozoospermic males.  
 
DIAGNOSIS 
Fertility History 
63
 
 Infertility duration  
 Childhood illness and problem in the development 
  Diabetes,cancer, respiratory infections and previous surgery 
 Sexually transmitted diseases  
 Exposure to toxins, chemicals and radiation 
 Medication history  
 Family history related to reproductive problem 
 
Developmental History 
64
  
 Cryptorchidism  
 Orchiopexy ( to treat cryptorchidism) 
 Testicular trauma or torsion  
 Pubertal development timing 
 Mumps  
 
Medical History 
64 
 
 Diabetes  
 Fever/viremia  
 Prostatitis or Pyospermia  
 Primary ciliary dyskinesia ( immotile cilia syndrome ) 
 Chronic upper respiratory infections ( affects sperm motility) 
 Hormonal abnormalities-Thyroid disorder, elevated estrogen and hyperprolactinemia  
 Urinary tract infections   
 Sexually transmitted disease  
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Past Surgical History and Cancer Treatments 
64
 
Retroperitoneal and pelvic surgery will impair ejaculation. Testicular cancer may be 
present with male infertility before or after the treatment. 50 percentage of testicular cancer 
will affect sperm density before chemotherapy. Chemotherapy in lymphoma, sarcoma and 
leukemia will cause permanent sterility after treatment. 
 
Physical examination 
63,  64, 65
  
Cremaster reflex 
Intact reflex indicates integrity of sensory and the motor nerves 
 
Inspecting the Pubis 
Hair will be more/less abundant. Triangular shape pattern with no vertical extension 
will indicate hormonal disorder. 
 
Inspecting the Penis  
 Size, symmetry, color and hair distribution. Skin lesion, excoriations, warts, abrasions 
and tumors.  
 Phlebitis - Tender/inflamed/nodular veins   
 Peyronie disease - Penile curvature in erection 
 Ulcer (Balanitis, granuloma inguinale, chancroid, herpes genitalis, primary syphlis or 
penile carcinoma).  
 Urethral meatus: Erythema, discharge, vesicles, plaques, pustules and intraurethral 
warts.  
 Urethritis or blockage in urethra (incontinence, dribbling) which will indicate urethral 
carcinoma or stricture. 
 Hypospadias  (incorrect position of urethral opening). 
 
Inspecting the Scrotum 
 Size and configuration 
 Fungal or bacterial infections and skin lesion.  
 Swollen area in the scrotum due to hernia in which peritoneum or portion of bowel 
will protrude into inguinal canal/scrotum which causes asymmetry. 
 Asymmetrical swelling may also be a sign of a varicocele, tumour and hydrocele 
 Scrotal thermography test to see the scrotal temperature 
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Palpating the Scrotal Contents 
 Srotum (each half) should be checked for the presence of testicle (large ovoid mass) 
 Epididymis (Ridge of tissue that lies vertically on postero-lateral surface of ovoid 
mass)  
 Spermatic cord (Firm, non-tender column of the blood vessel and tissue ascends 
through and leaves the scrotal sac near to the groin).  
 
Testicle 
 Examine for cryptorchidism  
 Examine for normal size - 2.5 to 5 cm, consistency, contour and tenderness.  
 Nodular, very firm, or tender testis indicate cancer .  
 Small and abnormal soft testis will indicate testicular atrophy or endocrine disorder  
 Testicle could be measured with orchidometer. Detrioration in spermatogenesis 
frequently accompanied with small volume testicle. Normal volume is 20 ml.  
 Smaller size and soft testis along with low sperm count strongly related with problem 
in sperm formation. Normal testis with low count may suggest probable obstruction.  
 
Epididymis   
 Acute epididymitis: Enlarged and tender epididymis when compared with the other 
side.  
 Epididymo orchitis: Testis and epididymis could not be distinguished from each 
other in palpation. They are very tender and scrotum is generally inflamed.  
 Chronic and painless induration of epididymis will indicate schistosomiasis 
(bilharzia), tuberculosis, or non-specific chronic epididymitis.  
 Cystic mass near to the upper pole of testis which are separated from the testis and 
epididymis are generally spermatoceles that contain milky, thin fluid and sperm 
Spermatic cord  
 Swollen region in the spermatic cord will be cystic ( hernia or hydrocele)  
 Solid ( rare connective tissue tumour or lipoma) 
 Filariasis- Diffuse swelling/ induration  
 Varicocele  
 Absence of vas deferens or Tuberculosis  
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The rectal examination 
 Warts, hemorrhoids, lesions, scars from trauma, mucous discharge and anal bleeding  
 Tenderness in the prostate will indicate acute or chronic prostatitis.  
 Prostate gland nodules ( Cancer or BPH ) 
 
Laboratory Tests   
 
Semen analysis 
49
  
 
Collection of semen for diagnostic or research purposes 
 The sample is supposed to be taken through masturbation and should be ejaculated 
into a wide mouthed, clean, glass or plastic container (non-toxic for sperm). 
 The container must be in ambient temperature of 20 °C - 37 °C 
 The container must be placed on the bench or incubator ( temp-37 °C) when the 
semen liquefies.  
 Incomplete sample especially the first which is rich in sperm will be missing. And in 
that case second sample must be taken, again after 2-7 days abstinence period. 
 
Liquefication 
At room temperature the sample will normally liquefies within 15 mts, though rarely 
it will take up to 60 mts or more. Normally liquefied sample will contain jelly like granules 
(i.e- gelatinous bodies) which will not liquefy but these do not show any clinical significance. 
Presence of the mucus strands will interfere with the semen analysis. 
 
Semen viscosity 
High viscosity will interfere with sperm motility, concentration, biochemical markers 
and detection of antibody coated sperm. 
 
Appearance of the ejaculate 
A normal semen after liquification will have homogeneous, grey and opalescent in 
appearance. It will be less opaque when the concentration of sperm is very low and also the 
colour will be different. In haemospermia the colour will be red-brown; and yellow colour in 
jaundice or taking certain drugs and certain vitamins. 
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Semen volume 
Semen volume is contributed principally by seminal vesicles and prostate gland and a 
small amount from bulbourethral glands/epididymides. Low volume is the feature of 
ejaculatory duct obstruction or congenital absence of vas deferens (bilateral), this is the 
condition in which seminal vesicles are developed poorly. Low volume may also be due to 
collection problem, retrograde ejaculation (partial) or androgen deficiency. High volume will 
be a sign of active exudation in active inflammation of accessory organs. 
 
Semen pH 
The pH exposes the balance between the values (pH) of different accessory gland 
secretions (alkaline seminal vesicular and acidic prostatic secretion). pH less below 7.0 with 
low semen volume and low sperm count will denote obstruction in the ejaculatory duct or 
congenital absence of vas deferens (bilateral), this is the condition in which seminal vesicles 
are developed poorly.  
 
Aggregation of spermatozoa 
The adherence of immotile sperms to each other or motile sperms to mucus strands or 
non sperm cell or debris  
 
Agglutination of spermatozoa 
Agglutination in particular refers to the motile sperms which stick to each other (head 
to head, tail to tail or mixed way). Agglutination implies the presence of anti sperm 
antibodies. Severe agglutination may affect the evaluation of sperm motility and sperm 
concentration. 
 
Sperm motility 
 Progressive motility (PR): Actively moving sperm, linearly or in large circle, and 
with regardless speed. 
 Non-progressive motility (NP): Other type of motility with absence in progression, 
e.g. flagellar force that hardly displacing the sperm head, or once a flagellar beat will 
be observed and swims in small circles. 
 Immotility (IM): No motility 
 Total motility: Progressive motility (PR) + Non-progressive motility (NP) 
40 
 
Sperm vitality 
It is clinically essential to identify whether immotile sperms are dead or alive. Vitality 
results must be evaluated with motility results. Presence of large percentage of vital but 
immotile sperm cells will indicate flagellum structure defect. High proportion of immotile / 
non viable sperm cells (necrozoospermia) will indicate epididymal pathology related sperm 
numbers. 
 
Sperm concentration 
 Sperm concentration: Number of sperms per unit volume of the semen  
 Total sperm number: Total number of sperms in the entire ejaculation  
 
The concept of normal spermatozoa 
Sperm consist of head ( with neck ) and tail ( with mid and principal piece). For a 
sperm to be referred normal, both the head and the tail should be normal.  
 
Classification of abnormal sperm morphology 
 Head defects: Large/small, pyriform, tapered, round, vacuolated, double heads, 
amorphous or any of this in combination. 
 Neck and midpiece defects: Insertion (asymmetrical) of midpiece into head, 
abnormal thin thick or irregular, sharp bent or any of these combination. 
 Principal piece defects: Mutiple, short, smooth hairpin bends, broken, sharply 
angulated bends, coiled , irregular width or any of this combinations. 
 
Cellular elements other than spermatozoa 
Epithelial cells from genito-urinary tract and leukocytes and immature germinative 
cells, and the latter two is together referred as round cells. Germ cells may comprise of round 
spermatids, spermatocytes, and rarely spermatogonia. Non sperm cells in ejaculation may 
indicate damage in the testicle (immature germ cells), efferent duct pathology (ciliary tufts) 
or accessory gland inflammation (leukocytes). Increased leukocytes (pyospermia, 
leukocytospermia) is related to infection and poor quality of sperm. Leukocytes may impair 
motility and DNA integrity by means of oxidative attack. 
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Test for antibody coating of spermatozoa 
49, 63
  
 Sperm antibodies may also be present without agglutination; likewise agglutination 
may be caused other than spermtozoa antibodies.  
 Anti-sperm antibodies belong to two immunoglobulin - IgA and IgG.  
 Blood test for antisperm antibodies may be carried out in man with reversed 
vasectomy and yet cannot impregnate the women or semen analysis showing 
clumping of sperms. ASA’s will also be developed after injury to testis or genital 
infection. The two recognized test to assess the presence of antisperm antibodies are: 
The Immunobead test and Sperm Mar test. 
Biochemical assays 
49  
 Secretory capacity of the prostate: Zinc, acid phosphatase and citric acid  
 Secretory capacity of the seminal vesicles: Fructose and prostaglandin 
 Secretory capacity of the epididymis:  L-Carnitine, neutral glucosidase and GPC  
 Low fructose is the feature of ejaculatory duct obstruction, partial retrograde 
ejaculation, congenital absence of vas deferens (bilateral) and androgen deficiency. 
Hormonal Levels 
63, 64  
 FSH, LH, testosterone, PRL and estradiol  (E2) 
 Hormone test are specified particularly when sperm concentration is below 10 million 
per milliliter. 
 Testosterone and FSH levels are generally assesed first. When level of testosterone is 
low then LH is measured.  
Other sperm function tests 
63
  
 Post-Ejaculatory Urine Sample: Urine sample is asessed to identify sperm 
following the ejaculation which will indicate retrograde ejaculation and also can be 
used to test infections. 
 Postcoital Test (Cervical mucus penetration test): To evaluate the effect of 
woman's cervical mucus to man's spermatozoa.  
 
Ultrasound 
63 
 
  To find out the testis size or to detect tumors, cysts, tumors, varicocele or abnormal 
blood flow  
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Genetic Testing 
63
  
  Tested in men with severe sperm deficient and with no obstruction. 
 
Testicular biopsy 
63, 64
 
 To distinguish between maturation arrest and obstruction. When mature sperms are 
identified in biopsy it can be cryopreserved for IVF/ICSI cycle. 
 Sertoli one syndrome (sperm producing cells in testis is found to be absent). 
Fertilization Tests 
63  
 
 The Hamster Test (Micro-penetration assay test): Sperm samples are used to 
fertilize the hamster eggs in which covering will be removed to allow sperm 
penetration. It is used to determine the best ART options for infertility men. 
 The Human Zona Penetration Test: The test makes use of spermtozoa to fertilize 
the dead human eggs, usually taken from the ovary. Results will give the same 
suggestion like hamster test  
 Acrosome Reaction Test: Induces the capability of the spermatozoa enzyme rich 
acrosome covering to dissolve  
 
Investigative Tests 
63
  
 Additional sophisticated lab test to measure the sperm function can also be carried 
out. They will assess the factors like level of cell damaging oxidants and computer aided 
sperm motility analysis.  
                                         Table  3.2.12  Differential Diagnosis  
64  
 
Oligozoospermia  
Defect in sperm count  
 
In count below 10 million /mL, FSH and testosterone should be 
assessed.  
In count below 5 million sperm per mL, karyotype or Y chromosome 
microdeletion test will be considered.  
Elevated FSH will signify primary testicular defect.  
Varicoceles are general cause of less sperm density. 
Asthenozoospermia  
Defect in sperm motility 
Varicocele and antisperm antibodies will be the cause for this defect. 
Teratozoospermia 
Defect  in sperm morphology 
The major cases are idiopathic.Varicoceles and temperature influence 
to spermatogenesis is also potential cause. 
Azoospermia 
Lack in sperm production 
 
Non-obstructive azoospermia indicates lack in sperm production 
Obstructive azoospermia indicates failure in delivering the sperm to 
ejaculate, due to ductal obstruction.  
The information on size of testis and presence of vas deferens 
indicates the diagnosis. CBAVD (Congenital bilateral absence of the 
vas deferens) an obstructive azoospermia will be diagnosed through 
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physical examination.  
MultipleSemenAbnormalities  
Oligoasthenoteratozoospermia 
The defect in sperm count, 
motility and morphology  
 
Most general cause is varicocele. Additional causes include 
environmental toxins, medications and cryptorchidism. In extreme 
cases (< 1 millionsperms/mL) there is increased occurrence of 
obstruction of male genital tract or genetic abnormalities. 
Defects in Isolated Semen  
Parameters  
(Aspermia) 
No seminal fluids 
May be due to retrograde ejaculation. Common causes include 
neurogenic abnormalities (spinal cord injury), multiple sclerosis, 
diabetes and use of α-blockers. Retroperitoneal surgery which includes 
the pelvic surgery and retroperitoneal lymph node dissection, may also 
cause impaired ejaculation.  
 
TREATMENT 
 
Antioxidants  
4, 55, 66  
 
 Antioxidants like vitamin C and E, lycopene, β-carotene, zinc, folic acid, selenium, 
lactoferrin, papaya and lipophilic diet will improve sperm parameters.  
 Carnitine (water-soluble antioxidant) obtained from human diet will protect DNA of 
sperm from free radical damage and apoptosis and will provide primary fuel for its 
motility. 
 Polyunsaturated fatty acid, chiefly omega-3 fatty acids-docosahexanoic acid may be 
the most important sperm membrane fluidity determinant. 
 CoQ10 and vitamin E were observed to be effective in Oligozoospermia.   
 
Hormone therapy 
63  
 
 In hypogonadism and gonadotropin deficiency GnRH (Gonadotropin-releasing 
hormone) will be useful. GnRH may also be helpful in restoring the sperm production 
following to chemotherapy treatment. 
 Sperm production rarely respond to the low doses of testosterone; estrogen and 
testosterone; clomiphene citrate (Clomid); menotropins (Repronal, Pergonal), human 
follicle-stimulating hormone (Gonal-F, r-hFSH) and human chorionic gonadotropin 
(hCG). 
 An enzyme, aromatase inhibitors block aromatase, is the main source of estrogen 
which present in various main body tissues. They are letrozole. (Femara) and 
anastrozole (Arimidex) whih will be helpful in male infertility related to unusual 
testosterone-to-estrogen ratios. 
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Nonhormonal Agents 
63 
 
 Bromocriptine – Parlodel is given in male infertility related with excess prolactin 
harmone. 
 Infections that affect male fertility will be treated with the antibiotics.  
 Men with less count will be treated with antihistamines which will block mast cells. 
  
Treatment for Antisperm antibodies 
63
  
 IUI (intrauterine inseminations) to avoid the cervical mucus or IVF (In Vitro 
Fertilization) in any case of antibody type.  
 Antisperm antibodies can be treated with steroids.  
 
Surgical Procedures 
63 
 
 Ejaculatory duct obstruction may be treated by scraping or excising the part where 
prostate gland  enclose the urethra and through reconstructing the duct.  
 Undescended testicles (in young boy) will be repositioned through surgery to prevent 
later on infertility.  
                         Table 3.2.13: Assisted Reproductive Technologies 
67, 68
 
 
 
 
Artificial/Assisted 
Insemination    
Sperm by concentrating before insemination or by sperm donation is 
introduced in to the uterus.  
Used to treat male infertility with weak sperm, low count or total 
testicular failure to produce sperm 
In vitro fertilization  (IVF)   Fertilization takes place outside the body. Used in when fallopian tubes 
of the women is blocked or man producing  too little sperms.Women are 
treated with the drugs that will cause to produce multiple eggs from the 
ovaries and once matured, eggs will be removed. Eggs are put in to the 
dish in a lab along sperm for fertilization. Later than 3-5 days, healthy 
embryos will be implanted in to the uterus.  
Zygote intrafallopian 
transfer (ZIFT) or Tubal 
Embryo 
Transfer is alike to IVF. Fertilization takes place in the lab. Very young 
embryo will be transferred in to the fallopian tube.  
Gamete intrafallopian 
transfer (GIFT) 
Transferring of sperm and eggs in to the fallopian tube. Fertilization 
takes place inside the woman's body.  
Intracytoplasmic sperm 
injection (ICSI)   
Used in men with serious sperm problems or older couples or in failed 
IVF efforts.A single sperm will be injected in to the matured egg. After 
that the embryo will be transferred to uterus/fallopian tube 
Donation of Gamete and 
Embryo   
In assisted insemination or IVF or its variants, the issue of egg, sperm or 
embryo donation becomes applicable. Sperm, eggs and embryos may be 
frozened through cryopreservation and these will be thawed later and 
will be offered for use to anybody who needs them, predominantly 
women or men with diminished egg/sperm. 
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Lifestyle Changes 
63  
 Smoking should be avoided 
 Overweight men can make an effort to reduce weight 
 Should take adequate rest; regular and moderate exercise  
 Stress reduction techniques will develop fertility  
 Tight underwear cause no hazard to fertility, however there will be no harm in looser 
clothing 
 Avoid hot showers and steam rooms to prevent over heating to testis 
 
Preventive measures 
3
  
 Sex education 
 Public health and hygiene  
 Control of STD (sexually transmitted diseases) 
 Rectification of nutritional deficiencies  
 Early on treatment for abnormal conditions 
 Prevention of the damage from chemical, trauma,.heat and x-ray exposure  
 Cotton seed oil, hydrogenated oils, saturated fats, trans-fatty acids, palm and coconut 
oil should be avoided.  
 
3.3. DRUG REVIEW 
 
Table 3.3.1: Traditional uses of the constituents of CKC as referred in Siddha literature  
Botanical & Mineral name         Parts                                                       Action & Uses 
Tribulus terrestris                        Fruit                                   Thathu sheena rothi
69
, Spermatorhoea
17
      
                                                                                                   Aphrodisiac
70
, Testosterone booster
71
 
                                                                                                       Impotency, Increases the semen
72
 
 
Curculigo orchioides                  Rhizome                                      Thatu pushti
69
, Bogum kuriaivu
73
 
                                                                                                   Aphrodisiac 
69, 40, 74 
Sexual debility 
70
 
                                                                                                                                        Impotency 
75
 
 
Mucuna prurita                           Seed                                 Nocturnal emission 
69 
Thathu viruthi 
69, 75
 
                                                                                                              Male virility, Spermatorrhoea,  
                                                                                  Male sexual Dysfunction, Hyperprolactinemia
70
 
                                                                                                                                  Aphrodisiac 
40, 74
              
 
Madhuca longifolia                      Flower                                                                     Aphrodisiac 
69
 
 
Cinnamomum tamala                   Leaf                                                             Thathunashtam 
69, 40, 74
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Cinnamomum verum                    Stem bark                                Thatunashtam 
69, 40, 74 
Aphrodisiac 
40
 
                                                                                                                                 Aanmai peruki
76
 
 
Syzygium aromaticum                  Flower bud                               Shena vinthu 
69 
Sukilanashtam 
40, 74
              
                                                                                                                                    Aphrodisiac 
72
 
 
Maerua arenaria                           Root tuber                                                          Thathu viruthi 
69
 
 
Coscinium fenestratum                  Stem bark                                           Tonic effects 
40 
Astringent 
69
 
 
Moringa oleifera                           Seed                              Neerthu pona vinthu 
40 
Veneral disease 
77
 
                                                                                         Premature ejaculation
69 
Vinthu thadipu 
69
 
74
 
                                                                                                                                    Aphrodisiac 
72
 
 
Mesua ferrea                                 Flower                                        Vinthu nashtam
74
Aphrodisiac 
75
 
                                                                                                          Male gonorrhoea 
69  
Impotency
71
 
   
Lawsonia inermis                          Seed                                              Vaginal discharge, Menorrhgia,                                                                                                
                                                                                                                                   Leucorrhoea 
78
 
 
Bombax ceiba                               Gum                               Sukilam balapadum 
40
Spermatorrhoea 
77
 
                                                                                                    Aphrodisiac 
69 
Vinthu undakum
79
 
                                                                                                                      Semen in suspension
17
 
Vitis vinifera                                 Dried fruit                                 Immunostimulant,Anti oxidant,   
                                                                                                    Aphrodisiac 
80 
Enriches blood 
79
 
                                                                                                    Anmai kuraivu 
73  
Sukila viruthi 
69
 
 
Bambusa aurundinaceae              Salt                                                                    Aphrodisiac 
69 40 77
 
 
Ilicium verum                               Fruits                                        Anmai kuraivu 
73
Thathu viruthi 
74
 
 
Phoenix dactilifera                          Unripe fruit                                      Inferility 
80 
Aphrodisiac 
69
 
40
 
80
 
                                                                                                                       Impotence, Diabetes 
69
 
 
Cyperus rotundus                         Rhizome                                     Aphrodisiac 
71 72 
Thathu viruthi 
69
 
 
Costus speciosus                           Root                                   Thatunashtam 
40 74
  Veeriya nashtam 
69
 
                                                                                                                           Aphrodisiac 
69
 
71 72 80
 
                                                                                              
Cuminum cyminum                         Fruit                                               Cooling effect 
72 
Aphrodisiac 
80
 
 
Myristica fragrans                        Seed                                         Vinthu nashtam 
69 
Vinthu kuraivu,   
                                                                                                 Aphrodisiac 
69
 
40
 
76
, Spermatorrhoea 
77
 
                                                                                                         Thatu nashtam 
69
 
74
 Impotency 
72
 
 
Glycyrrhiza glabra                        Root                              Thathu sheena rothi 
69 
Thatunattam 
69
 
40
 
74
 
                                                                                                                                    Aphrodisiac 
79
 
 
Asphaltum punjabinum                Parpam                                Inthriya nashtam 
74 
Spermatorrhoea 
81
 
                                                                                               Infertility, Bioenhancer, Aphrodisiac 
82
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Research studies done on the ingredients of CKC  
 
1. Tribulus terrestris Linn  ( Zygophyllaceae) 
 
Synonyms:  Tamil- Nerunjil; Sanskrit-Trikanta,Gokshura; Eng- Puncture Vine 
70
 
Habit and Habitat: Annual small herb which grows to the height of 10-60cm. It has 
carpel fruits with stellate appearance.
83
 
Traditional uses: Male reproductive disorders
84
 premature ejaculation, 
spermatorrhoea
85
 Infertility 
86
 oligospermia (thathu sheena rothi), testosterone booster, 
increases the semen, impotence and aphrodisiac action [ Table 3.3.1].  
Chemical Constituents:  There are three groups of active phytochemicals in Tribulus 
terrestris - 1) Dioscin: Increases sexual energy and free testosterone level 2) Sterols: 
Facilitates meiosis process during the spermatogenesis. Protects the prostate from 
swelling 3) Steroidal saponins: Effects on immune system .
87, 88
  
Research works  
 Reported to be effective in treating anti-sperm antibodies. 88 
 Clinical studies for 3 months with the treatment of Tribulus terrestris had showed 
improvement in sperm count and motility and in erectile dysfunction (ED). 
8 
 The active chemical PTN (protodioscin) a steroidal glycoside given in treating 
hypogonadism patients for 30 to 90 days had enhanced the testosterone and LH level. 
89 
 Exposure to Cd (cadmium) will have an effect on hypothalamus-pituitary-testicular 
axis, and will decrease FSH, LH and testosterone. Tribulus terrestris due to the 
antioxidant effect and metal chelating effect had protective effect on testis against 
cadmium induced testicular damage in experimental rats.
84
  
 Extraxt of the Tribulus terrestris promotes the production of testosterone and will 
build up the muscle mass and helps in the growth of male characters. Increases the 
production of red cells and the blood circulation. 
90
 
 Rabbits that received protodioscin had proerectile activity. 83  
 Tribulus terrestris reported to have aphrodisiac activity in sexually sluggish aged 
males. 
91
  
 Tribulus terrestris for eight weeks in Sprague dawley rats had increased ICP 
(intracavernous pressures) and sexual activity. Furostanol (glycoside fraction) of 
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Tribulus terrestris at 5, 10, 25 mg/kg dose in castrated rats for 14 days increased the 
sexual stimulation. 
92
 
 Lyphophilized powder (100 mg/kg) in male albino rats had showed anabolic effect 
and showed increase in the body and reproductive organs weight without any toxicity. 
93 
2. Curculigo orchioides Gaertn  ( Amaryllidecae)  
Synonyms: Tamil- Nilapanai kizhangu; Sanskrit-Taalmuuli; Eng- Golden eye grass 
70
 
Habit and Habitat: Small herb with short, stout and elongated tuberous root with 10 
cm long. Distributed in Nepal, India, China, Australia, Japan and Malaysia. 
94
 
Traditional uses: Venereal diseases 
95
 male infertility, spermatorrhoea 
96 
sexual 
debility (bogum kuriaivu), seminal strenght (thatu pushti), impotency and aphrodisiac 
action [ Table 3.3.1 ]. Even wild beer eat few days before sexual intercourse 
75 
Chemical Constituents: Glucosides: curculigoside - A, B, C and D, Cycloartane –
saponins: curculigosaponin- G and I, Phenolic glucosides: orchiosides - A and B, 
Phenolic glycoside orcinosides - A, B  and C 
97 
Research works 
 .Ethanolic extract of Curculigo orchioides (100 mg/Kg b.wt) in rats showed increased 
number of spermatocytes and spermatids. 
98
  
 The lyophilized aqueous extract of Curculigo orchioides (200 mg/kg b.wt) had 
showed progression in sexual activity. 
99 
 
 The aqueous extract of Curculigo orchioides ameliorates sexual dysfunction in rats 
against the streptozotocin induced hyperglycemic stress. 
100
  
 The aqueous extract of Curculigo orchioides ameliorates decreased spermatogeneis 
and heat shocked protein formation in rats and had protected reproductive organs 
from the heat induced sexual dysfunction. 
94 
 
  Curculigo orchioides relaxes corpora cavernosa smooth muscles in order that more 
blood will be pumped into and will help to overcome the erectile impotence. 
96
 
 Ethanolic extract of Curculigo orchioides comprises of androgen and adaptive 
effect.
96 
 Antioxidant and immunostimulant activities are reported. 98 
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3. Mucuna prurita hook (Leguminoceae ) 
 
Synonyms: Tamil- Poonaikkaali; Sanskrit-Kanduraa, Adhigandhaa; Eng- Cowhage 
70 
Habits and habitat: Climbing, annual shrub by means of long vines which reach 
above 15 m in length, seen in India, Caribbean and Africa. Contact with seed pod and 
young foliage produce severe itchiness.
101
 
Traditional uses: Impotency, male reproductive disorders, 
102
 in hyperprolactinemia, 
101 
male fertility and vitality 
103,104
  male virility, spermatorrhoea, sexual dysfunction, 
increase the sperm (thathu viruthi), nocturnal emission and aphrodisiac action [ Table 
3.3.1 ].  
Chemical Constituent: Mucunine mucunadine, mucunadinine and prurienidine. 
Copper, manganese, magnesium, iron and zinc.
105
 
Research works:   
 Seed powder and the extract of Mucuna pruriens reported to have fighting effect 
against the stress mediated compromise in spermatogenesis.
106
 
 Mucuna pruriens have positive effect in  improving spermatogenic loss and provide it 
as treatment of choice for extracting quality sperm to be used in IVF procedures.
106
 
 Improves sperm formation by restoration of endocrine axis and the testicular 
homeostasis which leads to improve the semen quality. 
106
 
 Reported to have anti-diabetic, anti oxidant and adaptogenic activity. 106  
 Treatment with Mucuna pruriens in male infertile groups showed increase in sperm 
count and motility. 
107
 
 Ethanolic extract of Mucuna pruriens  (dose of 150, 200, 250 mg/kg p.o) reported 
significant increase in sexual activity in wistar rats. 
108
  
 Improves the antioxidant defence system and protects the sperm damage in ageing.75 
 Mucuna pruriens corrects the fructose content in semen of the infertile males. 75  
 
4. Madhuca longifolia Linn  ( Sapotaceae) 
Synonyms: Tamil- Iluppai; Sanskrit- Gudapushpa, Madhusrav; Eng- South Indian 
Mahua 
70
 
Habits and Habitat: Large evergreen tree. Grown in India, Srilanka and Nepal.
109
 
Creamy white flowers consist of many stamens, with hairy ovary and long style.
110 
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Traditional uses: Blood purifier, given in low count 
111 
to increase seminal fluids 
109
 
aphrodisiac action [Table 3.3.1]. Flowers which are dried is used in alcohol 
production which will  preserve the drugs. 
112
 
Chemical Constituents:  Tannins, flavones, mallotus-AB, chalcones, srottlerin, 
isorottlerin, new oleanene,cardenolide, gum, volatile oil, saponins, triterpenoid and 
alkaloids.
113 
Consists of iron, arginine, calcium, phosphorus, potassium, sodium and 
magnesium.
114
 Facilitate the extraction of the active components from herbs and helps 
in the absorbation of  active components from gastrointestinal tract. 
112
 
Research works 
Antioxidant activity 
113
 and anti- bacterial action 
114 
 
5. Cinnamomum tamala Nees & Eberm ( Lauraceae ) 
Synonyms: Tamil- Lavangappattiri, Sanskrit- Tamaalpatra, Tejapatra, Eng-Indian 
Cassia.
70
  
Habit and Habitat: Tree is generally distributed in South America, Asia, India, 
Australia and Pacific region. Single tree normaly produces 10 to 25 kg dry leaves.
115
 
Traditional uses: Astringent, stimulant, diabetes and cardiac disorder
115
 low vitality 
116 
Oligozoospermia (thathunashtam) [ Table 3.3.1 ]. 
Chemical Constituents: Eugenol (chief constituent), cinnamaldehyde, spathulenol, 
methyleugenol, viridiflorene and aromadenendrene. 
115
 
Research work 
Anti-hyperglycemic
117
 immuno-modulatory 
118
 antioxidant and anti hyperlipidemic 
activities.
115
 
 
6. Cinnamomum verum Persl  ( Lauraceae) 
Synonyms: Tamil- Elavangappattai; Sanskrit- Daarusitaa, Varaanga; Eng- Cinnamon 
and Ceylon Cinnamon.
70 
Habit and Habitat: Native to Srilanka and South India. Cinnamon is the dried out 
inner-bark of the tree. 
119  
Traditional uses: Aphrodisiac (aanmai peruki), Oligozoospermia (thatunashtam) [ 
Table 3.3.1 ].  
Chemical Constituents: Cinnamaldehyde and eugenol. 
120 
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Research work 
 Cinnamon bark extract demonstrated significant increase in the sperm count and 
motility and weight of the reproductive organ. 
121
 
 Antioxidant activity 119 
 
7. Syzygium aromaticum (Linn.), Eberm ( Myrtaceae )  
Synonyms:  Tamil- Lavangam, Kiraambu; Sanskrit- Lavanga, Eng- Clove 
70
 
Habit and Habitat: Evergreen tree grows up to the height of 10 to 20 m. Native to 
Indonesia, India, Mauritius, Zanzibar and Ceylon. 
122  
Traditional uses: Oligozoospermia (shena vinthu, sukilanashtam), aphrodisiac action 
[ Table 3.3.1 ] prevent premature ejaculation.  
Chemical constituents: Eugenol, Eugenin, eugenol acetate, caryophyllene, triterpene, 
apigenin, tannins, quercetin, benzaldehyde and kaempferol. Minerals present are 
selenium, iron, manganes, potassium and magnesium. 
123,124
  
Research work  
 Hexane extract (15 mg/kg p.o) of the flower buds at low dose increased the 
testosterone level. 
125 
 Hydro alcoholic extract (50%) of the clove in mice demonstrated aphrodisiac activity. 
124
 
 
8. Maerua arenaria Hook. f. & Th. ( Capparidaceae ) 
Synonyms: Tamil- Bhumichakkarai; Sanskrit- Madhusravaa, Piluparni; Eng- Earth 
sugar root. 
70
 
Habit and Habitat: Woody twine straggler grows in the South Indian dry forest. 
Outer stele region of the roots are known to show peripheral vascular bundles. 
126
  
Traditional uses: Sterility
127
 increases sperm (thathu viruthi) [Table 3.3.1] and 
aphrodisiac action. 
128
 
Chemical Constituents: Phytosterols, saponins, alkaloids, amino acids, 
carbohydrates, glycosides 
126
 and lupine triterpenoid – 12 
Research work:  
Antipyretic activity 
130
 and aqueous extract (800mg/kg p.o) of Maerua arenaria 
exhibited significant reduction in glucose level. 
131 
 
 
52 
 
9. Coscinium fenestratum Gaertn  ( Menispermaceae ) 
Synonyms: Tamil- Maramanjal; Sanskrit- Harichandana; Eng- False Calumba
70 
Habit and Habitat: Tree Turmeric is broadly grown in Africa, Asia, Indochina, India 
and Sri Lanka 
132
 
Traditional uses: Tonic, astringent [Table 3.3.1] diabetes mellitus
133 
and anemia 
134
  
 
Chemical Constituents: Berberine (major active component) 
66
 sitosterol, ceryl 
alcohol, saponin, hentriacontane, oleic acid and palmitic acid 
133
 
Research work 
Alcoholic extract exhibits considerable increase in the hepatic antioxidant enzymes 
that protects the cells against the free radical damage and in normal and diabetic rats 
showed significant decrease in blood glucose level.
132 
 
 
10. Moringa oleifera Lam (  Moringaceae ) 
Synonyms: Tamil- Murungai; Sanskrit- Shigru; Eng- Drumstick, Horseradish
70
 
Habit and Habitat: Perennial, short and slender tree which grows to the height of 10 
m.Broadly distributed in sub-himalayan ranges, Africa, Arabia, Sri Lanka and 
Madagascar. Brown, triangular and pendulous pods splits in length-wise to three parts 
when it is dried. Contains twenty seeds which are dark brown and contains three 
papery wings. 
135
  
Traditional uses: Venereal disease, low viscous semen (neerthu pona vinthu), high 
viscous semen (vinthu thadipu) aphrodisiac, premature ejaculation [Table 3.3.1].  
Chemical Constituents: Methionine and cysteine and methionine (similar to human 
and cow’s milk and eggs of chicken) 136. Oil from the seeds is commercially familiar 
as ben oil, related to olive oil which contains stearic, palmetic, oleic acids and behmic 
135 
Moringinine and the alkaloids demonstrates the effect of the seeds. 
137  
 
Research work 
 Aqueous extract of Moringa oleifera ( 100, 200 and 500 mg/kg)  improve sexual 
behaviour in rats  (male) and increases the sperm count [138]. 
 Antitumour activity 136 and anti-pyretic activity 137 
  
11. Mesua ferrea Linn ( Guttifereae ) 
 Synonyms: Tamil- Sirunagappo; Sanskrit- Naagakeshara, Naagapushpa, Eng- Iron 
wood. 
70 
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Habit and Habitat: Indigenous to SriLanka and also found to be cultivated in 
Malaya, India, Peninsula, southern Nepal and Indochina 
139
.  Flowers  consist of white 
petals and has a center with many yellow clour stamens.
140 
 
Traditional uses: Oligozoospermia (vinthu nashtam), impotency, male gonorrhoea 
and aphrodisiac action [Table 3.3.1]. 
Chemical Constituents: Mesugin, Mesuferron, Mammeisin, Mesuanic acid, and 
Sitosterol. 
141
 
Research work  
            Anti-cancer activity 
142 
and ethanolic extract demonstrated antioxidant activity 
139
 
 
12. Lawsonia inermis Linn  ( Lythraceae ) 
Synonyms: Tamil- Maruthani, Sanskrit- Madayanti; Eng-Henna 
70
 
Habit and Habitat: Herbaceous and biennial shrub with greyish brown bark colour. 
Native to North Africa and south west Asia. Older trees have spine tip. Many, smooth 
and pyramidal seeds are.present. Brown seed coat which is thick and hard.
143
 
Traditional uses: Henna signifies fertility. Seeds are given in liver disorder and 
dysentery 
143
 vaginal discharge, menorrhagia and leucorrhoea [Table 3.3.1]. 
Chemical Constituents: Proteins, carbohydrates, fibers, fatty oils- behenic acid, 
stearic acid, oleic acid, palmitic acid, arachidic acid and linoleic acid. 
143 
Research work 
 Ethanol extract of the powdered seeds failed to prove antifertility activity 143 
 CNS depressant activity 144 
 
13. Bombax ceiba Linn ( Bombaceae ) 
Synonyms: Tamil- Ielavampisin; Sanskrit- Mocharas, Eng- white silk cotton tree 
70 
 
Habit and Habitat: Broadly spread in Indian forest to the height of nearly 1500 
m.Light brown gum is like the galls and will slowly change in to opaque dark brown 
colour. 
145
 
Traditional uses: Known to be called as sukila bandhini since it keeps semen in 
suspension state.
2
 Gives strength to semen (sukilam balapadum), spermatorrhoea, 
increases sperm (vinthu undakum), aphrodisiac [ Table 3.3.1 ] impotency, sterility, 
and nocturnal emission 
146 
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Chemical Constituents: Tannic acid, gallic, D-galacturonic acid, D-glactose, 
aldobiuronic acid, L-arabinose
145 
naphthoquinones, naphthol, anthocyanins, 
polysaccharides, lupeol and shamimin 
146
 
Research work 
Anti cancer, aphrodisiac, antioxidant, anti-HIV, antimicrobial activity and 
hypoglycemic 
146 
 
14. Vitis vinifera Linn Eberm ( Vitaceae ) 
Synonyms: Tamil- Draksha; Sanskrit- Draakshaa, Kishmish; Eng- Wine Grape 
70 
 
Habit and Habitat: Native to southern Europe and western Asia and cultivated all 
over India. 
147, 148
  
Traditional uses: Increases sperm (sukila viruthi), sexual debility (anmai kuraivu), 
enriches blood, aphrodisiac, immunostimulant [ Table 3.3.1 ] stress, antidiabetes and 
cardiovascular diseases 
149
 
Chemical Constituents: Flavonoids, polyphenols, procyanidins, resveratrol, 
anthocyanins, proanthocyanidins. 
149
 
Research work:  
Anti-microbial activity, Antioxidant 
149
 adaptogenic and immunomodulatory activity 
148
  
 
15. Bambusa aurundinaceae willd  ( Poaceae ) 
Synonyms: Tamil- Bamboo-manna, Moongiluppu, Sanskrit- Vanshalochana, 
Tvakkshiri; Eng- Spiny or Thorny Bamboo 
70
 
Habit and Habitat: Spread in India excluding Himalaya and indo-gangetic plain. The 
internal stalk of the female plant consists of silicious- bluish white colour concretion 
called as tabashir 
150
. Medicinal salt 
17 
Traditional uses: Aphrodisiac, stimulant and cooling effect 
17 
Chemical Constituents: Ninety percentage of silica, peroxide of iron, potash, 
alumina, urease, lime, cholin, vegetable matter and cyanogenetic glycoside 
150 
 
16. Ilicium verum Hook.f. ( Magnoliaceae ) 
Synonyms: Tamil- Anasippo, Takkola; Eng- Star Anise 
70
 
Habit and Habitat: Tree (medium size) which give aggregate and capsule fruit. 
Fruits are star shaped and radiating to 5-10 boat formed sections with shiny brown 
55 
 
seeds which has high oil content. Before ripening fruits should be picked and should 
be dried. Spreaded in Asia, China and native to Vietnam.
151 
 
Traditional uses: Increases sperm, thathu viruthi and impotency (aanmai kuraivu) [ 
Table 3.3.1 ]. 
Chemical Constituents: Anethole (major active compound), tannins, limone, α-
pinene, β-phellandrene, farnesol, α-terpineol and safrol 151 
Research work  
            Antioxidant effect 
151
 and androgenic effect 
152 
 
 
17. Phoenix dactilifera Linn ( Arecaceae ) 
Synonyms: Tamil- Perichchankay; Sanskrit- Kharjuuraka; Eng- Date palm 
70
 
Habit and Habitat: Main food in North and the Middle-East Africa, native to the 
Gulf countries.
153 
One-seeded berry fruits with epicarp that enclose the fleshy-
mesocarp. Seed is enclosed by the hard-endocarp. 
154
 
Traditional uses: Infertility, impotence, diabetes and aphrodisiac action [Table 
3.3.1]. Act against alcohol toxicity  
153 
 
Chemical Constituents: Iron, zinc, selenium, copper, calcium, cobalt, magnesium, 
fluorine, manganese, phosphorus, potassium, sodium, boron and sulfur.
155 
Flavonoid 
and the estradiols that has  positive effect on sperm quality. 
156
 
Research work 
 Activate  cellular immune system in the mice 157 
 Aqueous and the methanolic extract showed stimulatory effect on the tissue of the 
bone marrow for haemopoietic activities 
158 
 
 Aqueous extracts showed  antioxidant activity 159 
 Aqueous extract of the dates ameliorates atrazine testiculo-toxicity effect and 
improved the sperm parameters and the testicular oxidative enzymes. 
153
  
 
18. Cyperus rotundus Linn ( Cyperaceae ) 
Synonyms: Tamil- Koraikkizhangu; Sanskrit- Mustaka; Eng- Nut Grass 
70
  
Habit and Habitat: Common perennial herb similar to grass normally grows to 7 to 
40 cm in tall. Rhizomes at first are white, fleshy with scaly leaves and later turn into 
dark brown, wiry and fibrous. Indigenous to India. 
160
  
Traditional uses: Spermatorrhoea
161
 increases sperm (thathu viruthi) and aphrodisiac 
action [ Table 3.3.1 ].  
56 
 
Chemical Constituents: Flavonoids, polyphenols, ascorbic acid, sesquiterpene, 
cyperenone, cyperene, cyperol, mustakone, copadiene, rhamnopyranoside and 
kobusone 
162 
Research work:  
 Aqueous extract exhibited maximum preventive effect against testicular damage 
(400mg/kg).
16 
  Antioxidant, antimicrobial and antidiabetic activity 162 
19. Costus speciosus (Koen.) Sm. ( Costaceae ) 
Synonyms: Tamil- Ven Kottam, Sanskrit- Kembuka, Kebuka, Eng- wild Ginger 
70
  
Habit and Habitat: Erect plant which grows to the height of 2.7 m and has tuberous 
root stock. Indigenous to Malay Peninsula of the Southeast-Asia. 
164
  
Traditional uses: Given in aphrodisiac, thatunashtam, veeriya nashtam 
(Oligospermia) [ Table 3.3.1 ] spermatorrhoea
165 
 
Chemical Constituents: Costunolide, flavonoids, eremanthin, phenol, ascorbic acid, 
β-carotene, glutathione and α-tecopherol. Diosegenin the precursor in steroidal 
hormone synthesis and hence attained value in drug industry. Costunolide and 
eremanthin 
166,167,168 
Research work 
 Normal glycemic effect  in streptozotocin-stimulated diabetic rats 168  
 Antistress activity 164 
 
20. Cuminum cyminum Linn  ( Apiaceae ) 
Synonyms: Tamil- Cheerakam; Sanskrit- Ajaaji; Eng- Cumin 
70
  
Habit and Habitat: Small, tender, annual plant, grows to the height up to 30-cm. 
Originated in Mediterranean region, Egypt, Syria and grows broadly in Iran and also 
in Turkey. Commonly mentioned in bible, mostly by Isaiah and Mathew. Yellow- 
brownish grey fruit (cumin seed) and contains nine protuberances. 
169
 
Traditional uses: Infertility, testicle swelling 
134 
sexual stimulant 
169
 aphrodisiac and 
cooling effect [Table 3.3.1].  
Chemical Constituents: It consists of cuminol, cymene, carvone, terpene and 
cuminaldehyde. 
170 
 
 
 
57 
 
Research work 
 Cuminum cyminum (0.25 g/kg p.o) to alloxan induced diabetic-rats for 6 weeks 
exhibited decrease in blood-glucose level and increase in the haemoglobin level.
171 
 
 Antistress and Antioxidant activity. 172  
 
21. Myristica fragrans Houtt  ( Myristicaceae ) 
Synonyms: Tamil- Jaathikkai; Sanskrit- Jaatishasya, Jaatiphala; Eng- Mace, Nutmeg 
70
 
Habit and Habitat: Evergreen bushy tree which grows to the height of 10–20 m.  
Distributed in Indonesia, India and Srilanka. Dried out kernel of the broad-ovoid 
shaped seeds. 
122
 
Traditional uses: Spermatorrhoea, Oligozoospermia (thatu nashtam, vinthu kuraivu, 
vinthu nasham), impotency, aphrodisiac [Table 3.3.1] and raises the blood circulation. 
122
 
Chemical Constituents: Myristicin, lignan and eugenol (demonstraed to maintain the 
antioxidant level). 
173
 
Research work:  
 Ethanolic extracts (50%) of nutmeg in mice improved the sexual activity in mice 
significantly. 
122
 
 Seed extract decreases the deleterious radiation effect on testis. 173 
 
22. Glycyrrhiza glabra Linn (Leguminoceae) 
Synonyms: Tamil- Athimathuram; Sanskrit- Madhurasaa, Atirasaa; Eng- Liquorice
70  
Habit and Habitat: Indigenous to Asia and the Mediterranean region. Consist of 
fibrous and soft, bright- yellow tap root. 
174 
 
Traditional uses: Sexual debility
175
enlarged prostate
176
erectile dysfunction 
177
 male 
infertility
178
 anemia (a plastic) 
179
spermatorrhoea 
134
 Oligozoospermia (thathu sheena 
rothi, thatunashtam) and aphrodisiac [Table 3.3.1].  
Chemical Constituents: Glycyrrhizin, glabrolide, glabrin A&B, isoglabrolide, 
glycyrrhizinic acid, glycyrrhetol, triterpene sterols, triterpenoids, saponin, coumarins 
and isoflavones.
180 
  
Research works 
 Aqueous root extract demonstrated immunomodulatory activity. 179 
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  Extract showed radio-protective activity, antidepressant effect 181 and antioxidant 
activity. 
182
  
 Inhibits the growth and also spread of the androgen-refractory cancer of prostate. 182 
 The extract showed aphrodisiac activity (150, 300 mg/kg p.o -28 days) in rats. 93 
 
23. Asphaltum punjabinum  
Synonyms:  Tamil- Kalmatam, Uerangyum; Sanskrit- Shilajit, Silaras; Eng- Bitumen, 
Mineral pitch 
70
  
Habit and habitat: Himalayan rock exudation in India, also in Nepal, Bhutan, Tibet 
and China. Gomutra Shilajit (Iron-shilajith) blackish-brown in colour is qualified as 
the best. 
183
 
Traditional uses: Natural mineral rasayana and enhances the bioavailability of the 
herbs in the body. 
183
 Have effect on reproductive and the nervous tissues. Has 
specific action on endocrine system. Given in treating infertility 
184
 thyroid disease 
185 
Oligozoospermia (inthriya nashtam), sexual weakness, spermatorrhoea [Table 3.3.1] 
genitourinary diseases and anaemia.
186
 
Chemical constituents: Shilajit-humus consists of organic- 60 to 80%; mineral-20 to 
40%;  trace  element- 5% ( Fe, Zn,Ca, Mg, Cu, Mn, P, Mo ).
187,188, 
hippuric acids, 
gums, traces of resin, fatty acids and albuminoids.
184
 Proceed as synergistic enhancer 
when added with other drugs. Organic substance transports minerals to their target 
cell. 
189
 Urinous odour is due to the presnce of benzoates and benzoic acid (main 
active principles ) and activity of shilajit is due to the presence of fulvic acid and 
humic acid (primary active components).
190
 Fulvic acid (carrier molecule) transports 
nutrients in-to deeper tissues and also removes toxins. Fulvic acid facilitate the 
absorption of iron and helps in its bioavailability to bone marrow-stem cells to 
produce blood. 
185 
Research works 
 Spermatogenic activity is proved in rats and serum testosterone was higher in male 
rats treated with Shilajit. 
11 
 The semen quality is enhanced due to the inclusion of Shilajit (processed) components 
into semen of the oligozoospermic patients. 
11
  
 Immunomodulator activity 189 and antioxidant activity. 186 
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24. Adhatoda vasica Nees ( Acanthaceae ) 
Synonyms: Tamil- Aadaathodai; Sanskrit- Vaasaka; Eng- Malabar nut 
70 
 
Habit and Habitat: Herbaceous bush (sub), indigenous to India and grows in the 
open plains, generally in lower Himalayan ranges. Grows up to 1300 m beyond the 
sea level. Distributed in Punjab, Assam, Bengal, Ceylon, Singapore and Malaysia. 
Small capsule fruits with four seeds. 
191,192
   
Traditional uses: Fruits posess the main potential of the herb. 
192
  
Chemical constituents: Alkaloids (in defatted seeds) – vasicinol, vasicine and 
vasicinone 
134
 
Research works 
Ethanolic extract of the leaf (800 mg/kg p.o) for 15 days showed significant radio 
protective effect on radiation induced-chromosomal damaged cells of bone marrow in 
rats. 
193 
 
 
25. Alternanthera sessilis Linn ( Amaranthaceae ) 
Synonyms: Tamil- Ponnonkanni keerai; Sanskrit- Matsyaakshi; Eng- Sessile joy 
weed 
70 
 
Habit and Habitat: America, India and Africa. Seed is ovate, orbicular, inverted and 
compressed. 
194
 
Traditional uses: Shoot with added drugs restore virility.
98
 Roots treat 
spermatorrhoea. 
195 
 
Biochemical constituents: Seed oil – Myristic, ricinoleic, oleic, palmitic, linoleic 
acid and stearic. 
196 
Research work 
            The genus claim immunomodulator effect 
19
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4. Plan of Work           
                                         
 
                                             
                                                
 
 
 
 
 
 
 
 
 
 
 
RESEARCH 
METHODOLOGY 
PRECLINICAL 
 
 
Standardisation of the study drug 
     Identification and authentication of the ingredients 
Pharmacognostical study of the selected plant materials 
Preparation of the study drug 
Analytical studies 
Thermo gravimetric analysis (TGA)  
ICP-OES elemental analysis 
 
 
 
 
 
 
Animal studies 
Toxicity study (Safety) WHO guidelines -   Acute toxicity  
                                                                       Long term toxicity 
Pharmacological study ( Efficacy) - Spermatogenic activity 
 
  
CLINICAL 
Pilot study  (6 
months) 
Main study (1 year) 
To assess the sperm and 
harmone parameters 
To asess the clinical safety 
parameters 
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5. METHODOLOGY  
 
5.1 Materials and Methods -  Pre Clinical 
          
      Table 5.1.1: The ingredients, anatomical parts used and their quantities in CKC 
 
S.No                          Ingredients Part used Quantity 
  1 Nerunjil   (Tribulus terrestris Linn) Fruit 35gms 
  2 Nilapanai  (Curculigo orchioide Gaertn) Rhizome 35gms 
  3 Murungai (Moringa oleifera Lam) Seed 35gms 
  4 Poonaikaali (Mucuna prurita Hook) Seed 35gms 
  5 Iluppai poo (Madhuca longifolia Linn) Flower 35gms 
  6 Bhumi chakkarai (Maerua arenaria Hook) Root tuber 35gms 
  7 Seerakam (Cuminum cyminum Linn) Fruit 35gms 
  8 Lavangabathiri (Cinnamomum tamala Nees) Leaf 35gms 
  9 Lavangapattai (Cinnamomum verum Presl) Stem Bark 35gms 
 10 Kirambu (Syzygiumaromaticum Linn) Flower bud 35gms 
 11 Elavampisin (Bombax ceiba Linn) Gum 35gms 
 12 Drakshai (Vitis vinifera Linn) Fruit 35gms 
 13 Koshtam (Costus speciosus Koen) Root 35gms 
 14 Athimathuram (Glycyrrhiza glabra Linn) Root 35gms 
 15 Sirunagappo (Mesua ferrea Linn) Flower 35gms 
 16 Perichankai (Phoenix dactilifera Linn) Unripe fruit 35gms 
 17 Moongil uppu (Bambusaaurundinaceae Willd) Salt 35gms 
 18 Jaathikkai (Myristica fragrans Houtt) Seed 35gms 
 19 Korai kizhangu (Cyperus rotundus Linn) Rhizome 35gms 
 20 Takkolam (Ilicium verum Hook) Flower 35gms 
 21 Maramanjal (Coscinium fenestratum Gaertn) Stem bark 17.5gms 
 22  Aadaathoda (Adhatoda vasica Nees) Seed 35gms 
 23 Maruthani (Lawsonia inermis Linn) Seed 35gms 
 24 Ponnakani (Alternanthera sessilis Linn) Seed 35gms 
 25 Gomutra silasathu (Asphaltum punjabinum) Fine-ash 35gms 
                        
 Table 5.1.2: Raw Drugs Procurement 
 
           Drugs                               Drug procurement 
Adhatoda vasica  
 
Alternanthera sessilis  
 
Asphaltum punjabinum 
 
Other herbal drugs 
Research Institute for Indian System of Medicine, Himachal Pradesh, India 
   
National Institute of Siddha, Tamilnadu, India 
 
SKM- Tamil Nadu, India 
 
Govindhasamy chetty store, Tamilnadu, India 
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Identification and Authentication of Raw Drugs 
Adhatoda vasica seeds were procured from the Research Institute for Indian System 
of Medicine, Joginder Nagar, Mandi, Himachal Pradesh, India. Alternanthera sessilis seeds 
were collected from the herbal garden, National Institute of Siddha, Chennai, India. Other 
herbal drugs were procured from Govindhasamy chetty store, Chennai, India. Gomutra 
silasathu (mineral drug) was procured from SKM, Tamil Nadu,India. Drugs were identified, 
authenticated and voucher specimen (NIS/MB/59/2012) was deposited in the Department of 
Medicinal Botany, National Institute of Siddha, Chennai. 
 
         Table 5.1.3: Analytical studies conducted - Institutes and Laboratory 
 
     Studies conducted         Samples         Institutes and Laboratory 
Pharmacognostical study   Adhatoda vasica  
Alternantherasessilis  
 PARC - Plant anatomy research 
centre, Tamilnadu,  India 
Phyto chemical analysis  
 
 
Physico chemical anlaysis 
 
 
Chromatographic studies ( 
TLC/HPTLC ) 
Adhatoda vasica seeds 
Chandrakanthi chooranam 
 
Adhatoda vasica seeds 
Chandrakanthi chooranam 
Silasathu Parpam 
 
Adhatoda vasica seeds 
Chandrakanthi chooranam 
 
 
 
CCRS [Siddha Central Research 
Institute ], Tamilnadu, India 
ICP OES analysis 
 
 
Microbial contamination 
Specific-pathogens 
Aflatoxin  
Pesticide residue  
 
Particle size analysis 
Chandrakanthi chooranam 
Silasathu Parpam 
 
 
Chandrakanthi chooranam 
 
 
 
Silasathu Parpam 
 
 
 
Sargam Laboratory, Tamilnadu, India. 
TGA analysis 
 
CHN analysis 
Chandrakanthi chooranam 
 
Silasathu Parpam 
Department of Chemistry, Indian 
Institute of Technology, Chennai, 
India 
 
Pharmacognostical study 
In literature survey no pharmacognostical studies have been carried out on the seeds 
of Adhatoda vasica Nees, and Alternanthera sessilis Linn, hence the study was undertaken 
for the establishment of proper identification and authentication of the seeds. 
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Seed Analysis - Macroscopic and microscopic  
The analysis was carried out for Adhatoda vasica Nees and Alternanthera sessilis 
Linn seeds. Seeds were fixed in FAA solution (5ml of Formalin + 5ml of Acetic acid + 90 ml 
of 70% ethyl alcohol) for 24 hrs. After that the samples were dehydrated through graded 
series of the  tertiary - butyl alcohol
.197
 Infiltration of the samples were carried out by the 
slow addition of paraffin wax (58-60
°
C-melting point) till the TBA-solution reach super 
saturation.The samples were cast in to the paraffin blocks. 
 
Sectioning 
The paraffin fixed samples were fragmented with the help of Rotary Microtome. The 
sections thickness was 10 to 12 µm. De-waxing of the fragmentations were by customary 
procedure. 
198 
The fragments were stained by toluidine-blue since because it is a 
polychromatic-stain. 
199
 The results (staining) were really good and a few cytochemical-
reactions were also found. The dye showed pink (cellulose walls), blue (lignified cells), dark 
green (suberin), violet (mucilage) and blue (protein bodies) colour. Wherever essential 
fragments were also stained with IKI (starch), fast green and safranin. 
 
Photo-micrographs 
Microscopic explanation of the tissues is enhanced with micrographs where ever 
required. Photographs with various magnifications were captured with the help of Nikon lab 
photo 2 -microscopic units. For regular examinations bright field was employed. For crystal 
study, lignified cells and starch grains polarized light was applied. Since these constitutions 
contain birefringent property, they emerge brighter against the dark background when viewed 
through a polarized light. Figure enlargement is specified by scale-bars.
200
 
 
Chemical  ( Phyto / physico ) analysis 
Chemical analysis were carried out in Adhatoda vasica seeds by the procedures 
refered in the standard literature. 
201, 202, 203
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Purification process of the herbal and mineral ingredients 
204,40,82,25
   
Primarily all the drugs were purified as per the procedures mentioned in Siddha 
literature. Glycyrrhiza glabra, Coscinium fenestratum, Cyperus rotundus and Maerua 
arenaria were washed in water, outer skin were peeled off and then dried in the sunlight. 
Seeds present in Phoenix dactilifera and Myristica fragrans were removed, outer portion 
were dried in sunlight and used.Curculigo orchioides was dried, powdered and then par 
boiled in milk for 1 samam [3hours], then dried under sunlight and then powdered. Impurities 
of Costus speciosus, Cuminum cyminum, Mesua ferrea, Bombax ceiba, Cinnamomum verum, 
Cinnamomum tamala, Ilicium verum, Syzygium aromaticum, Bambusa aurundinaceae 
Madhuca longifolia, Tribulus terrestris, Vitis vinifera, Moringa oleifera, Adhatoda vasica, 
Mucuna prurita, Lawsonia inermis and Alternanthera sessilis were removed and dried in 
sunlight. Gomutra silasathu was mixed with the cow’s urine and then filtered with a thick 
cloth. And then dried in the sunlight.Layer was formed on the filtrate ( fig 5.1.2A) which was 
then removed and dried up. This method was repeated until no more layer was formed (7 
times).  
 
Preparation of Gomutra Silasathu parpam 
25 
Gomutra Silasathu parpam ( one among the 25 ingredients of CKC ) was prepared as 
per the method demonstrated in the Siddha literature
.. 
35gms [1 palam] of the silasathu 
(purified) was soaked in pulitha arisi kazhuviya neer (fermented rice water) for three days. 
Fresh fermented rice water was used for each days. On the 4
th
 day, the drug was put on the 
mortar to triturate with the pulitha kazhuneer for twelve hours (4 samam). Pellets were 
prepared (fig 5.1.2 B) and dried. Following drying, the pellets were placed in between two 
earthen pots, positioned one above the other. The earthen pots were sealed with cloth (cotton) 
smeared by fuller’s earth and dried in the sun light. Pellets were then put in to oxidation 
process (Pudam) with twenty five cow-dung cakes. After ignition, it was permitted to quench 
itself. The finishing products were taken out, pulverized and then stored in air tight 
containers. 
 
Preparation of the study drug Chandrakanthi Chooranam
 25
 
All the purified herbal ingredients and silasathu parpam was together powdered and 
shifted in to a 100 size mesh. Chooranam was par boiled with milk (final purification 
process)  then finally dried and stored.
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Drug storage 
The trial drug was stored in clean and dry wide mouthed bottle. It was kept in room 
temperature and protected from sunlight. 
 
Analytical studies  
Gomutra silasathu parpam  
Analytical studies of Gomutra silasathu parpam was carried out to ensure that the 
parpam added in the study drug CKC is of standard quality. 
 
Siddha specification for parpam 
205
 
Siddha specifications for parpam was analyzed through parameters specified in the 
standard siddha manuscript. It was observed for luster in the daylight, since lustre should not 
be present as per siddha text. Parpam was rubbed between the thumb and the index finger and 
it must enter in to the lines of fingers. Parpam was sprinkled over still water which was taken 
in the beaker and it must float on water surface. Little quantity was kept on the tongue and it 
must be tasteless. 
 
Physico-chemical parameters 
Loss on drying (at 105°C), Ash values (total ash; water soluble ash; acid insoluble 
ash), pH and the particle size were examined by standard methods. 
203 
 
 
ICP-OES Analysis 
206 
  
Nutritional elements like Potassium; Calcium; Magnesium; Iron ; Sodium; 
Manganese; Zinc; Copper; Nickel; Selenium; Tellurium; Cadmium were studied. 
 
Particle size 
The particle size for Gomutra silasathu parpam was analyzed out in 3 sieve sizes  (150 
micron, 75 micron and 45 micron) 
207 
 
CHN Analysis 
 CHN analysis was examined in a PE 2400 series II- CHNSO analyzer; Perkin Elmer; 
USA. 
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   Table 5.1.4: Chromatographical study ( HPTLC and TLC ) 
 
HPTLC/TLC  Methods Chandrakanthi chooranam Adhatoda vasica seeds 
Extract preparation 4 gms of the drug was taken and 
soaked in chloroform in the night. 
Then boiled in a water bath for 
about 10 mts which is then filtered 
and then concentrated to 10-ml. 
4 gm of the drug was initialy refluxed 
with 100-ml hexane, after that it was 
filtered to eliminate the fatty 
materials. Process should be repeated 
with an additional hexane (100ml). 
Then the filtrate was soaked during 
the night in the chloroform. Then 
boiled in a water bath for about 10 mts 
which is then  filtered and then 
concentrated to 10-ml. 
Solvent system 
 
Toluene: Ethyl-acetate - 5:0.5; v/v 
showed good separation  
Toluene: Ethyl-acetate - 10:1.5; v/v 
showed good resolution  
The appropriate solvent system was attained by the trial and error method. 
This sovent was employed in developing extract on TLC-plate. 
Volume of the extract 
     (Chloroform) 
7, 10  and 12 µl 5, 10  and 15 µl    
                                                           Visualizing reagent 
The reagent vanillin sulphuric acid was selected as the visualizing reagent (1gm of vanillin was added in 
the ethanol: sulphuric acid mixture in the ratio of 95:5) because it gives the colour for most of the 
secondary metabolites categories. 
                                                               Instrument 
To develop the TLC plate CAMAG- twin chamber was used. Applicator Linomat IV- CAMAG; Muttenz; 
Switzerland: was used for the extract application. Aluminium plate was precoated through silica gel - 
60F254 which is of 0.2 mm in thickness (Merck) and it was used for TLC plate. Bands width as of 8 and 6 
mm of distance in between the tracks were used on the plate (6 x10 cm).  For finger print study scanner 
CAMAG TLC - 030618 which is attached with the WINCATS- software were employed under UV-254 
and 366 nm and then after the derivatization at 540 nm. For photo documentation CAMAG-visualizer was 
applied at UV 254 nm; 366 nm and in the visible lights following to the dipping in the reagent vanillin-
sulphuric acid which is then followed with heating in the air circulated oven until the formation of the 
coloured spots. 
                                                                 Procedure 
With the help of the applicator (Linomat IV) the cholroform extract was then applied on TLC plate in the 
volume of 7, 10 and 12 µl as 8 mm bands by 6 mm space in between the tracks and then developed in the 
above stated solvent method. This developed plate (TLC) was dried in the air and then photographs were 
captured under the UV-254 and 366 nm. Plate was then scanned using the scanner under the UV- 254 nm 
and UV-366 nm. Finger print was documented.  Plate was then dipped in the reagent of vanillin-sulphuric 
acid, which is heated in the oven at the degree of 105°C until the formation of the coloured spots. 
Photograph was captured immediately and then scanned for finger printing profile at 540nm.  
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Chandrakanthi chooranam 
 
Organoleptic characters  
 
          Figure 5.1.4: Organoleptic character study in Chandrakanthi chooranam 
    
 
 
Preliminary Phytochemical Test 
 
The test was studied out as per standard methods mentioned in the literature
. 201, 202
  
                                    
                                    
                                   Table 5.1.5: Phytochemical study method  
 
Phytochemical Test                                 Method Colourof appearance 
     Protein  
 ( Biuret test ) 
Sample solution was taken in the test tube and 
sodium hydroxide solution is added to it. Little 
drops of very dilute copper II –sulphate (1%) 
solution was then mixed gently.   
 
      Purple colour  
 
Steroids  
(Lieberman 
Burchard Test) 
 
In a dry test tube, to the extract (few mg) 
chloroform (2ml) was added. Then acetic acid 
(few drops) was added, heated and then acetic 
anhydride (few drops) and concentrated 
sulphuric acid (2 drops) were added.  
 
      Green colour 
Flavonoids  
(Shinoda test) 
 
Substance was made to dissolve in alcohol and 
added to bits of magnesium and conc- 
hydrochloric acid and then heated over a water 
bath. 
 
     Magenta colour 
Triterpenoids  
(Noller’s Test)  
To the few mg of the extract, tin and thionyl 
chloride was added and heated in water bath.  
      Purple colour 
      Phenol 
 
5 % alcoholic ferric chloride was added to the 
substance in water 
Dark blue/Green colour 
Colour 
Taste Consitency 
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    Tannin 
 
Sample substance is shaken with the water and 
then added with lead acetate solution.  
     White precipitate  
Test for Alkaloids 
(Dragendorff’s Test)  
 
Few mg of extract in separate test tube was 
warmed with 2% Sulphuric acid for 2 minutes. 
And it was filtered in separate test tube and few 
drops of Dragendorff’s reagent were added.   
Orange-red precipitate  
 
    Glycosides  
 
Sample substance is added with anthrone and 
conc- sulphuric acid and then heated in a water 
bath.  
      Green colour 
Cardiac glycoside  
(Keller-Killani Test) 
To the extract glacial acetic acid (2ml) 
containing a drop of ferric chloride solution was 
added and then 0.5 ml of conc-sulphuric acid was 
added.  
Blue colour in the acetic 
acid layer  
Reducing sugar  
(Fehling’s Test) 
Fehling’s reagent was added to the sample 
solution.  
Brick red precipitate 
or coloration 
    Saponin 
 
To the extract (few mg) distilled water is added 
and then shaken well.  
Formation of foam 
 
Physico-chemical parameters 
 
Loss on drying (at 105°C), Ash values (total ash; water soluble ash; acid insoluble 
ash), water soluble and alcohol soluble extractive; pH and the particle size were carried out as 
per standard guidelines
 203,208
  
 
                                Table 5.1.6: Physico- chemical study method 
  
 
Parameters Apparatus/ Chemicals                 Procedure            Calculation 
 
Loss on drying 
  at 105°C   
( Percentage ) 
 
1] Analytical balance 
range, 0 to 210 g 
2]  Air circulated oven 
3]  Beaker – 100 ml 
4 g of accurately weighed 
drug was dried at 105º for 5 
hours and weighed. The 
process of drying and 
weighing at 1 hr period until 
the difference between two 
succeeding weights 
corresponding to not more 
than 0.25 per cent was 
continued. Constant weight 
was attained when two 
succeeding weighings after 
drying for 30 mts and cooling 
for 30 mts in a desiccator. 
Showed not more than 0.01 g 
in difference. 
 
 
 
 
      Sample wt losss x 100                          
        Wt of the sample  
 
Total ash 
( Percentage )  
1] Analytical balance 
range 0 to 210 g 
2] Muffle furnace 
3]   Water bath  
4]   Silica dish 
5]   Desiccator 
2-3 g accurately weighed, 
ground drug in a preweighed 
silica dish was incinerated. 
The percentage of ash with 
reference to the air dried drug 
was calculated 
    
      Wt of ash x 100 
     Wt of the sample  
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Water soluble     
      Ash 
( Percentage ) 
1]Analytical balance, 
range 0 to 210 g 
2]  Muffle furnace 
3]  Silica dish 
4]Whatman 41 filter paper 
5]  Distilled water 
 
Ash obtained from the above 
test was boiled in 25 ml of 
distilled water for few mts. 
One more time the process 
was repeated. This insoluble 
matter was filtered on an 
ashless filter paper and 
ignited in a silica crucible to 
constant weight. The 
percentage of water soluble 
ash with reference to the air 
dried drug was calculated 
 
Total ash(wt -water insoluble 
residue(wt) x 100 
    Wt of the sample 
 
 
   
Acid insoluble    
       Ash 
( Percentage ) 
1] Analytical balance, 
range 0 to 210 g 
2] Muffle furnace 
3] Silica dish 
4] Hydrochloric acid AR 
5] Distilled water. 
 
Ash obtained from the 
previous test was boiled in 25 
ml of dilute hydrochloric acid 
for 5mts. Insoluble matter 
was filtered on an ashless 
filter paper, washed with hot 
water and ignited in a silica 
crucible to constant weight. 
The percentage of acid-
insoluble ash with reference 
to the air dried drug was 
calculated 
 
 
Acid-insoluble residue (wt) x 
100 
Wt of the sample 
 
Water-soluble 
extractive 
( Percentage ) 
1] Analytical balance: 
range 0 to 210 g,  
2] Water bath 
3] Air oven 
4] Glass stoppered flask  
5] Distilled water(100 ml) 
6] Pipette – 25 ml 
7] Beaker – 100 ml 
 
5 g of the air dried drug 
(coarsely powdered) was 
macerated with 100 ml of the 
distilled water in a closed 
flask for 24 hours, shaking 
often for 6 hrs and allowing 
to stand for 18 hrs. It was 
filtered quickly, taking 
precautions against loss of the 
solvent. 25 ml of the filtrate 
was evaporated in a tared flat 
bottomed shallow dish, and 
dried at 105º, to constant 
weight and weighed. The 
percentage of alcohol-soluble 
extractive with reference to 
the air-dried drug was 
calculated. 
 
 
 
 
Wt of the extractx100x  
100 
25 x wt of the sample 
 
 
Alcohol soluble 
extractive 
1] Analytical balance, 
range 0 to 210g 
2] Water bath 
3] Air oven 
4] Beaker – 100 ml  
5] Glass stoppered flask  
6] Pipette – 25 ml 
7] Distilled alcohol     
        (100ml) 
 
 
5 g of the air dried drug 
(coarsely powdered) was 
macerated with 100 ml of 
alcohol of the specified 
strength in a closed flask for 
24 hrs, shaking often  for 6hrs 
and allowing to stand for 18 
hrs. It was filtered quickly, 
taking precautions against 
loss of solvent. 25 ml of the 
filtrate was evaporated in a 
tared flat bottomed shallow 
 
 
Wt of the extract x 100 x 100 
25 x weight of the sample 
taken 
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dish and dried at 105º, to 
constant weight and 
weighed.The percentage of 
alcohol-soluble extractive 
with reference to the air-dried 
drug was calculated. 
Alkalinity 1] Conical flasks 
2]Whatman 41 filter paper 
3]  Distilled water  
4]Graduated-pipette10 ml 
5]0.1N Hydrochloric acid 
6]Phenolphthalein 
   indicator 
Few drops of phenolphthalein 
indicator were added to the 
filtrate collected from water 
soluble ash analysis. Titrated 
against 0.1 N Hydrochloric 
acid. End point was the 
disappearance of pink colour. 
Report the alkalinity per gram 
of the sample (ml of 0.1N 
HCl/g of the sample). 
 
   
 
 
ICP-OES Analysis 
206  
 
Heavy metals ( mercury, lead, arsenic and cadmium ) and nutritional elements that 
supports spermatogenesis ( Iron, calcium, magnesium, copper, zinc and selenium & zinc ) 
were studied as stated by the standard guidelines. 0.5 g of the study drug ( CKC ) was 
accurately weighed and taken in a 250 ml beaker. 15 ml of conc nitric acid and per-chloric 
acid mixture (taken in the ratio 2:1) and microwave was digested to get the clear solution. 
Then the solution was filtered in a filter paper (Whatmann No.41)  into a standard flask (100 
ml ) and made equal to the mark using the de-ionized water.  This resulting solution was used 
to study about the elements which was present in the sample of drug. Perkin-Elmer: ICP-OES 
Optima; 5300 DV outfitted with an AS-93- auto sampler with WinLab3- software was 
employed for the analysis. Nitrogen was utilized for optical purge gas at the flow speed of 1.4 
L / mt and at 365 kPa pressure.   
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Microbial contamination and specific Pathogens 
208
 
Microbial contaminations (total bacterial and fungal count) and other specific 
pathogens (E. coli; Staphylococcus aureus; Salmonella spp and Pseudomonas aeruginosa) 
were tested as indicated by standard procedures. 
 
Test for Aflatoxin and Pesticide residue 
208
 
The mycotoxins/ aflatoxins (B1; B2; G1 and G2) and pesticide residues (organo 
chlorine; organo phosphoru ) were tested as by standard procedures. 
 
Thermo gravimetric analysis 
The TGA analysis (thermogravimetric analysis) of CKC was carried out using the TG 
instrument - TGA Q500 V20.10- Build 36. Quantity of sample (accurately weighed) was 
heated in a high resolution- nitrogen atmosphere and by maintaining at the rate of 20⁰/mts.  
 
Toxicity study (Acute and Long term) 
Acute and long term toxicity study was carried out following the World Health 
Organization (WHO) guidelines [1993] with the minor modifications. [209] 
 
Drug and Dose :  
The therapeutic dose for the study drug (CKC) for acute and long term toxicity study 
was calculated by extrapolating the human-clinical dose (12 gm/day) to rat dose (216mg / 
200gm b.wt; 1.08 gm /kg b.wt) which was based on the ratio of the body surface. 
210 
Drug 
was made in to suspension by adding with its vehicle milk [2ml] in mortar-pestle. The drug 
was administered to rats with respect to their individual weights. 
 
Route of administration 
Oral route was selected, both for acute and long term toxicity study as it is the clinical 
route of administration. 
 
Procurement and rearing of experimental animals  
Adult male wistar rats weighing 130-220 gms were used for both acute and long term 
toxicity study. The animals were procured from National Centre for Laboratory Animal 
Sciences (NCLAS), NIN, Hyderabad. They were housed three per cage under standard 
laboratory conditions at a room temperature at 20±2
0
 C. Ventilated by air conditioning with 
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100% fresh air and humidity was maintained between 50-70%. The animals were subjected 
under standard photo-periodic condition of 12:12 hr light dark cycle. The animals were fed 
with standard rodent pellet procured from M/s. Provimi Animal Nutrition India Pvt Ltd, 
Bengaluru and purified RO water (Kent RO water filter cum purifier) ad libitum. Animals 
were acclimatized to laboratory conditions one week prior to the initiation of the experiments. 
The protocol for experimentation was approved by Institutional Animal Ethics Committee 
(Ref.no: NIS/IAEC/I/2011/2(A)) of National Institute of Siddha, Chennai, Tamilnadu, India.  
 
Acute toxicity study  
 
Experimental design 
 
                               Table 5.1.7: Experimental design in acute toxicity study  
Sample Size                               18 wistar rats  
Sex                                     Male 
Route of Administration                                    Oral  
Experiment Duration                                14 days 
Drug                     Chandrakanthi chooranam 
Dose 10.8 gm/kg/p.o (10 times the dose equivalent to human therapeutic 
dosage was selected to ascertain its safety potential ) 
 
Animal grouping and interventions 
The animals were randomly divided into three groups (I, II and III ) of six rats (n=6) 
each. Individual identification of the animal was made by marking. Group I animals served as 
control and received 10ml/kg b.wt of distilled water. Group II received once with 10ml/kg 
bwt of milk and served as vehicle control. Group III served as the treated groups and received 
10 times the dose equivalent to human therapeutic dose [10.8gm/kg/p.o.] of CKC 
               
               Table 5.1.8: Animal grouping and intervention in acute toxicity study 
  
 
 
 
In-life observation 
Doses were administered to the wistar rats which were overnight fasted with water ad 
libitum. All the rats were observed for general conditions, signs of toxic symptoms and 
mortality for every hour during the first day with particular concentration given during the 
first 4 h and thereafter every day for 14 days. Parameters such as mortality, allergic reactions, 
           Groups          Intervention   No of Rats  
 Normal Control- Group I           Distilled water             6 
Vehicle control - Group II                 Milk             6 
 10 x TD           - Group III     CKC (10.8g / kg b.wt)              6 
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skin colour changes, response to handling, secretions, pilo-erection, posture, gait, diarrhoea, 
tremors, sleep, convulsion signs, circling, depression, sedation, excitement and cyanosis were 
observed and then recorded. 
 
Physiological parameters 
 
Feed and water consumptions were recorded daily. Individual body weight of the 
wistar rats were recorded previous to the dosing, on the 7
th
 day and prior to the sacrifice on 
the 14
th
 day.  
 
Gross necropsy 
 
After the observation period of 14 days, all surviving rats were sacrificed and were 
subjected to the complete gross necropsy to examine any signs of systemic-toxicity. External 
surface of the body, cranial, orifices, thoracic and the abdominal cavities and its contents 
were examined. Lastly, the vital organs like heart, lungs, liver, kidneys, spleen, brain and 
testis was grossly examined. 
 
Long term Toxicity 
 
Experimental design 
 
                               Table 5.1.9: Experimental design in long term toxicity study  
 
Sample Size                                  30 wistar rats  
Sex                                       Male 
Route of Administration                                       Oral 
Experiment Duration As a rule of WHO-guidelines for the clinical administration of 
drug, between 1-6 months, the toxicity study administration 
period is from 3- 6 months and as a result 3 months [ 90 days ] 
was selected as the treatment schedule.  
Drug Chandrakanthi chooranam 
Dose Three dose levels were studied to produce the range of toxic 
effects and mortality rates.  
 Therapeutic dose:  1.08gm/kg b.w of CKC 
 Average dose  (3 x TD): 3.24g/k g b.w. of CKC 
 Higher dose (5 x TD): 5.4 g / kg b.w. of CKC 
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Animal grouping and interventions 
The wistar rats were randomly divided into five groups ( I, II,III,IV and V ) of six rats 
(n=6)  each. The groups of animals were transferred in to different cages and were marked for 
their identifications. Group I animals served as control and received 10ml/kg b.wt of distilled 
water. Group II received 10ml/kg b.wt of milk and served as vehicle control. Group-III rats 
received CKC at a dose equivalent to human therapeutic dose (1.08gm/kg/p.o), Group-IV rats 
received 3 times the dose equivalent to human therapeutic dose (3.24g/k g/ p.o.) of CKC. 
Group V rats received 5 times the dose equivalent to human therapeutic dose ( 5.4gms/kg 
b.wt ) of CKC.  
 
          Table 5.1.10: Animal grouping and interventions in long term toxicity study 
 
 
  
 
 
 
Sampling, Sacrifice and Surgical procedure: 
Twenty-four (24) hours after the 90
th
 day of treatment, following over-night fasting 
(12 h) blood was collected from the rats through retro orbital- plexus into 2 tubes, one 
contains EDTA for the analysis of haematological parameters and the other in to a sterile 
plain bottle without additives wich was centrifuged at 4000 rpm at 4◦C for 10 mts to get the 
serum for biochemical estimations. The resulting samples was obtained and stored at −20 °C 
prior to the biochemical estimation. After this all the wistar rats were sacrificed with the 
excess anaesthesia. The abdominal cavity was opened via a midline incision.The organs like 
heart, lungs, spleen, kidneys, liver, testis, brain, stomach and thymus were excised and 
examined for gross lesions and weighed. Representative tissue samples were preserved in 
10% formalin solution for histopathological evaluation. 
 
Pathological Evaluation 
Final body weight, organ weight, blood picture, blood biochemical markers and 
histological examination of internal organs were determined. 
 
 
             Groups                 Intervention  No of Rats  
Normal Control -  Group I            Distilled water          6 
Vehicle control  - Group II                 Milk          6 
     1x TD           - Group III CKC  ( 1.08 g / kg b.wt)           6 
     3 Xtd            - Group IV CKC  ( 3.24g / kg b.wt)           6 
     5 x TD          - Group V CKC  ( 5.4 g / kg b.wt)           6 
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Physiological parameters 
Daily consumption was measured by calculating difference between the amounts of 
food and water given and their remnants on the next day. The body weights of all rats were 
recorded [gm] before and after the session [90days] of each respective drug administration 
(before sacrifice).  
 
Organ weights 
Organs like heart, lungs, spleen, kidneys, liver, testis, brain, stomach and thymus were 
dissected out, freed from the surrounding fats and connective tissues. Mopped with the tissue 
paper and was weighed (absolute). Organs were weighed on the digital balance soon after the 
dissection to avoid drying [wet weight were recorded]. 
 
Blood chemistry- panel  
 
Hematological Assays 
Variables were analyzed using automated bayer- hematology analyzer which includes 
total white blood cell count ( WBC ), lymphocytes ( LYMP ), Monocytes ( MONO ), 
Granulocytes( GRAN), Total red blood cell count ( RBC ), platelet count ( PLT ), platelet crit 
( PCT ); mean corpuscular volume ( MCV ), mean corpuscular haemoglobin ( MCH ), mean 
corpuscular haemoglobin concentration (MCHC), haemoglobin ( Hb ), Hematocrit ( HCT) or 
packed cell volume ( PCV ), red blood cells width ( RDW ), Platelet distribution width ( 
PDW ), mean platelet volume ( MPV) 
 
Biochemical Assays 
Biochemical variables like glucose, urea, creatinine, total cholesterol, triglycerides 
(TGL), total Protein (TPN), albumin, globulin, total bilirubin, Aspartate amino transferase  
(AST) and Alanine amino transferase (ALT) were determined using chemical analyzer RA 
50. Electrolyes were analyzed by Transasia electrolyte analyzer-EC lyte transasia.  
 
Histopathological study  
The tissues examined were: Heart, lungs, spleen, intestine, kidneys, liver, testis, brain 
and thymus. Tissue samples were preserved in formalin (10%) for histopathological 
evaluation. The tissue samples were usually embedded into paraffin; 2-m thick sections were 
stained with H & E (hematoxylin and eosin). All the sample slides were examined 
microscopically for any pathological observations.  
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Pharmacological study 
 
Spermatogenic activity 
 
Chemicals 
Chemicals used in this study were obtained from the Sigma Chemicals Company, 
U.S.A. Further analytical grade- chemicals were procured from the S.d. Fine Chemicals Ltd., 
Mumbai, India.  
 
Drug and Dose  
The therapeutic dose for the study drug (CKC) for acute and long term toxicity study 
was calculated by extrapolating the human-clinical dose (12 gm/day) to rat dose (216mg / 
200gm b.wt; 1.08 gm/kg b.wt) which was based on the ratio of the body surface. 
210
 Drug was 
made in to suspension by adding along with its vehicle milk [216mg of CKC in 1ml of milk]. 
The drug was administered to rats with respect to their individual weights. 
 
Procurement and rearing of experimental animals 
Adult male wistar rats weighing 180-210 gms were used for this study. The in-bred 
animals were procured from the animal house of C.L. Baid Metha College of Pharmacy, 
Chennai, India. They were housed three per cage under standard laboratory conditions at a 
room temperature at 22±2
0
 C. The animals were subjected under standard photoperiodic 
condition of 12:12 hr light dark cycle. The animals were fed with standard rodent pellet 
procured from Avian feed farms, Bangalore and water ad libitum. Animals were acclimatized 
to the laboratory conditions a week prior to the initiation of experiment. The protocol for 
experimentation was approved by the IAEC- Institutional Animal Ethics Committee 
(Ref.no:IAEC/XLI/01/CLBMCP/2013) of C.L.Baid Mehta College of Pharmacy, India.  
 
Experimental design 
 
              Table 5.1.11: Experimental design in spermatogenic study  
Sample size  18 wistar rats  
Sex Male 
Route of Administration Oral 
Experiment Duration 60 days 
Drug  Chandrakanthi chooranam 
Dose  1.08 gm / kg b.wt 
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Animal grouping and interventions 
The animals were randomly divided into three groups ( I, II and III ) of six rats (n=6)  
each. Individual identification of the animal was made by marking. Group I animals served as 
normal control and received 1ml double distilled water for 60 days. Group II received 0.5 ml 
of ethanol (25%) /kg /b.wt /day and served as negative control (alcohol induced).
98
  Group III 
served as the treated group and received 0.5 ml of  ethanol (25%) /kg/b.wt along with 
1.08g/kg of CKC for 60 days. Administration was done once daily by oral gavage in the 
morning (between 7.30a.m – 9.00 a.m) 
 
Body and genital organ weights 
The body weights of all wistar rats were recorded [gm] before and after the 
experiment [60days]. The wistar rats were sacrificed on the next day after the last day of drug 
administration [61
st
] and the reproductive organs like testes, prostate, seminal vesicle and 
epididymis were dissected out and freed from surrounding fat and connective tissue and 
weighed on a Cubis Precision Balance for absolute weight.  
 
            Table 5.1.12: Animal grouping and interventions in spermatogenic study 
 
Sampling, Sacrifice and Surgical procedure 
Twenty-four (24) hours after the 60
th
 day of treatment, following over-night 
fasting(12hrs), the wistar rats were anaesthetized under ether anaesthesia and the blood 
samples were collected into clean dry centrifugal tubes by the carotid bleeding with the aid of 
a 21G needle. The blood was allowed to stand for about 15mts to clot and was further spun in 
a centrifuge at 1000g for 10 mts. Serum was separated from the clot with Pasteur pipette into 
the sterile sample tubes. The serum samples obtained was stored at −20°C prior to the 
estimation of total protein, total cholesterol and testosterone. After this all the wistar rats were 
sacrificed with i.p. (intraperitonial) injection of thiopentone. The abdominal cavity was 
opened up through a midline incision to expose the genital organs. Testes, prostate, seminal 
vesicle and epididymis were excised, all the fats were trimmed of and the tissues were wiped 
with the tissue paper and then weighed. Left testicles were collected to examine the sperm 
             S. No                  Intervention No of Rats  
Normal Control -Group I                 Distilled water         6 
EthanolInduced-Group II 25% of ethanol ( 0.5 ml /kg/b.w/day)         6 
Treatment        -Group III CKCchooranam ( 1.08 g / kg b.w / day)  
+ 25% of ethanol ( 0.5 ml /kg/b.w/day) 
        6 
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characters and the right testicles to examine testicular and epididymal histopathological 
study. The sections were studied microscopically for histo architecture changes. The left 
caudal- epididymis were transferred into a sterile bottle which contains 2 ml of the normal 
saline for semen examination. Semen samples from the caudal epididymis (left) were tested 
for the parameters such as count, motility, viability and morphology. Counting was 
performed through haemocytometer and light microscope with 100X 
 
Blood chemistry- panel 
Estimation of serum total cholesterol 
Span diagnostic kit was applied for the estimation of total cholesterol, which followed 
cholesterol oxidase/peroxidase (CHOD-POD) method. 
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                                             Table 5.1.13: Reagents used 
 
 
 
 
 
 
 
 
 
 
 
 
                                          
                                             Table 5.1.14: Reaction Parameters 
 
    
 
 
 
 
                                       Table 5.1.15: Summary of assay details 
 
 
 
 
 
Reagent composition Conc. in the final test mixed 
Good’s butter (PH 6.7) 50mmol/l 
Phenol 5mmol/l 
4 - Aminoantipyrine 0.3 mmol/l 
Cholesterol esterase  >200 U/l 
Cholesterol oxidase >100 U/l 
Peroxidase >3 KU/l  
Standard: The concentration of standard glucose used was 
200mg/dl 
Assay &Procedure: Fresh clear and unhaemolysed serum was 
used for the evaluation.  
Reaction type End point 
Wavelength 505 nm  
Optical path 1 cm 
Temperature 370°C 
Measurement Against reagent blank  
Pipetted in to test tube Blank Standard Test 
             Reagent 1000 μl 1000 μl 1000 μl 
            Standard  - 10 μl - 
            Sample - - 10 μl 
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The reaction mixtures were mixed up well and then incubated for 10 mts at 370°C. The 
absorbance of the reaction mixtures at 505nm against reagent blank was taken. The 
absorbance was calculated by using a Shimadzu spectro photometer (model 1601).  
 
Calculation 
                                                                   Absorbance of test  
 Total cholesterol (mg/dl) =                                                         × Conc. of standard.  
                                                              Absorbance of standard  
 
Estimation of total protein 
The amount of total protein was evaluated using standard kits employing the methods 
of Lowry using folin phenol reagent (Lowry et al) 
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Estimation of glycogen content 
The supernatant sample (0.5ml) were subjected to the alkali digestion with KOH 
(30%) in boiling water-bath for 20mts. 3 ml of the ethanol was added and the tubes were kept 
in a freezer overnight. They were centrifuged at 3000-rpm for 40 mts. The precipitate was 
dissolved in warm water, re-precipitated with ethanol and then centrifuged again. The final 
precipitate was dissolved in 3 ml of distilled water and heated for 5 mts in a boiling water-
bath. Aliquots of the sample were mixed with 4 ml of anthrone reagent, heated in a boiling 
water-bath for 20 mts. Green colour developed was studied at 600 nm with utilizing 
Systronics UV VIS- spectrophotometer. The glycogen content in the tissues was expressed as 
mg. 
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Estimation of serum testosterone 
Serum testosterone was evalutaed by the ECLIA method using standard test kit 
[Rache – German]. Assays were carried out according to the manufacturer's instructions.  
 
Enumeration of sperm parameters 
 
Semen analysis 
Examination of sperm count, motility, viability and morphology was carried out by 
making small cuts in the area of the cauda-epididymis which was close to vas deferens and 
then applied gentle pressure to exude epididymal contents. 
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Sperm Count 
214 
Semen sample was drawn in to WBC pipette and diluted to the ratio of 1:100 with the 
modified Krebs Ringer-bicarbonate buffer containing 0.05% collagenase (pH 7.4). After this 
1:1000 dilution was carried out with NaCl (1.8%) and formalin (2%). Sperm suspension was 
placed in the haemocytometer with improved double Neubauer ruling, which was used for the 
counting of the sperms. Counts for 2-4 haemocytometer chambers were averaged.
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Sperm count evaluation 
 Total number of sperm cells in all the four chamber = X  
 X multiplied by 10,000 to obtain the number of cells (Y) per ml of diluted sample  
 Y multiplied by 100 (the dilution factor) to obtain (Z) sperm cells per ml of original 
semen sample.  
Sperm Motility 
214
 
The sample was mixed with 20mM HEPES (4-(2-hydroxyethyl)-1-piperazine ethane 
sulfonic acid contains L-Glutamine with BSA- Bovine serum albumin (5%). Final sample 
suspension was mixed with formalin and was used to examine motility using the bright field 
microscope with the magnification of 100 x  
 
Motility (%) =                   Number of motile spermatozoa  
                              Total number of spermatozoa (motile + immotile)  x 100   
 
Percentage viability 
215
 
Sperm suspension was diluted with trypan blue solution (0.4%) in the ratio of 1:1 
dilution and then was pipetted up and down many times to make sure the uniform cell 
suspension with the use of same pipette tip and was allowed to stand for 5 to 15 mts. Small 
amount of the trypan blue-cell suspension was transferred in to the hemocytometer chambers 
carefully. The cells were viewed under a microscope at the magnification of 100 x. Live 
sperm appeared colourless with bright margin under contrast and dead cells stained blue and 
are non-refractile. 
 
Percentage of sperm viability:         Total Viable cells (Unstained)  
                                                       Total cells (Viable +Dead)] X 100 
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Sperm morphology 
216
 
Staining  
1mL of sperm suspension was transferred in to a test tube. 1% eosin Y (2 drops) was 
added to a test tube and then mixed by gentle agitation. Spermatozoa were incubated at the 
room temperature for approximately 45 to 60 mts and allowed for staining.  
 
Slide preparation  
Slides was cleaned up with the detergent and washed in water and then in alcohol, 
dried before use. 1-2 drops of the stained sperm suspension was placed approximately one cm 
from frosted end of the pre cleaned microscope-slide lying on the flat surface. Second slide 
was held on the right hand with long edge of the slide that gently touches across the width of 
the sperm slide and was pulled across to make a sperm smear.  Smear was allowed to dry and 
then was fixed with the formalin.  
 
Characterization of normal and abnormal sperm 
Sperm abnormality was observed based on the subsequent parameters like headless 
tail, tail less head, curved tail, coiled tail and looped tail. Normal sperm was observed based 
on appearance and the absence of above refered parameters.  
 
Percentage of normal = No of normal sperm / Total number of sperms in the filed X 100  
Percentage of abnormal = No of abnormal sperm / Total number of sperms in the filed X 100  
 
Procedure for histopathology 
The rats from each group were sacrificed with i.p. ( intraperitonial) injection of 
thiopentone . The abdominal cavity was opened via a midline incision and the genital organs 
were exposed. Right testicles was excised. The testicle samples were washed with the normal 
saline and then fixed in neutral formalin (10%) for 48 hrs for further histological observation. 
Paraffin sections were taken at the thickness of 5 μm and then processed in the alcohol-
xylene series and then was stained with the haematoxylin-eosin dye. The section was 
examined microscopically for any histopathological changes. The magnification at 10 X (low 
power) and 45 X (high power) was carried out. 
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5.2. Patients and Clinical Methods 
Clinical study was carried out in to two phases 
 Pilot study 
 Main Clinical Trial 
Pilot study 
This study was designed to the assess the feasibility, safety and tolerability of 
administration of study drug CKC in Oligozoospermic patients prior to conducting phase II 
main clinical trial. Study was conducted in the out patient department of National Institute of 
Siddha, Chennai, India. Out of initially screened 21 male patients aged between 21-45 years, 
16 patients were excluded as they could not meet up the inclusion criteria and 5 patients were 
enrolled for the trial. Only those who gave the written consent were included in the study. 
Method followed was similar to that of the main clinical study. Separate case record forms 
were maintained for each patients. All subjects were closely followed for adverse effects 
related to the treatment. The obtained datas were subjected to statistical analysis and the 
safety and efficacy of the treatment were validated 
 
Main Clinical Trial 
                                           Table 5.2.1: Study design 
Study population Infertile male, age-21-45yrs, low sperm count 
Study type Open label, safety and efficacy study, Phase-II, Interventional 
Study centre National Institute of Siddha 
Allocation Non- Randomized 
Intervention Single group assignment  
Study period 1year 
Sample size 40 
 
Clinical Trial Registration 
The Trial was registered in Clinical Trials Registry (India) with the registration 
number CTRI/2014/01/004281 and registered in Clinical Trials.gov with the registration 
number NCT01847963. 
 
Ethical Clearance  
The study protocol was approved by the Ethical Committee of National Institute of 
Siddha [NIS/IEC/2011/1/12] 
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Clinical source 
Male patients of 21 to 45 years old presenting with the complaint of primary or 
secondary infertility, visiting out patient department of National Institute of Siddha, Chennai, 
India, who were diagnosed as oligozoospermia with count lower than 15 million sperm cells / 
ml. 
Selection Criteria  
                                                   Table  5.2.2 Inclusion criteria 
 
 Male infertile patients with age between 21-45 years 
 Marriage history  for >1 year  
 Sperm count 1-15 million/ml [ below one million is excluded] 
 Patients with normal liver & renal function test 
 Willing to give specimen of semen  before & at the end of the clinical trial 
 Informed patients giving written consent 
 
                                             Table 5.2.3: Exclusion criteria 
 Azoospermia-complete absence of sperm in the ejaculate 
 Aspermia-complete lack of semen 
 Necrospermia- spermatozoa in semen are dead 
 Clinical diagnosis of varicocele & hydrocele 
 History of undescended testis 
 Inguinal hernia on physical examination 
 Male accessory gland infection 
 History of DM, Hypertension and Cardiac Disease 
 Any recent medical or surgical illness 
 Underwent treatment for promoting spermatogenetic fertility in last 3 months 
 Other systemic disease requiring specific therapies 
 Known Thyroid disease 
 Past history of  renal, hepatic or any other chronic illness in the patient  
 
Screening examinations  
Male patients who had a history of primary and secondary infertility for a period of 
more than 1-years were initially selected for the study. Detailed history was taken regarding 
previous illness, infections or surgery. Physical examination was carried out to rule out any 
endocrinological disorder or genital abnormality. Semen examination and safety parameters 
like blood glucose, haematological test, renal function tests, liver function tests, lipid profile, 
VDRL test and urine routine test were performed. Thyroid test, seminal culture, scrotal 
ultrasonography and antisperm-antibodies were also evaluated in patient with suspected 
pathology. A total of 116 male patients aged between 21-45 years were initially screened 
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from April to October 2013, from the out patient department (OPD) of National Institute of 
Siddha. 40 patients were enrolled for the clinical trial. Only those who gave written consent 
were included in the study.    
 
                             Figure  5.2.1 Screening Examination of Patient 
 
 
Informed consent  
 
Consent from each subject was obtained in response to a fully written and verbal 
explanation of the nature of the study before the start of the trial. The details were given in 
two languages (Enlish and Tamil). Patients were free to withdraw their name from the study 
at any time without giving any reason.  
 
Selection of patient 
 
A total of 40 eligible men from totally screened 116 men with fertility problems were 
diagnosed as Oligozoospermia on the basis of semen analysis and fulfilling the inclusion 
criteria were registered for the clinical study.  
 
 
 
Total 116 Patients 
Screened  
Detailed History 
Physical 
Examination 
Safety Parameters 
Semen Investigation 
Harmone  
Parameters 
40 Patients 
enrolled 
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 Figure 5.2.2: The selected  Oligozoospermic Patients (40) comes under two categories 
            
 
 
Investigations 
Parameters were assessed at baseline (Day 0), at the end of the trial (Day 91) and at 
the end of the follow up (day181). Semen analysis and all the other safety parameters were 
performed at same Institution laboratory. Harmone analysis were assessed at Hitech 
Diagnostic center, Tamilnadu, India. 
 
A] Semen examination 
Semen examination were performed in order to diagnose and assess the effect of the 
therapy.at World Health Organization (WHO) recommended standards. 
49 
Rapid analyses 
were performed within one hour after collection. Macro and microscopic assessment of the 
semen were carried out to measure the semen volume [ml], liquification time [minutes], 
semen viscosity [high/low], sperm concentration [million/ml], percentage of progressive and 
total motile spermatozoa, percentage of normal forms of sperm and pus cells (per field). The 
seminal fluid characteristics were assessed twice before the registration of each patient and 
both at least one week apart.  
                                   Table 5.2.4: Collection of semen  
Abstinence 5 days  
Method Mastrubation  
Container Dried and wide mouthed bottle with 50ml capacity 
Place A private room adjacent to the Institute laboratory  
Collection time Between 9.00 AM to 12.00 PM   
 
 
Total 40 
patients 
Patients with 
normal form of 
sperms less than 
4 % - 21 
Patients with count less than 
15million/ml - 40 (all the patients) 
Patients with progressive motility less 
than 32% - 40 ( all the patients) 
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B] Harmone Analysis 
Serum samples were measured for testosterone and follicle stimulating hormone 
(FSH) by ECLIA method and luteinizing hormone (LH) by CLIA method.  
 
C] Safety parameters  
i] Hematological Analysis:  
Hb (gm/dl), Total RBC (cells/µl), Total WBC count (million/µl)), Erythrocyte 
sedimentation rate (ESR) and Platelets (lakhs /µl) 
 
ii] Biochemical Analysis 
Blood Glucose( mg/dl), serum total cholesterol (mg/dl), HDL ( mg/dl), LDL( md/dl), 
VLDL ( mg/dl), serum triglycerides ( mg/dl), blood urea (mg/dl), serum creatinine (mg/dl), 
uric acid (mg/dl), serum total bilirubin (mg/dl), serum total protein (gm/dl), AST (IU/ml), 
ALT  (IU/ml) and alkaline phosphatase (IU/L).  
 
iii] Urine routine 
Albumin, Sugar, bile salts, bile pigments, Urobilinogen, Acetone and occult blood. 
 
D] Siddha Investigations 
Envagai thervu (eight fold examination), Neer Kuri (examination of urine) and Nei 
Kuri [oil on urine sign] 
32 
 
 
Line of Treatment 
Viresanam [Purification of Alimentary Tract] 
The Selected patients had been given Agasthiar Kuzhambu at the dose of 130 mg with 
ginger juice in the early morning in empty stomach to bring the mukutram to equilibrium.
218 
 
                                Table 5.2.5: Interventional Medicine 
25  
 
Drug:  Chandrakanthi chooranam 
Posology: 12gm –OD; Bed time 
Route of Administration: Oral route 
Administration period: 3 months ( 90 days)  
Anupanam  (Adjuvant): Milk ( 150ml) 
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                                   Table 5.2.6: Pathiyam and Apathiyam 
30, 40, 36
  
                                       Pathiyam  ( Diet and behaviors to follow ) 
 
 
           Diet 
Greens - ( Drumstick, Climbing brinjal, Spinash, Amaranthus tritis) 
Goat meat; Emperor and Eel fish 
Plantain flower, Drumstick, Mango fruit, Black grapes, Black plum, 
Pomegranate  
Cow’s milk, Cashew, Almond and Walnut   
       Behaviour  Oil bath twice in a week  ( avoid intercourse on the day of the oil bath ) 
                                    Apathiyam  (Diet and behaviors to avoid)  
           Diet Avoid Horse gram, Mango, Bitter guord and Sesban leaves 
      Behaviour Avoid intercourse in day time and during digestion of the food 
                                                        Other Advices 
Avoid tobacco, smoking, alcohol, drug abuse, hot baths, strenuous activities, occupation in hot 
environment, wear loose under wear and control obesity 
     
Conduct of the study 
219, 220 
  
 The study was conducted in accordance with the guidelines of the Indian Council for 
Medical Research (ICMR) and GCP adapted from ICH and accepted by Ayush.  
 The study was conducted for one year in between April 2013 and April 2014 in the 
out patient department of National Institute of Siddha, Chennai, India.  
 After recruitment, patients were put on 90 days of interventional Medicine  
 To take uniform quantity of medicine all the patients were given 15 zip lock cover (1 
zip lock cover containing 12gms of CKC) of CKC in every trial visit. 
 Patients were advised to take the trial drug appropriately. They were advised to follow 
the appropriate diet mentioned by the investigator. The patients were instructed to 
bring unused drug on next visit. The details were recorded in drug compliance form. 
 After completing three months duration and follow up period, patients were instructed 
to take investigations concerning sperm parameters, harmone parameters and safety 
parameters.  
 
Trial Visits 
During the treatment period of 90 days, the subjects were required to present 
themselves at the trial center at precised intervals: Visit 1 on Day 16; Visit 2 on Day 31; Visit 
3 on Day 46, visit 4 on day 61, visit 5 on day 76, and visit 6 on day 91.  
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                                         Figure 5.2.3: Trial Visits of Patients 
                            
Case record form (CRF)  
Patients were given unique registration number. The screening forms were filed 
separately. History of present and past illness, personal history, family history, habits, 
physical examination findings, subjective parameters, objective parameters, investigations, 
drug compliance, dietary advice, informed consent and adverse events were systemically 
recorded in the CRF for analysis. The case taking proforma was elaboratively designed for 
the purpose of incorporating Siddha method of diagnosis as mentioned in the classics. After 
enrolling the patient in the study, a separate file for each patient was opened and all forms 
were be kept in that file. 
 
Assessment criteria 
A] Objective parameters 
Sperm concentration, progressive and total motile spermatozoa, normal forms of 
sperm, testosterone, follicle stimulating hormone (FSH) and luteinizing hormone (LH)  
 
B] Subjective parameters 
i] Clinical Symptoms 
Erectyle dysfunction, premature ejaculation and nocturnal emmision were recorded. 
 
ii] Siddha clinical parameters 
Envagai thervu (eight fold examination), uyir thathukal (bio energetic principle) and 
udal thathukal (physical constituents) were assessed. 
 
Visit 1 
on Day 
16 
Visit 2 
on Day 
31 
Visit 3 
on Day 
46 
visit 4 
on day 
61 
visit 5 
on day 
76 
visit 6 
on day 
91 
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Follow up 
After the completion of treatment the patients were kept under follow up, for the 
period of three months and were then assessed for the overall effect of the therapy if any. 
Follow up records were further documented in the CRF.  
 
Adverse Effect 
The safety and tolerability of study medications was assessed based on adverse effects 
reported by patients or observed by the investigator during evaluation. Every 15
th
 day the 
patients were assessed for clinical improvement and adverse effects. In case of adverse 
effects either reported or observed in the course of study period the patient will be advised to 
stop the medicine and it will be documented in the adverse effect form in CRF and will be 
intimated to the Pharmacovigilence committee of NIS  
 
Withdrawal  Criteria 
                                     Table 5.2.7 Patients Withdrawal  Criteria 
 
 
 
 
In the case of adverse effect reported, the trial drug was stopped and withdrawal form was 
filled up in CRF and then the patient was treated in OPD of NIS. In case of emergency, the 
patients were referred to nearby Government hospital for management. 
 
Observation criteria 
Contemporary variables 
  Age, nature of work, educational status, Socio economic status, sexual habits, 
sleeping pattern, diet, addiction, infertility, duration of infertility, pscychological status, 
gonadotoxic agents, previous illness, family history, blood group, bathing habit, BMI, semen 
parameters, clinical parameters, harmone parameters and safety parameters were assessed.   
 
Siddha variables 
Kaalam [ Patients age ], Thinai (Habitat), Noi utra kaalam (season),  Thega ilakanam 
( bio type), Udal thathukal ( physical constituents), Envagai thervu (eight fold examination), 
 
Any adverse effects reported  
Patients failed  to strictly adhere to the study protocol  
Patients turned unwilling to continue the clinical trial 
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Naadi nadai (Pulse play ), Uyir thathukkal (Functional constitution of the body) and status of 
agni (basal metabolic heat) were assessed. 
 
Outcome measures 
Primary outcome measures 
Semen parameters were graded into four groups depending upon the response to CKC 
as follows: a) Good, b) Moderate c) Mild and d) Poor 
 
                                   Table 5.2.8: Primary outcome measures 
   Grading 
 
 Sperm count 
    (million) 
  Progressive Motility 
       (Percentage)         
Total Motility 
 (Percentage) 
Normal Forms 
    (Percentage) 
    Good                   >30             > 40     > 50       > 10 
   Moderate         20-30           32- 40     40 – 50       4- 10             
     Mild                    2-19             1-31     1-39        1-3 
     Poor              no changes        no changes   no changes     no changes 
 
Secondary outcome mesaures 
Changes in the level of serum testosterone, FSH, and LH  
 
Compliance 
 As per ICMR guidelines, Phase II is a therapeutic exploratory trials and normally 20 - 
25 patients should be studied for assessment of each dosage. 
8 
 In this study 37 patients have completed the trial out of estimated 40 registered 
patients and their data were analyzed. 
 Three patients dropped out from the study prior to completion for the reasons: of 
withdrawal (n=2); discontinuation (n=1).  
 
Data collection and Management 
The datas were kept securely, access was granted for the purpose of the study and the 
confidentiality of the patients was maintained. Datas of subjective parameters, objective 
parameters and safety parameters collected at baseline, at the end of the treatment and at the 
end of the follow up were taken out from the case record form and were computed in the MS 
Excel software and was considered for statistical analysis. Demographic datas, disease related 
datas, Siddha classic investigations and diagnostic methods were collected from the CRF and 
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was properly analyzed. After sorting the data, a calculation was performed to obtain the 
percentage of subject with the individual factor and were documented. The Data entries were 
monitored by the guide and all the analysis were done by the Investigator. 
 
Statistical Analysis  
Analysis were done by one way analysis of variance (ANOVA) followed by Dunnet’s 
multiple comparison test. All the statistical analysis was carried out using SPSS Software 
version 19. Datas were expressed as mean ± standard error of the mean (SEM). The datas 
obtained from toxicity studies were analyzed using Student’s t-test to compare the treatment 
groups with control group.The datas obtained from spermatogenic study were analyzed using 
Student’s t-test to compare the treatment group with control and induced group.The datas 
obtained from clinical study was analyzed using Student’s t-test to compare the values from 
the baseline to the end of the treatment and end of the follow up. For toxicity study 
significance levels was set at  *p < 0.05 and **p < 0.01 and for spermatogenic study 
significance levels was set at  *p < 0.05 and ***p < 0.001 and for clinical study significance 
levels was set at *p < 0.05;  **p < 0.01 and ***p < 0.001 [Main clinical trial and Pilot study]. 
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6. RESULT 
 
Pharmacognostical study 
 
Alternanthera sessilis  
 
Macroscopical characters of the seed 
The seeds were dark brown  in colour (fig 6.1a, 6.1 b) with absence of odour, shape is 
of elliptical, with broad blunt end and opposite end being short conical in shape (fig 6.2). The 
length of the seed is 400µm and wide is 250 µm. 
 
Microscopical characters of the seed 
The testa (seed-coat) was hard and thick. The thickness was 10µm and the thickness 
was uniform all through the seed. Outer surface was uneven with ridges being irregular. 
Outer surface of the testa (seed coat) had 2 or 3 prominent wings or appendages (fig 6.3). The 
length of the wings was 80µm and the thickness was 30µm. The wings were multicellular and 
with thick wall. The shape was conical. The testa (seed coat) comprises of sclerotesta or outer 
sclerotic epidermis and with inner seed coat (which was also sclerotic). There are 2 or 3 
layers of the fibrous cells. (fig 6.3, 6.4). Endosperm was thin walled, large and with 
polyhedral outline. (fig 6.5, 6.6). 
 
Adhatoda vasica  
 
Macroscopic characters 
Seeds were brown, flat, elliptical-oblong and fairly thick. Seeds were rugose and sub 
orbicular. It was measured 6 by 5mm. A prominent- median ridge runs starting from base to 
top (fig 6.7). 
 
Microscopic characters 
Seed comprises of thin seed coat- testa and a pair of plano-convex thick cotyledons. 
Testa consisits of outer-sclerotesta (sclerotic seed coat) and inner-sarcotesta (parenchymatous 
part). Highly undulate sclerotesta with the regular-ridges and furrows all through seed surface 
(fig 6.8) were observed. Thin sarcotesta which includes the outer thin walled and large cell 
layer (parenchyma cells) and inner - thin layers with thick- walled cells. Parenchymatous 
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zone was thin at lateral part of seed which was developed into wider; many-layered at 
chalazal end (fig 6.9, 6.10). Sarcotesta cells comprises of inclusion of the dark cells. 
Sclerotesta which was greatly folded into the ridges and wide-furrows has outer and the inner 
tangential- wall. Radial walls are spindle shaped and were thickened (fig 6.11, 6.12 ). And the 
thick radial-walls were lignified. The thickness of the sclero testa was 40 mm and of the 
whole testa was 150 µm. Radicle was circular in the sectional and the diameter is 550 µm. It 
comprises of the procambial strand and young meristematic-tissue. Cotyledons were of 
plano-convex and with the flat surface facing to each others. The cotyledons cells were of 
parenchymatous and includes thick starch grains (fig 6.11, 6.8). 
 
Powder Microscopy 
The seed coat fragments were seen in the surface view. Outer epidermis is sclerotesta 
that appears to be ameboid in the outline since because of the thick and liquefied wavy - 
anticlinal walls. Lumen of the cells was wide with variable outline (fig 6.13, 6.14). Sarcotesta 
cells are parenchymatous (inner zone). Cells are observed in small fragments and are 
polyhedral within the outline. Cell walls being thick with pits. Cells have thick inclusions 
which are amorphous and dark stained (fig 6.15). Broken pieces of cotyledons were 
commonly present in the powder. Cells were rectangular or squarish. Cell walls were straight 
and thick. Starch grains were abundantly present in the cells. The size of the cells was 20 to 
30 x 10 to 15 nm (fig 6.16). The cotyledonary cells were also found in the solitary conditions. 
They were rectangular- squarish or with triangular outline. Cells were darkly stained (fig 
6.17). Spherical and shinning OB (oil bodies) of different sizes was seen abundantely in the 
powder and they don’t stain by safranin. Oil bodies were smaller to large in size and were 
found to be free floating on water medium (fig 6.18). Spherical and large SG (starch grains) 
were sparingly seen and they found to stain dark to IKI. The grains were mainly concentric 
with central-hilum and the diameter is up to 70 µm  (fig 6.19 ). 
 
Physico-chemical parameters 
Loss on drying ( at 105⁰C ) was 6.8 %.; total ash was 4.07 %; acid insoluble ash was  
0.15 % ; water soluble extractive was 27.73 % and alcohol soluble extractive was  19.45 % 
.(Table 6.1). 
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Phytochemical analysis 
 
Phytochemical results showed the presence of flavonoid, alkaloid, phenol, triterpene, 
saponin, coumarin, steroid, glycosides and tannin. Anthraquinone was found to be absent. 
(Table 6.2) 
                              Table 6.2 Phytochemical Results of A. VASICA seed 
 
 
 
 
 
 
 
 
 
TLC/ HPTLC  RESULTS 
 TLC photo-documentation at UV 254 nm demonstrated 3 spots at the Rf values - 0.03; 
0.50 and 0.89, at UV 366 nm demonstrated 4 spots at the Rf values - 0.06; 0.50; 0.58 
and 0.89 and after the derivatization by vanillin-sulphuric acid demonstrated 4 spots 
at the Rf values - 0.05; 0.53; 0.67 and  0.89. (fig 6.20-A,B,C; Table 6.3).           
Table 6.3: Spots colour at Rf values under pre and post derivative conditions 
     UV 254 nm     UV 366 nm After Derivatization by Vanillin-Sulphuric acid 
Rf- value Spot colour Rf- value Spot colour     Rf - value          Spot colour 
0.03  
    Green 
- 
0.06  
Pale Blue 
 
      0.06  
              Violet 
 
0.50 0.50       0.53 
0.89 0.58       0.67 
- 0.89       0.89 
 
            TABLE 6.1:  Physico-chemical analysis of  A. VASICA Seeds 
   Physico chemical Parameters  ( %, w/w )   First Second Mean  
        Loss on Drying  (at 105°C ) 6.9   6.7 6.8 
Ash values 
 
 
              Total Ash  
     Acid- soluble Ash  
  Water- insoluble Ash  
4.07  4.09 4.07 
0.15 0.15 0.15 
1.75  1.80 1.78 
Extractives 
values 
         Alcohol  Soluble  
       Water  Soluble  
19.8  19.1 19.45 
27.40 28. 05 27.73 
Phytochemical Test Results 
Flavonoid 
Alkaloid 
Phenols  
Triterpene  
Saponin 
Coumarin 
Steroid 
Glycosides 
Tannin 
Anthroquinone 
 Present 
  Present 
  Present 
  Present 
  Present 
  Present 
  Present 
  Present 
  Present 
  Absent 
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 The finger print study ( HPTLC ) of A. vasica seed at UV- 254 nm demonstrated 9 
peaks; at Rf - values 0.19- 11.85%; 0.63- 44.54 % and 0.81- 21.91 %; which are the 
major peaks. All other spots at the Rf - values 0.10; 0.24; 0.47; 0.70 and 0.75 were 
minor peaks. 3-D chromatogram study at UV- 254 nm of 3 tracks showed the 
proportional increment in the height of the peak. (fig 6.21A, 6.21B , Table 6.4 ). 
            Table 6.4: Rf values and percentage peak area of the chloroform extract  
                                    of Adhatoda vasica seed at - UV 254 nm 
 
Peak Start Start Max Max Max End End Area Area 
 Rf Height Rf Height % Rf Height  % 
  1 0.09 0.6 0.10 16.0 5.08 0.12 0.3 183.0 3.57 
  2 0.16 0.6 0.19 22.5 7.18 0.22 8.5 607.3 11.85 
  3 0.22 8.7 0.24 13.0 4.14 0.27 3.1 308.5 6.02 
  4 0.46 4.0 0.47 29.0 9.24 0.48 6.6 189.0 3.69 
  5 0.60 8.9 0.63 168.0 53.47 0.66 13.6 2281.3 44.53 
  6 0.69 9.2 0.70 11.6 3.69 0.72 3.2 216.0 4.22 
  7 0.74 2.5 0.75 18.1 5.75 0.76 11.3 215.6 4.21 
  8 0.78 11.6 0.81 35.9 11.4 0.86 1.4 1122.8 21.91 
 
 HPTLC - finger print study of A. vasica seed at - UV 366 nm demonstrated only 2 
peaks at the Rf 0.38  - 7.31 % and 0.65 - 92.69 %. 3D chromatogram study at - UV 
366 nm of all the 3 tracks are presented. ( Table 6.5  (fig 6.22A, 6.22B )  
Table 6.5: Rf values and percentage peak area of the chloroform extract of adhatoda 
vasica seed at - UV 366 nm 
 
Peak Start Start Max Max Max End End Area Area 
 Rf Height Rf Height % Rf Height  % 
1 0.37 1.4 0.38 29.2. 25.37 0.39 1.5 155.4 7.31 
2 0.60 1.5 0.65 85.8 74.63 0.69 2.5 1969.7 92.69 
  
 HPTLC- finger print study of A. vasica seed at - 540 nm after the derivatization 
through vanillin-sulphuric acid demonstrated 7peaks at the Rf values - 0.07; 0.09; 
0.15; 0.49 - 80.79 %); 0.55; 0.61 - 10.28 % and 0.81- 1.21 %. 3D chromatogram study 
at 540 nm of all the 3 tracks are presented ( Table 6.6 (fig 6.23A, 6.23B).  
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Table 6.6: Rf values and percentage peak area of the chloroform extract of Adhatoda  
vasica seed at - UV 540 nm 
 
Peak Start Start Max Max Max End End Area Area 
 Rf Height Rf Height % Rf Height  % 
  1 0.06 0.1 0.07 15.8 2.83 0.08 1.7 151. 1 0.42 
  2 0.09 2.0 0.09 12.3 2.19 0.11 0.5 111.6 0.31 
  3 0.14 1.0 0.15 11.4 2.05 0.16 5.3 141.6 0.40 
  4 0.24 5.6 0.49 258.5 46.30 0.54 118.7 28751.6 80.79 
  5 0.54 118.9 0.55 153.8 27.54 0.57 32.8 2342.1 6.58 
  6 0.57 33.0 0.61 87.8 15.73 0.66 38.6 3658.5 10.28 
  7 0.78 1.5 0.81 18.7 3.35 0.84 1.2 431.5 1.21 
 
Analytical study of Gomutra silasathu parpam 
Siddha Specifications 
The dark colour, lusterless, entering in to the lines of the fingers, floating over the still 
water, tasteless and odourless were observed and the results are mentioned. (Table 6.7, fig 
6.24) 
                     Table 6.7: Siddha specification for Parpam ( Gomutra Silasathu )  
 
 Specification                             Results 
Colour                          Dark colour 
Taste                             Tastless 
Luster                          Lusterless 
Smell                         Odourless 
Over the surface of water                               Floats 
In the lines of the finger  Entered in to the lines of the index and thumb finger 
 
Physico-chemical parameters 
GSP (Gomutra silasathu parpam) was examined in the duplicates for analyzing loss 
on drying (at 105⁰C), total ash; water soluble and acid insoluble-ash and pH of the 10% 
solution.  
 Table  6.8:  Physico-chemical analysis of GSP ( Gomutra Silasathu Parpam ) 
Physico chemical Parameters (% ; w/w) First Second Mean 
 Total ash 77.30 77.60 77.45 
Acid insoluble Ash 21.6 20.3 20.45 
Water soluble Ash  23.6 23.9 23.75 
Loss on Drying  (at 105°C) 2.30 2.20 2.50 
pH                       6.04 
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ICP-OES Study 
The analysis exposed the presence of K (potassium), Ca (calcium), Mg (magnesium), 
Fe (iron), Na (sodium), Mn (manganese), Zn (zinc), Cu (copper), Cr (chromium) and Ni 
(nickel). Their quantity was revealed to be 156261; 32039; 21739; 17318; 12470; 320; 185; 
107; 28.6 & 19.2. Se (Selenium), Te (tellurium) and Cd (cadmium) were revealed to be BDL 
( below detection level ) which are shown in table 6.9. 
           
    Table 6.9:  ICP-OES analysis of Gomutra Silasathu parpam for trace elements 
 
    Elements                             Quantity- in ppm  
K (potassium)                                                156261 
Ca- Calcium                                                     32039 
Mg (magnesium)                                             21739 
Fe (Iron)                                                          17318 
Na (Sodium)                                                    12470 
Mn (Manganese)                                                  320 
Zn (Zinc)                                                              185 
Cu (Copper)                                                         107 
Cr (Chromium)                                                   28.6 
Ni (Nickel)                                                          19.2 
Se (Selenium)                                                    BDL 
Te  (Tellurium)                                                  BDL 
Cd (Cadmium)                                                 BDL 
       BDL: Below Detection level ; D.L: Detection Limit; D.L.1.0 
 
 
Particle Size Analysis 
Particle size study was done in 3 sieve sizes - 150; 75 and 45 microns. The analysis 
demonstrated that the GSP accomplish its fineness.  
                                             
                                          Table 6.10: Particle size of GSP  
 
  
 
 
 
CHN analysis 
CHN- analysis results of GSP ( Gomutra silasathu parpam ) is showed in table 6.11. It 
revealed the percentage (%) of carbon to be 12.31; hydrogen to be 0.55 and nitrogen  to be 
1.21                      
Sieve- size ( IS sieve )    Inference 
     150 micron   Passes completely 
       75  micron       82.46 % 
       45 micron       68.79 % 
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                               Table 6.11:CHN analysis of GSP  
 
 
 
 
Analytical study of Chandrakanthi choornam 
Organoleptic characters 
CKC ( Chandrakanthi choornam)  is  brown coloured- fine powder with the spicy 
odour. Taste is found to be sweet, astringent and slightly bitter. 
                        Table 6.12:  Organoleptic characters of CKC  
Characters      Results 
Colour Brown 
Taste Sweet,astringent and slight bitter  
Odour Spicy  
Consistency Fine powder 
 
Preliminary phytochemicals 
Phytochemical study showed the presence of steroids, amino acids, phenols, tannins, 
flavonoids, saponins, anthraquinones, glycosides Triterpenoids and alkaloid was found to be 
absent.    
Table 6.13:  Phytochemical results of CKC  
 
                               
 
 
 
 
 
 
                                    
 
 
 
Physico-chemical parameters 
The drug CKC passes through mesh size of 100. The inference were 8.45 percentage 
of loss on drying  (at 105°C ); 13.04 perecntage of total ash; 3.39 percentage of water soluble 
Analysis Parameters Inference ( % ) 
Carbon ( C ) 12.31  
Hydrogen ( H ) 0.55  
Nitrogen ( N ) 1.21 
Phytochemical  Test                                  Inference 
Steroid - Lieberman Burchard’s Test              Present 
Amino acids - Biurette’s test                          Present 
Phenol                                                             Present 
Tannin                                                             Present 
Flavonoids - Shinoda’s test                             Present 
Saponins                                                          Present 
Anthraquinones                                              Present 
Glycosides                                                      Present 
Triterpenoids - Noller’s Test                          Present 
Alkaloids - Dragendorff’s Test                      Absent 
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ash; 5.61 percentage of acid insoluble ash; 4.04 perecentage of acid soluble ash; 19.25  
percentage of water soluble extractive; 16.85 percentage of alcohol soluble extractive and pH 
value of 6.37.          
              Table 6.14: Physico-chemical parameters of CKC  
 
ICP-OES Analaysis 
Heavy metals (mercury, lead, cadmium andarsenic ) were found to be DL ( below 
detection level - 0.05 ppm ). The quantity of nutritional elements like Ca ( calcium ), Mg ( 
magnesium ), Fe ( iron ), Zn ( zinc ) and Cu ( copper ) were estimated to be 6482.9; 1870; 
988.6; 21.98 and 8.09 ppm in that order. The quantity of calcium was estimated to be high. 
Mg and Fe were observed to be moderate comparatively. Zn and Cu were identified to be in 
lesser amount 
                            Table 6.15: Heavy metal analysis of CKC  
     
 
 
 
 
 
 
                      
                                         
                                       Table 6.16: ICP-OES analysis of CKC  
 
                                
 
 
 
 
 
Physico-chemical Parameters (%) First Second Mean 
Loss on Drying  (at 105°C ) 8.591 8.325 8.458 
 
Ash values 
Total Ash  
Acid insoluble Ash 
      Water soluble Ash 
13.074 13.011 13.043 
5.788 5.434 5.611 
3.244 3.539 3.392 
Extractive values Alcohol Soluble  
Water Soluble  
16.8 16.9 16.85 
19.20 19.30 19.25 
pH                       6.37 
Particle size Passes completely through 100  size mesh 
Heavy metals AYUSH/WHO/FDA  
Specification 
       Inference 
Cd ( Cadmium )               0.3 ppm    
     BDL  
 
Pb (Lead )              10 ppm 
Hg ( Mercury )               1 ppm  
Ar ( Arsenic )               3.0 ppm 
     BDL ( Below Detection level ) ;  DL ( Detection Limit ) -0.05 ppm 
   Elements Quantity - ppm 
Mg ( Magnesium )        1870.0 
Ca ( Calcium )         6482.9 
Zn ( Zinc  )         21.98 
Cu ( Copper  )         8.09 
Fe ( Iron )         988.6 
Se ( Selenium )          BDL  
BDL ( Below Detection level ) ; DL ( Detection 
Limit ) 
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Thin Layer Chromatography 
The TLC- photo documentations of CKC (at UV 254 nm; UV 366 nm and after 
derivatization) were presented in fig 6.25. Rf- values and spots colour under UV 254 nm; UV 
366 nm; after derivatization were shown in the table 6.17. TLC photo documentation of CKC 
(Chandrakanthi choornam) at UV 254 nm revealed 5 visible green spots at the Rf value - 
0.19; 0.14; 0.24 – major; 0.43 and 0.75. At UV 366 nm showed 8 spots at the Rf - 0.09 - pale 
blue; 0.23 - greenish blue; 0.32 - greenish blue; 0.41- greenish blue; 0.48- greenish blue; 0.54 
- pale blue; 0.59 - blue and 0.65- greenish blue. TLC plate- after derivatization  ( with vanillin 
sulphuric acid ) revealed seven spots at the Rf - 0.05 – purple; 0.17 – purple; 0.38- purple;  
0.44- purple;  0.58- purple; 0.69- bluish purple  and 0.96 - purple.( fig 6.25 ) 
            Table 6.17: Rf values and spots colour of Cholroform extract of CKC  
               UV 254 nm        UV 366 nm    After Derivatization 
  Rf -value Spots colour Rf- value Spots colour Rf - value Spots colour 
                
         0.09 
         0.14 
         0.24 
         0.43 
         0.75 
 
 
 
 
 
     Green 
  0.09    Pale blue     0.05  
 
      Purple 
 
  0.23 
  0.32 
  0.41 
  0.48 
 
 Greenish blue 
 
    0.17 
    0.38 
    0.44 
    0.58 
  0.54 
  0.59 
  0.65 
    Pale blue     0.69 Bluish Purple 
      Blue     0.96 
 
Purple 
  Greenish blue 
 
High Performance Thin Layer Chromatography  
The HPTLC- finger printing of CHCl3 extract of CKC at UV- 254 nm (fig 6.26 ) 
revealed  seven peaks at the Rf 0.09; 0.14; 0.24; 0.31; 0.43; 0.54; 0.75. The percentage (% ) 
area of respective peaks were - 9.58; 22.11; 39.00; 3.64; 17.43; 1.38 and 6.87 in 
corresponding order. Table 6.18 reveals the Rf values and the percent (%) peak area of the 
peaks at UV- 254 nm. HPTLC- finger printing of CHCl3 extract of CKC at UV 366 ( fig 6.27 
) revealed nine peaks at the Rf - 0.09; 0.12; 0.23; 0.32; 0.41; 0.48; 0.54; 0.59 ; 0.65. The 
percentage (%)  area of the peaks were- 2.83; 1.67; 3.00; 19.96; 27.45; 36.22; 4.50; 2.41 and 
1.96 in the corresponding order. Table 6.19 revealed the Rf- values and the percent (%) peak 
area of the peaks at UV 366-nm. HPTLC - finger printing of CHCl3 extract of CKC after 
derivatization at 540 nm ( fig.6.28 ) revealed eleven peaks at the Rf- 0.15; 0.36; 0.44; 0.54; 
0.67; 0.72; 0.76; 0.78; 0.81; 0.87; 0.90. The percentage (%) area of the peaks were 3.37; 
21.66; 18.42; 6.16; 16.98; 17.97; 1.73; 1.68; 0.66; 3.74; 7.63 in the respective order. The 
Table 6.20  revealed Rf-values and the percent (%)  peak area of the peaks after derivatization 
at 540nm.  
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      Table 6.18: Rf values and percent area of all the peaks of CKC under UV-254 nm 
 
Peak Start Start Max Max Max End End Area Area 
 Rf Height Rf Height % Rf Height  % 
  1 0.07 0.3 0.09 52.4 11.16 0.10 46.6 1049.8 9.58 
  2 0.11 47.5 0.14 98.4 20.98 0.16 0.1 2423.7 22.11 
  3 0.20 1.4 0.24 184.1 39.25 0.28 1.3 4274.7 39.00 
  4 0.28 1.5 0.31 16.3 3.47 0.33 9.1 398.5 3.64 
  5 0.40 7.6 0.43 84.3 17.97 0.49 6.5 1910.5 17.43 
  6 0.53 9.8 0.54 11.9 2.55 0.55 0.4 151.3 1.38 
  7 0.71 6.2 0.75 21.7 4.63 0.79 0.5 752.9 6.87 
 
          Table 6.19: Rf values and percent area of all the peaks of CKC at UV-366 nm 
 
Peak Start Start Max Max Max End End Area Area 
 Rf Height Rf Height % Rf Height  % 
  1 0.07 0.7 0.09 21.5 4.26 0.10 8.1 383.1 2.83 
  2 0.11 7.8 0.12 16.7 3.31 0.14 1.9 225.9 1.67 
  3 0.20 0.6 0.23 0.23 2.90 0.26 0.2 405.5 3.00 
  4 0.27 0.1 0.32 0.32 17.89 0.36 14.2 2700.9 19.96 
  5 0.36 14.3 0.41 0.41 21.20 0.45 11.7 3713.6 27.45 
  6 0.45 11.8 0.48 0.48 41.73 0.52 10.6 4901.4 36.22 
  7 0.52 10.9 0.54 0.54 4.31 0.57 8.8 609.2 4.50 
  8 0.57 8.9 0.59 0.59 2.24 0.62 1.3 325.8 2.41 
  9 0.63 0.7 0.65 0.65 2.15 0.67 4.9 265.3 1.96 
 
       Table 6.20: Rf  values and percent area of all the peaks of CKC at UV-540 nm 
 
Peak Start Start Max Max Max End End Area Area 
 Rf Height Rf Height % Rf Height  % 
  1 0.12 0.5 0.15 23.0 4.11 0.17 0.9 470.2 3.37 
  2 0.30 9.8 0.36 59.9 10.73 0.40 39.5 3023.5 21.66 
  3 0.41 39.6 0.44 95.1 17.02 0.48 6.7 2571.1 18.42 
  4 0.50 2.7 0.54 24.1 4.31 0.59 3.2 860.2 6.16 
  5 0.62 3.3 0.67 84.9 15.19 0.69 1.4 2371.1 16.98 
  6 0.71 19.7 0.72 151.5 27.10 0.75 6.8 2508.5 17.97 
  7 0.75 7.6 0.76 21.7 3.88 0.77 13.8 242.1 1.73 
 8 0.77 14.0 0.78 14.7 2.64 0.80 0.6 234.0 1.68 
 9 0.80 0.9 0.81 11.6 2.07 0.82 0.2 91.6 0.66 
10 0.84 2.5 0.87 19.4 3.47 0.89 0.6 521.8 3.74 
11 0.89 0.1 0.90 53.0 9.48 0.93 27.0 1065.7 7.63 
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Microbial contamination and specific pathogens 
The bacterial count and the fungal count were observed to be within the specified 
limits. The specific pathogens (Salmonella spp, E. coli, Pseudomonas aeruginosa and 
Staphylococcus aureus ) were known to be absent.  The inferences were tabulated in the table  
6.21. 
      Table 6.21  Microbial contamination and specific Pathogens results of CKC 
 
Aflatoxins / mycotoxins and Pesticide Residues 
Aflatoxins / mycotoxins ( B1; B2; G1& G2 ) were observed to be BDL (below 
detection limit). Pesticide residues (organo chlorine /organo phosphorus) were found to be 
not detected in CKC. Results of aflatoxins and the pesticide residues were shown in the table 
6.22 
                        Table  6.22-  Aflatoxins / mycotoxins and Pesticide Residues 
 
 
 
 
 
                                                      (DL: 0.005 mg/kg ) 
 
Thermo gravimetric analysis:  
 
TGA- spectra of CKC (fig 6.29) revealed peaks at- 120⁰C; 235⁰C; 390⁰C; 910⁰C. At 
the degree of 120 centigrade (120⁰C) 5.148 percentage of the drug CKC decomposes. At the 
degree of two hundred and thirty five centigrade  (235⁰C ) 12.78 percentage of the drug CKC 
was decomposed / disintegrated. Likewise at 390⁰C; 41.29 percentage of the drug CKC was 
disintegrated and at the 910 degree centigrade, 13.43 perecentage of the drug CKC was 
disintegrated.  
 
 
   Microbial Test      Inference AYUSH/WHO/FDA -Specification 
Total Fungal count 305 CFU/g         NMT 10
3
 CFU/g 
Total bacterial count 17,000CFU/g         NMT 10
5
 CFU/g 
Salmonella pp  
  Absent/g 
 
 
            Absent/g 
 
  E. coli   
Staphyloccus aureus  
Pseudomonas 
aeruginosa 
  Aflatoxins and Pesticide Residues         Inference 
Aflatoxin B1,B2,G1 and G2  BDL (DL: 0.3 μg/kg) 
Organo phosphorus /organo chlorine Not detected  
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Toxicity study 
Effect on feed, water intake and survival of wistar rats 
No abnormal changes was observed in the feed and water intake of wistar rats 
between the control and treated groups in both acute and long term toxicity study.No 
mortality were observed in both acute and long term toxcity and the survival was hundred 
percent.    
 
Acute Toxicity study 
The study drug CKC treated rats at 10 TD dose level.did not show any death, 
behavioural changes and toxic signs immediately after dosing, during 14 days and at the end 
of the trial.On necropsy, no gross pathological abnormalities were observed in the vital 
organs (fig 6.30A, 6.30B) and hence the toxicity of the drug at 10 TD dose level can be ruled 
out. 
 
Body weight gain 
Weight gain (body) of vehicle control group showed significant (P<0.05) increase and 
10 TD group showed non significant changes when compared to that of the control group. 
(Table 6.23, 6.24, fig 6.30) 
 
     Table 6.23: Final body weight gain (mean) of each animal in acute toxicity study 
 
 
 
 
  
Table 6.24: Final body weight gain of each group in acute toxicity study 
 
 
 
 
 
            
 
 
Groups   Male Wistar Rats- Weight gain in gms 
1 2 3 4 5 6 
Normal control 43 40 31 37 40 31 
Vehicle control 43 40 41 48 51 46 
5 TD CKC 60 72 75 26 30 28 
Groups Body weight change in (g) 
Normal control 37 ±  2.0490 
Vehicle control 44.83 ± 1.7400* 
5 TD CKC 48.5 ±  9.4080 
Values are expressed as mean ±S.E.M; *P<0.05  
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Figure 6.31: Final body weight gain (mean) of each animal in acute toxicity study 
 
                          
 
Long term Toxicity study 
Body Weight Gain 
Body weight gain of vehicle control, 3 TD (P < 0.05) and 5TD (P<0.001) group 
showed significant increase than the control group. TD group showed non significant changes 
(P > 0.05) in the body weight gain.( table 6.25, 6.26, fig 6.31 ) 
 
Table 6.25: Final body weight gain (mean) of each animal in long term toxicity study 
 
 
 
 
 
 
   Table 6.26: Final body weight gain of each group in long term toxicity study 
`Groups Body weight change in (g) 
Normal control 122  ±  5.9910 
Vehicle control 148  ± 7.8730* 
1 TD CKC 158  ± 18.2890 
3 TD CKC 166  ± 12.9630* 
5 TD CKC 171  ±  9.4960*** 
Values are expressed as mean ±S.E.M; *P<0.05; 
***P<0.001  
         
 
 
0 
50 
100 
1 2 3 4 5 6 
Body weight gain of each animal  
5 theraphetic dose  
vehicle control 
Normal control 
Groups        Male Wistar Rats- Weight gain in gms 
1 2 3 4 5 6 
Normal control 133 115 145 115 125 104 
Vehicle control 168 157 140 147 163 115 
1 TD CKC 129 92 151 191 218 168 
3 TD CKC 154 221 146 130 169 179 
5 TD CKC 211 175 146 178 167 151 
105 
 
Figure 6.32: Final body weight gain  (mean) of each animal in long term toxicity study 
 
                    
Hematology 
Values of Hb; RBC; WBC; differential counts; MCH; MCHC; Platelets; MPV; PLT; 
PCT; HCT of the male wistar rats treated with the study drug of all doses levels ( TD, 3TD, 
5TD) showed  non-significant changes when compared to the control group.  MCV value of 
the vehicle control group -showed significant increase (p < 0.05) (within normal laboratory 
limits). The results do not indicate any serious pathological conditions. (Table 6.27) 
 
Clinical Chemistry 
 The values of trigycerides; globulin; bilirubin, sodium and blood sugar of wistar rats 
treated with the three dose levels  ( TD, 3TD and 5TD ) showed non significant 
changes (P >0.05) when compared with that of the control groups.  
 Blood urea was found to be significantly decreased (P< 0.05) in TD group which was 
comparable to the normal control groups and showed non significant changes in 
vehicle, 3TD and 5TD group. 
 Serum creatinine was found to be significantly increased (P< 0.05) in vehicle and TD 
group (within normal limits); and in 3TD and 5 TD groups showed non sinificant 
changes (P >0.05).  
 Total cholesterol showed non significant changes (P >0.05) in 5TD group; significant 
increase in vehicle (P< 0.05), 3TD group (P< 0.05) and TD (P< 0.01) group  (within  
normal limits ).  
0 
100 
200 
300 
1 2 3 4 5 6 
Body weight gain of each animal 
 
NC VC 1 TD 3 TD 5 TD 
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 Total protein was increased significantly (P< 0.05) in 5TD group and showed non 
significant changes (P >0.05) in vehicle, TD and 3TD group.  
 Albumin was increased significantly (P< 0.05) in 5TD and showed non-significant 
changes (P >0.05)  in vehicle, TD and 3 TD groups (within normal range).  
 AST was increased significantly in 3TD (P< 0.05) and vehicle group (P< 0.01) and 
non significant changes (P >0.05) in TD and 5TD group.  
 ALT showed significant decrease (P< 0.05) in 3TD group and non significant changes  
 (P >0.05) in vehcile, TD and 5 TD groups.  
 Potassium showed significant decrease (P< 0.01) in 5TD group and non significant 
changes (P >0.05) in vehcile, TD and 3 TD groups.  
 Chloride showed significant decrease in (P< 0.01) vehicle, (P< 0.05) 3TD and (P< 
0.05) 5TD group and non significant changes (P >0.05) in TD group. All were within 
normal limits. ( Table 6.28) 
            
              Table 6.27: Effect of CKC on hematological parameters in wistar rats 
Parameters Normal control Vehicle control 1 TD CKC 3 TD CKC 5TD CKC 
Hb 9.1 ± .7358 12.3±1.0327 10.9±.4879 10.4± 1.4652 10.1±.7055 
RBC 5.7± .4317 7.8 ± .6669 7.0 ± .3363 6.6 ± .9262 6.4 ± .4446 
WBC 7.7± 1.1870 9.083 ± 1.0167 6.2±.4757 7.0±1.2028 7.3±1.0920 
LYM 56.31 ± 2.1911 56.85± 1.3076 56.68± .9816 52.33± 1.6368 58.31±1.1083 
MON 3.7±.1962 3.9± .3981 4.0 ±.1310 3.8 ± .3842 4.0 ± .1803 
GRAN 39.9± 2.0241 39.2 ± 1.4098 39.2± .9290 43.7 ± 1.3686 37.8 ±1.1545           
MCV 46.13± .4455 47.93±.3989* 46.16±.3148 46.21±.5023 46.71± .2960 
MCH 15.78±.2182 15.68 ±.1759 15.30±.1915 15.46±.0919 15.98 ±.1249 
MCHC 34.383± .3458 32.85±.4794 33.30±.2769 33.58± .3563 34.2 ±.2887 
PLT 230.50±16.707 277± 28.931   233.67 ±15.549 323.33± 63.566 257.33 ±15.794 
MPV 5.683 ±.0401 5.750 ± .0671 5.700 ±.0683 5.967 ±.0919 5.700 ±.0365 
PCT .13050 ±.009 .15933 ±.0184 .13250 ± .007 .19333±.039547 .14750±.0081 
HCT 26.367 ±2.0089 37.583 ±3.2963 32.700 ±1.5360 31.000 ±4.5195 29.717 ±2.2198 
RDW 12.033 ±.4310 11.517 ±.3311 11.650 ±.1688 12.350 ±.2110 11.750 ±.1432 
PDW 14.583± .0833 14.733±. .0615 14.767 ±..0760 14.867 ±..0989 14.667 ±..0333 
                                              Values are expressed as mean ±S.E.M; *P<0.05 
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Organ Weights 
 
Table 6.29: Effect of different dose levels of CKC on organ weight [mg] in wistar rats  
 
 Normal control Vehicle control 1 TD CKC 3 TD CKC 5TD CKC 
Brain 1.60 ± .0719 1.76 ± .0585 1.52± .0650 1.56± .0290 1.62 ± .0785 
Heart 1.01± .0369 0.97±  .03337 0.94 ±  .0682 0.91±  0.0463 0.9 2± .0428* 
Lungs 1.77±. 0.1173 1.34 ±. 0.0683 1.46 ±0.0440 1.57± 0.1183 1.39± 0.0726* 
Liver 10.13 ± 0.3979 8.47 ± .3597 8.91±  0.5843 8.68 ± 0.7400 9.68± .3103 
Stomach 1.41± 0.1244 1.44  ± 0.1064 1.45 ± .0263 1.46 ±  0.0444 1.48 ± .0292 
Thymus 0.43 ± 0.0445 0.38 ± 0.0230 0.37 ± 0.0111 0.32 ± 0.0329 0.33  ± 0.0403     
Testis 2.75 ± 0.0839 2.83 0.0612 2.84  ±  0.1359 2.86± 0.0469* 2.89  ± 0.0549 
Kidney 1.31± 0.0852 1.19 ±0.0486 1.2 1± 0.0930  1.10 ± 0.0535 1.12 ± 0.0441 
                                              Values are expressed as mean ±S.E.M; *P<0.05   
 
 
Absolute weights of brain, liver, stomach, kidney and thymus were found to be 
comparable with those of the control group rats. Increase in absolute weight of testis 
(p < 0.05) was noted in animals of 3 TD group. Absolute weight of heart was found to be 
                          Table 6.28: Effect of CKC on biochemical parameters in wistar rats 
Parameters Normal control Vehiclecontrol 1 TD CKC 3 TD CKC 5TD CKC 
Glucose 96.17 ± 7.472 110.83±16.660 80.50±4.660 79.67±5.942 90.33±3.739 
Urea 35 ± 1.317 29.17 ± 4.183 28.83 ± 1.558* 30.17 ±3.124 35 ± 4.575 
Creatinine 0.6±.0365 0.7 ±.0428* 0.8±.0365* 0.5±.0885 0.7±.1014 
Cholesterol 63.33 ± 6.200 84.33± 4.645* 95.17±9.958** 83.17±5.388* 76.11±16.105 
Triglycerides 96.50±14.843 123.50± 6.206 135.33±13.583 103.33 ±9.032 132.67±16.760 
Protein 7.6± .2887 7.0 ±.1926 7.0 ±.3983 7.8 ±.6019 10.35 1.1147*               
Albumin 3.2±.2692 3.2±.1116 3.2±.1470 3.3±.2500 4.3±.2257* 
Globulin 3.7±.1478 3.7 ±.2044 3.7±.4301 4.5±.5426 5.9 ±.9807 
Bilirubin 0.3± .0333 0.5±.0931 0.4±.0703 0.5± .1195 0.4 ±.1057 
AST 136.6±3.774 154± 7.317**    138.50 6.412 173.83±14.481* 160.67±17.416 
ALT 63.50± .992 74 ±9.274 60.17± 2.798 53.33± 3.593* 57.17 ±3.114 
Sodium 134.33± 1.085 133.33± .803 133.50±.619 132.83±.654 133.83 ±.477 
Potassium 7.0±.000 7.6± .3117 7.4 ±.1910 6.6± .2473 7.3 ±.0957** 
chloride 106.83±.792 104.33±.494** 105.17± .477 104.33± .494* 104.67± .333* 
                                   Values are expressed as mean ±S.E.M; *P<0.05 ; ** P< 0.01  
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significantly decreased (p < 0.05) in 5TD group and absolute weight of lungs was found to be 
significantly decreased (p < 0.05) in 5TD and vehicle group. (Table 6.29) 
 
Histopathology 
Vital organs like brain, heart, liver, kidney, spleen, lungs, stomach, intestine, thymus 
and testis from both treated (1TD, 3TD, 5TD) and control (normal and vehicle) group 
animals showed normal architecture. Mild focal chronic gastritis was observed in glandular 
part of the stomach in one animal of 5TD group (1/6). [Table 6.30, fig 6.33] 
 
                Table 6.30: Effect of CKC on histopathological study in wistar rats 
 
Spermatogenic Activity 
Body Weight Changes 
Ethanol treated group showed significant decrease (p< 0.001) in the mean body 
weight changes of the rats when compared to that of the control group. Significant increase 
(p< 0.001) in mean body weight changes was observed in study drug group when compared 
to ethanol induced group. [Table 6.31] 
Table 6.31: Effect of CKC on Body weight of rats in Spermatogenic study) 
 
 
 
                Samples               Groups Male Rats ( n=6 ) 
Brain, Heart, Lungs, Liver, Thymus, 
Spleen, Intestine, Kidney, Testis 
Normal control, vehicle control   
1TD  / 3TD / 5TD 
 
     Normal 
 
               Stomach 
Normal control, vehicle control 
1TD and 3TD group 
     Normal - 5/6 
            5TD group 1/6-chronic gastritis 
       1TD- 1 Therapeutic dose;   3 TD -3 Therapeutic dose ;   5TD -5 Therapeutic dose 
           Groups Initial body weight  (gm)   Final Body weight (gm) 
Normal Control [NC]          182± .47679        196.78±1.8675 
Induced Group [ IG]            180.75± .2997        151±.4782 ***  a 
Treatment Group[TG]          181.80± .3464   190.46±.5725   *** b & c 
                        Values are expressed as mean ±S.E.M; *P<0.001   
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Reproductive organ weights 
Significant reduction (P<0.001) in the mean values of the weight of epididymis and 
prostate was noted in ethanol treated  group  when compared to control group and the mean 
value of the weight of testis of the ethanol group showed non significant reduction when 
compared to control group. Study drug treated group showed significant increase (p < 0.001) 
in the weight of testis, epididymis and prostate when compared to ethanol induced group. 
                           Table 6.32: Effect of CKC on reproductive organs of male wistar rats 
    Groups Testis  ( g ) Prostate ( g ) Seminal Vesicle ( g ) 
Normal Control [I] 1.57±.0644 0.54±.0148 0.56±.01355 
Induced Group [ II]   1.43±.0185 a 0.30±.0204  a*** 0.42±.0053    a***  
Treatment Group[III] 1.52±.0056  b*** ; c 0.49±.0025  b***; c* 0.53±.0051    b/c***  
Values are expressed as mean ±S.E.M, n=6, a- Group I vs Group II, b-Group II vs.    
Group III, c - Group I vs Group III;  ***P < 0.001 
 
Biochemical parameters 
Cholesterol 
Significant increase in mean value of cholesterol (p < 0.001) was noted in the ethanol 
group when compared to that of the control group rats. Study drug group showed significant 
decrease (p < 0.001) in the mean value of cholesterol when compared to the ethanol induced 
group and is not too far from the control group value. [Table 6.33] 
 
Glycogen 
Significant decrease (p < 0.001) in the mean values of glycogen was observed in the 
induced group than the control group. The mean value of glycogen of the study group showed 
high significant increase (p < 0.001) than both ethanol induced and normal control group. 
[Table 6.33] 
 
Protein 
Ethanol induced group showed significant increase (p < 0.001) in the mean values of 
protein than control group. The mean values of protein in the study drug group showed non 
significant decrease than the induced group and showed significant increase (p < 0.001) than 
the control groups. [Table 6.33].  
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 Serum testosterone (TT) 
The serum TT levels of the ethanol induced group had showed significant (p < 0.001) 
decline. The rats of the treatment group showed significant (p < 0.001) recovery in the 
testosterone level from the induced group. [Table 6.34] 
 
 
 
 
 
 
 
Effect on sperm indices 
Rats exposed to ethanol (25%) group showed significant decrease (P<0.001) in the 
sperm count, motility, normal forms of sperm and viabilty and significant increase (P<0.001) 
in abnormal forms of sperm when compared to that of the control group. Treatment group 
showed significant increase (P<0.001) in sperm count, motility, viability, normal form of 
sperm and significant decrease (P<0.001) in abnormal form of sperm when compared to that 
of the ethanol induced group. [Table 6.35] 
    Table 6.33: Effect of CKC on biochemical parameters of male rats in spermatogenic study 
       Groups Total Cholesterol   
        ( mg/dl ) 
    Total Protein  
        (mg /dl ) 
      Glycogen   
     ( mg/gm ) 
Normal Control [I] 102.25 ± 0.3547  5.7±0.0856 13.617±.0872 
Induced Group [ II]   120.4 ±0.3983 a***  6.29±0.0545   a*** 10.34±.07668   a*** 
Treatment Group[III] 99.36 ±0.4616  b/c***  5.72±0.0475  b ; c***  14.56±.11450  b/c***  
Values are expressed as mean ±S.E.M, n=6, a- Group I vs Group II, b-Group II vs.    Group 
III, c - Group I vs. Group III, ***P < 0.001 
Table 6.34: Effect of CKC on Serum Testosterone level (ng / DL) 
Normal Control -Group I 75.38± 1.2316 
Ethanol Induced-Group II 34.40±5.2305  a***                 
Treatment         - Group III 63.30±5.62645   b*** &  c 
Values are expressed as mean ±S.E.M, n=6, a- Group I vs Group II, 
b-Group II vs.    Group III, c - Group I vs. Group III, ***P < 0.001. 
                        Table 6.35: Effect of CKC treatment on Sperm parameters of rats 
Groups     Count 
(million/ml) 
Motility (% )          Morphology ( % ) Viability  
   ( % ) Normal  Abnormal 
Normal 
Control [I] 
103.73±1.19 76.31±1.93 86.22±2.45 13.77±2.45 67.27± 1.84 
Induced 
Group [ II]   
57.32±.58  
a***  
20.86±1.89 
a*** 
25.06±2.96 
a*** 
74.93±2.96  
a***  
44.44±1.96 
 a*** 
Treatment 
Group[III] 
90.85±5.796  
b*** & c 
60.28±4.761 
b*** &  c* 
88 ±.8025 
***b & c 
11.99±.802  
***b &  c 
63.02±2.23 
b*** &  c 
Values are expressed as mean ±S.E.M, n=6, a- Group I vs Group II, b-Group II vs. 
Group III, c - Group I vs. Group III, *P<0.05 ,  ***P < 0.001. 
111 
 
Histopathological Examination:  
Histocytology of testicular tissue of the control group animals (Group I) showed well 
differentiated germ cells with respect to spermatogonia which also includes the spermatid and 
sperm. It was observed that the presence of mature somatic cells projects the perfect 
histomorphology of the testicular cells in this group. Normal sertoli cell was aligned properly 
on the basement membrane with oval dome shaped nucleus which showed the normal 
morphology of the seminiferous tubule. (fig 6.34 A,B; fig 6.35 ) 
 
Microscopic observation of Group II animals (ethanol) showed decreased number in 
normal sertoli cells with the irregular cytoarchitecture, further there is evident of decrease in 
the number of spermatogenic cells into the lumen of seminiferous tubule. The Primary 
spermatocytes of the sample belonging to group II showed condensed chromatin similarly the 
number of leptotenes and zygotenes are very minimal in this group. Arrangement of 
connective tissue surrounds many very minimal numbers of polygonal cells. (fig 6.36 A, B). 
Size and shape of the sperm appears abnormal in the group treated with alcohol. ( fig 6.37) 
 
Histological examination of rat testis belonging to Group III (CKC) stained by 
hematoxylin and eosin showed many seminiferous tubules encircled by prominent 
membrane. Leptotene and zygotene spermatocytes appeared rich in number. Primary 
spermatocytes with large centered nucleus and dense chromatin were observed. Seminiferous 
tubules showed plenty of sertoli cells with normal histology and also increased spermatogenic 
cells into the lumen of seminiferous tubule. The seminiferous tubules showed normal 
spermatogenesis and spermiation.Sertoli cells with apparent triangular nucleus were observed 
in the group supplemented with test drug. And also proper distribution of collagen fibers 
along with the seminiferous tubule was observed. Tubules appeared to be uniform in size and 
shape. Specimen belonging to the group III showed normal flat basement membrane. 
Absolute interstitial layer was observed. Animals treated with test drug showed normal 
morphology of cauda epithelial layer and also numerous number of spermatid cells were 
observed. Presence of epididymal lobule was normal. This group showed normal flat 
basement membrane. Size and shape of the Spermatozoa were observed to be normal. 
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Histometric study 
 
Diameter of Tubules 
Histogram of seminiferous tubules of the control group animals were 206.6, 205.9 and 
203.8 μm as showed by reading on the micrometer scale. Ethanol treated animals showed 
shrunken pattern evident by decrease in the width (103.6; 157.7; 122.4 μm) and in treatment 
group it is recovered (183.9; 192.7; 210.7 μm) from the induced group. (fig 6.38 ) 
 
Diameter of Testis 
Measurement of thickness of testis in the control group animals were 183.7 x 128.6, 
186.6 x 131.8 and 201.6 x 107.2 μm as showed by reading on micrometer scale. Ethanol 
induced group animals showed shrunken values (180.0 x 126.7, 141.8 x 142.0, 155.0 x 126.7 
μm) and in the treatment group it was recovered (174.3 x 137.7, 188.4x137.0, 238.8 X 134.1 
and  208.6x125.4  μm ) from the ethanol induced group.(fig 6.39 ) 
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Clinical study 
Pilot study  
Haematological parameters 
The mean value of Hb ( 15.79; 15.9 ), RBC ( 5.26; 5.24 ), T.WBC ( 7900.0 ; 7940.0) 
and platelets ( 2.74; 2.76 ) were statistically non-significant (p >0.05 ) AT (after treatment ) 
and AFU (after follow up). The mean value of ESR ( 5.2 )  showed  significant decrease ( 
P<0.01) AT (within normal range) and showed non significant changes ( 4.80 ; p >  0.05 ) 
AFU.[Table 6.36 A, B ] 
          Table 6.36A: Effect of CKC on haematological parameters in pilot study (AT) 
 
        Table 6.36 B: Effect of CKC on haematological parameters in pilot study (AFU) 
 
Biochemical parameters 
 The mean value of blood sugar ( 102.2; 104.0 ), HDL ( 38.6; 38.2 ), urea ( 22.0; 22.0), 
creatinine ( 0.82 0.84 ), total bilirubin ( 0.90, 0.88 ), total protein ( 6.16, 6.32 ) showed 
non significant changes both AT and AFU.  
 Serum cholesterol showed significant decrease AT (153.4; p < 0.001) and AFU ( 
153.0; p < 0.05). 
                 
 
 
Haematology         Mean Mean 
diff 
S.D S.E t p 
BT          AT 
HB 15.72 15.9 0.18 0.178 0.080 2.25  
 
p >  0.05 
RBC 5.28 5.26 0.02 0.258 0.115 0.17 
T.WBC 7660.0 7900.0 240.0 250.9 112.5 2.13 
Platelets 2.68 2.74 0.06 0.151 0.67 0.88 
ESR 6.8 5.2 1.6 0.894 0.4 4.0 P<0.01** 
                              Values are expressed as mean ±S.E.M, n=5,  
                               p-values :Significance levels:    **P<0.01 
Haematology          Mean Mean 
diff 
S.D S.E t p 
BT          AFU 
HB 15.72 15.9 0.18 0.148 0.0663 2.714  
 
p >  0.05 
 
RBC 5.28 5.24 0.04 0.151 0.0678 0.590 
ESR 6.8 4.80 2.0 2.0 0.894 2.236 
T.WBC 7660.0 7940.0 280.0 258.844 115.758 2.419 
Platelets 2.68 2.76 0.08 0.30331 0.1356 0.590 
                              Values are expressed as mean ±S.E.M, n=5,  
                                   p-values : non Significant:    p >  0.05  
114 
 
            Table 6.37A: Effect of CKC on biochemical parameters in pilot study (AT) 
 
  
          Table 6.37 B: Effect of CKC on biochemical parameters in pilot study (AFU) 
 
 
 
 
Biochemical       Mean Mean 
diff 
S.D S.E t p 
BT          AT 
R.Sugar 105.6 102.2 3.4 3.286 1.47 2.313 p >  0.05 
S.Cholesterol 158.4 153.4 5.0 1.414 0.632 7.906 P<0.001*** 
HDL 37.0 38.6 1.60 2.702 1.208 1.324 p >  0.05 
LDL 90.8 85.2 5.60 2.510 1.122 4.989 P<0.001*** 
VLDL 45.8 40.4 5.40 0.548 0.245 22.045 P<0.001*** 
TGL 177.2 162.4 14.8 9.445 4.224 3.504 p < 0.05* 
B.Urea 22.6 22.0 0.60 3.130 1.40 0.429 p >  0.05 
S.Creatinine 0.80 0.82 0.02 0.04 0.02 1.0 p >  0.05 
Uric acid 4.08 3.120 0.96 0.250 0.112 8.552 P<0.001*** 
T.Bilirubin 0.90 0.90 0.00 0.14 0.06 0.00 p >  0.05 
T.Protein 6.76 6.16 0.6 0.651 0.2915 2.058 p >  0.05 
AST 31.4 23.6 7.80 1.924 0.860 9.067 P<0.001*** 
ALT 41.4 35.0 6.40 4.775 2.135 2.997 p < 0.05* 
SAP 165.6 160.4 5.20 1.095 0.490 10.614 P<0.001*** 
                               Values are expressed as mean ±S.E.M, n=5,  
                       p-values :  Significance levels:   *p < 0.05,  ***P<0.001 
Biochemical         Mean Mean 
diff 
S.D S.E t p 
BT         AFU 
R.Sugar 105.6 104.0 1.60 3.362 1.503 1.064 p >  0.05 
S.Cholesterol 158.4 153.0 5.40 4.09 1.833 2.946 p < 0.05* 
HDL 37.0 38.2 1.20 4.382 1.960 0.612 p >  0.05 
LDL 90.8 85.6 5.20 5.119 2.289 2.272 p >  0.05 
VLDL 45.8 39.6 6.2 1.643 0.735 8.437 p < 0.001*** 
TGL 177.2 165.4 11.80 7.918 3.541 3.332 p >  0.05 
B.Urea 22.6 22.0 0.60 2.793 1.249 0.480 p >  0.05 
S.Creatinine 0.80 0.84 0.04 0.089 0.04 1.00 p >  0.05 
Uric acid 4.08 3.40 0.68 0.248 0.1113 6.107 p < 0.001*** 
T.Bilirubin 0.90 0.88 0.02 0.1304 0.0583 0.343 p >  0.05 
T.Protein 6.76 6.32 0.440 0.7369 0.3295 1.335 p >  0.05 
AST 31.4 26.8 4.60 1.57 0.678 6.782 p < 0.001*** 
ALT 41.4 36.6 4.80 3.421 1.530 3.138 p < 0.05* 
SAP 165.6 161.0 4.60 2.074 0.927 4.960 p < 0.001*** 
                            Values are expressed as mean ±S.E.M, n=5,  
                            Significance levels:  *p < 0.05, ***p < 0.001 
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 LDL showed significant decrease (85.2, P<0.001) AT and non significant changes 
(85.6, P<0.05) AFU. TGL showed significant decrease (162.4, p < 0.001) AT and 
showed non significant changes (165.4, p > 0.05) AFU.    
 VLDL (40.4, 39.6), uric acid ( 3.12, 3.40 ), AST (23.6, 26.8 ), SAP ( 160.4, 161.0 ) 
showed significant decrease (p < 0.001) AT and AFU.  
 ALT (41.4, 36.6) showed significant decrease (p < 0.05) AT and AFU. All were 
within normal range. 
Semen Parameters 
The trial drug provided significant increase (P < 0.001 ) in the sperm count ( 41.6, 
36.0 )  progressive motility ( 39.8, 36.2 ), total motility ( 51.2, 50.0 ) and normal form of 
sperm ( 53.8, 51.8 ) both AT and AFU. Non significant changes (p > 0.05) was observed in 
the volume (1.8, 1.60) and the liquification time (26.0, 26.0) both AT and AFU.      
          
          Table 6.38 A: Effect of CKC on semen parameters  in pilot study (AT) 
 
      Table 6.38 B: Effect of CKC on semen parameters  in pilot study (AFU) 
 
 
        
 
 
Semen 
Analysis 
      Mean Mean 
diff 
S.D S.E t p 
BT           AT 
Count 8.6 41.6 33.0 12.708 5.683 5.806  
 
P<0.001*** 
Pr.Motility 9.6 39.8 30.2 3.834 1.715 17.61 
T.Motility 23.2 51.2 28.0 7.176 3.209 8.724 
Morphology 34.2 53.8 19.6 4.827 2.159 9.080 
Volume 1.3 1.8 0.50 0.50 0.223 2.236 p >  0.05 
 Liquification 27.0 26.0 1.0 4.183 1.871 0.535 
                         Values are expressed as mean ±S.E.M, n=5,  
                           p-values :Significance levels:    ***P<0.001 
Semen 
Analysis 
     Mean Mean 
diff 
S.D S.E t p 
BT       AFU 
Count 8.6 36.0 27.4 12.708 5.683 5.806  
 
P<0.001*** 
Pr.Motility 9.6 36.2 26.60 2.608 1.166 22.80 
T.Motility 23.2 50.0 26.8 12.43 5.562 4.818 
Morphology 34.2 51.8 17.60 3.847 1.720 10.230 
Volume 1.3 1.60 0.30 0.908 0.4062 0.739  
p >  0.05 Liquification 27.0 26.0 1.0 6.519 2.915 0.343 
                           Values are expressed as mean ±S.E.M, n=5,  
                             p-values :Significance levels:    ***P<0.001 
116 
 
 
 
Harmone Parameters 
 
The mean value of testosterone ( 5.70, 5.55 ) and LH ( 6.46, 6.29 ) showed significant 
increase ( P <0.001) AT and AFU and FSH  showed significant increase ( 7.74, p  < 0.01 ) 
AT and ( 7.40, p < 0.05) AFU. 
 
      Table 6.39 A: Effect of CKC on harmone parameters in pilot study (AT) 
 
 
 
        Table 6.39 B: Effect of CKC on harmone parameters in pilot study (AFU) 
 
 
 
 
 
 
 
 
 
 
 
 
Harmone        Mean Mean 
diff 
S.D S.E t p 
BT          AT 
Testosterone 4.16 5.70 1.536 0.172 0.077 19.869 P<0.001*** 
FSH 6.63 7.74 1.110 0.544 0.243 4.556 p < 0.01** 
LH 5.612 6.46 0.854 0.119 0.053 16.008 P<0.001*** 
                                Values are expressed as mean ±S.E.M, n=5,  
                        p-values : Significance levels:    **p < 0.01, ***P<0.001 
Harmone        Mean Mean 
diff 
S.D S.E t p 
BT         AT 
Testosterone 4.16 5.558 1.392 0.2394 0.107 13.0 P<0.001*** 
FSH 6.63 7.406 0.776 0.5539 0.247 3.132 p < 0.05* 
LH 5.612 6.298 0.686 0.1234 0.055 12.43 P<0.001*** 
                         Values are expressed as mean ±S.E.M, n=5, 
                 p-values :Significance levels:   *p < 0.05,   ***P<0.001 
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Main Clinical Trial 
 
I] Observation based on patients general status 
 
1) Age (n-37 ) 
 
                             Fig 6.40A: Observation of patients based on age 
                          
It was observed that the maximum of 22 (59%) patients were found between the age 
group of 31 to 40 years, 11 ( 30 %) patients were between 21-30 years and 4 ( 11 %) patients 
were between 41-45 years.  
 
2) Nature of work  (n-37 ) 
 
                  Fig 6.40 B: Observation of patients based on Nature of Work 
                        
Majority of the patients 19 (51 %) were doing  physical exertional work, 12 (32 %) 
patients were doing intellectual work, 02 (5 %) patients were doing chemical/radiation work 
and 04 (11%) patients comes under  thermal  nature of work.  
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3) Educational status (n-37 ) 
 
10 (27%) patients had primary education, 6 ( 16%) had secondary education,18 (49%) 
had graduation and 3 ( 8% ) were illliterate. 
               
              Fig 6.40 C: Observation of patients based on Educational Staus 
                       
 
4) Socio economic status (n-37 ) 
            
             Fig 6.40 D: Observation of patients based on Socio Economic Staus 
                      
27 (73%) patients comes under middle economic status and 7 (19%) patients of low 
economic status and 3 (8%) patients of high economic status. 
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5) Sexual habit (n-37 ) 
 
                   Fig 6.40 E: Observation of patients based on Sexual habits 
                       
 
21 (57%) patients comes under normal, 2 (5%) patients comes under perversion and 
14 (38%) patients had the history of masturbation before marriage. 
 
6) Sleeping pattern  (n-37 ) 
                             
                  Fig 6.40 F: Observation of patients based on Sleeping Pattern 
                      
 
Only 9 (24%) patients had sound sleep, 16 (43%) had disturbed sleep and 12 (32%) 
patients were having delayed sleep   
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7)  Diet (n-37 ) 
 
                                Fig 6.40 G: Observation of patients based on Diet 
                          
Majority of 34 patients (92%) were of mixed type and remaining 3 (8% ) patients 
were vegetarian. 
 
8) Addiction (n-37 ) 
 
6 patients (16%) were addicted to smoking, 9 (24 %) patients to alcohol, 2 patients (6 
%) to tobacco, 4 patients (11 %) both to smoking and alcohol and 16 (43%) patients were 
having no addiction     
         
                     Fig 6.40 H: Observation of patients based on Addictions 
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9) Infertility (n-37 ) 
 
                     Fig 6.40 I: Observation of patients based on Infertility 
                      
36 (97%) patients were presented with primary infertility and 1 (3%) patient complained of 
secondary infertility. 
 
10] Duration of infertility (n-37) 
                       
             Fig 6.40 J: Observation of patients based on duration of infertility 
                             
Highest proportion of duration of infertility was observed between 1-5 years in 23 
(62%) patients, 8(22%) patients showed duration between 6-10 years, 5(13%) patients 
showed between 11-14yrs and in 1 (3%) patient the duration was found above 15 years.  
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11) Psychological state (n-37 ) 
 
                    Fig 6.40 K: Observation of patients based on Psychological State 
                   
6 (16%) patients had normal psychological status, 5 (13%) patients were in 
depression, 8 (22%) patients were in anxious state, 4 (11%) patients were in fear and anger 
state each and 10 (27%) were under stress 
 
12) Gonadotoxic agents (n-37) 
 
                   Fig 6.40 L: Observation of patients based on Gonadic toxic agents 
                            
 
Maximum of 27 ( 73%) patients had no history of exposure to gonadotoxic agents and  
10 (27 %) patients had history of exposure to gonadotoxic agents.  
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13) Previous illness (n-37) 
 
                       Fig 6.40 M: Observation of patients based on Previous Illness 
                        
 
2 (5%) patients had the history of mumps, 3 (8%) patients had TB and maximum of 
33 ( 86%) patients had no exposure to previous illness. 
 
 
14) Family history (n-37) 
 
                       Fig 6.40 N: Observation of patients based on Family History 
                       
 
Only  3 (8% ) of the patients had the family history of delayed conception in mother 
or siblings, 1 (3%) patient had history of infertility in siblings and 33 ( 89% ) patients had no 
family history 
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15) Blood group (n-37 ) 
 
Maximum of 15 (40%) patients reported O+ group, 11 (30%)  patients reported  A+ 
group, 4 (11%) patients reported AB+ group and 7 (19%) patients reported B+ group. 
 
                Fig 6.40 O: Observation of patients based on Blood Group 
                    
 
16) Bathing habit (n-37) 
 
                         Fig 6.40 P: Observation of patients based on bathing habit 
                   
15 (41%) patients were having the habit of hot water bath and 22 (59%) patients were 
having the habit of normal water bath. 
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17) BMI (n-37 )  
 
                        Fig 6.40 Q: Observation of patients based on BMI 
                       
BMI signifies 2 (5 %) patients were underweight, 4 (11%) patients were over weight, 
4 (11%) patients were obese and 27 (73%) comes under normal category. 
 
II] Observation based on Laboratory findings 
 
Semen Parameters 
 
1) Semen volume (n-37) 
 
                       Fig 6.41A: Observation of patients based on Semen Volume 
                           
BT 18 (49%) patients were reported with semen volume below 1ml; 16 (43%) 
patients reported semen volume of 1-2 ml and rest 3 (8%) patients reported semen volume of 
more than 2 ml. AT 5 (14%) patients reported semen volume below 1ml, 22 (59%) patients 
showed improvement in semen volume between 1 –2 ml and 10 (27%) patients showed 
improved volume more than 2ml. AFU 8 (22%) patients reported volume below 1ml, 24 (65 
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%) patients reported volume between 1-2ml and 5 (13%) patients reported volume of above 
2ml. 
 
2) Liquification time  (n-37) 
 
                       Fig 6.41 B: Observation of patients based on liquification time 
                             
Liquification time of the patients BT was 16 (43%) in 10_15 mts, 11 (30 %) in 
16_30mts, 10 (27%) in 31_45mts and AT with the proportion of 20 (54%) patients in 
10_15mts, 13 (35%) patients in 16_30mts, 4 (11%) patients in 31_45mts and AFU showed 
the proportion of 18 (49%) patients in 10_15mts, 12 (32%) patients in 16_30mts and 7 (22%) 
patients in 31_45 mts.  
 
3) Semen Viscosity (n-37) 
 
                         Fig 6.41 C: Observation of patients based on Viscosity 
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BT 6 (16 %) patients showed high viscous semen, 2 (5 %) patients of low visous 
semen and AT the values decreased to 1(3%) patient in high visous semen, no patients (0%) 
in low viscous semen and AFU the values were 2 (5%) patients in high viscous semen and no 
patients (0 %) in low visous semen. 
 
4) Puscells (n-37) 
 
                          Fig 6.41 D: Observation of patients based on pus cells 
                              
 
BT 5 (13%)  patients showed pus cells of more than value of 5,  4 (11%) patients  
showed  less than 5 and AT the values decreased to 1 (3%) in more than 5, 4 (11%) patients 
in less than 5 and AFU the values were  no patients (0%) in more than 5 and 2 ( 5%) patients  
in less than 5.  
 
5)  Sperm count  (n-37) 
Out of 37 patients, BT 22 (59%) patients were having sperm count below 10 
millions/ml; 15 (41%) patients were having sperm count 11-20 millions/ml, AT 9 (24%) 
patients were having count below 10 millions/ml, 1 ( 3%) patient showed improvement up to 
11-20 millions/ml; 9(24%) patients were improved in sperm count of 21-30 millions/ml; 7 
(19%) patients were improved up to sperm count of 51 – 60 millions/ml, 11(30%) patients 
were improved up to sperm count of 61- 70 millions/ml; and AFU 8 (22%) patients reported 
count below 10 millions/ml, 6 (16) patients reported up to 11- 20 millions/ml; 8 (22%) 
patients reported sperm count up to 21-30 millions/ml;3(8%) patients  reported count up to 
31-40millions /ml, 6(16%) patients  reported count of 41-50 millions/ml and 6 (16%) patients 
reported count up to 51-60 millions /ml.  
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                                   Fig 6.41 E: Observation based on Sperm count 
                      
 
6) Progressive Motility (n-37) 
 
              Fig 6.41 F: Observation of patients based on Progressive Motility 
                       
 
BT out of 37 patients 25 (68%) patients reported progressive motility of 0-10%; 
9(24%) patients were having progressive motility of 11-20%; 3 (8%) patients were having 
progressive motility of 21-30%;  AT 5 (14%) patients were having progressive  motility of 0-
10 %, 2  (5 %) patients improved up to 11-20%; 10 (27%) patients improved up to 31-40%; 
18 (49 %) patients improved up to 41-50%; 2 (5%) patients improved up to 51-60% and AFU 
4(11%) patients reported progressive motiliy of 0-10%, 3(8%) patients reported  up to 11-
< 10 11_20 21_30 31_40 41_50 51_60 61_70 
AFU 22% 16% 22% 8% 16% 16%   
AT 24% 3% 24%     19% 30% 
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20%, 4(11%) patients reported up to 21-30%, 10( 27%) patients reported up to 31-40%, 
16(43%)patients reported up to 41-50%. 
 
7) Total Motility (n-37) 
BT out of 37 patients, 3 (8%) patients were reported total motility of 0-10%; 13(35%) 
patients were having total motility of 11-20%; 15 (41%) patients were having total motility of 
21-30%; 6(16%) were having  total motility of 31-40%. AT 2 (5%) patients were having 
progressive  motility of 0-10 %, 2  (5%) patients improved up to 11-20%; 3(8%) patients 
improved up to 31-40%; 7 (19%) patients improved up to 41-50%; 8 (22%) patients 
improved up to 51-60%,7(19%) patients improved up to 61-70%, 5( 14%) patients improved 
up to 71-80%, 3(8%) patients improved up to 81-90%. AFU 3 (8%) patients reported 
progressive motiliy of 0-10%, 4(11%) patients reported up  to 21-30%, 2(5%) patients 
improved up to 31-40%, 10( 27%) patients reported up to 41-50%, 11(30%) patients reported 
up to 51-60%, 4(11%)patients reported up to 61-70%, 3(8%) patients reported 71-80% of 
total motility. 
              
                Fig 6.41 G: Observation of patients based on Total Motility 
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8)  Normal sperms (n-21) 
 
                         Fig 6.41 H: Observation of patients based on Normal form of Sperm 
 
 
 
 
 
 
 
 
 
 
 
 
BT 21 patients were having less than normal form of sperm. AT out of 21 patients, 6 
(29%) patients were having  0-5 % normal form of sperm, 4  (19%) patients improved  up to 
5-10%; 6(29%) patients improved up to 11-20%; 5  (23%) patients improved up to 20-30%; 
AFU 8 (38%) patients reported normal form of sperm of  0-5%, 5 (24%) patients reported up  
to 5-10%, 7 (33%) patients reported up to 11-20%, 1(5%) patients reported up to 20-30% of 
normal form of sperm.  
 
Harmone parameters 
 
9) Testosterone (n-37) 
 
    BT 2 (5%) patients were having testosterone below 2.8 ng/ml, 34 (92%) were having range 
between  2.8 to 8 ng/ml, 1(3%) patients were having above 8 ng/ml. AT 36(97%) patients 
were improved to the range between  2.8 to 8ng/ml  and 1 (3%) patient was having above 
8ng/ml value. AFU 35(95%) patients were reported to have 2.8 to 8ng/ml testosterone and 2 ( 
5%) patients were reported to have above 8ng/ml of testosterone.  
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                   Fig 6.42A: Observation of patients based on Testosterone 
                           
 
10) FSH (n-37 
 
BT 25(68%) patients were having FSH in the range between 1.7 to 8.6 mIu/ml, 12 
(32%) patients were above 8.6 mIu/ml, AT and AFU same proportion was reported. 
 
                               Fig 6.42 B: Observation of patients based on FSH 
                           
 
11) LH  (n-37) 
 
BT 34 (92%) patients were having LH in the range between 1.5-12.4mIu/ml, 3(8%) 
patients were having LH above 12.4 mIu/ml. AT same proportion was reported. AFU 
35(95%) patients reported the range between 1.5 to 12.4mIu/ml and 2 (5%) patients reported 
to have above 12.4mIu /ml. 
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                           Fig 6.42 C: Observation of patients based on LH 
                                   
 
12) Urine routine:  
 
Albumin, Sugar, bile salts, bile pigments, Urobilinogen, Acetone, occult blood all the 
parameters were found to be absent BT, AT and AFU. 
 
III] Observation based on Clinical symptoms (n-37) 
BT 20 (54%) patients with erectyle dysfunction, 26 (70%) patients with premature 
ejaculation and 11(30%) patients with nocturnal emission were reported and AT 6 (16%) 
patients with erectyle dysfunction, 4 (11%) patients with premature ejaculation and 2 (5%) 
patients with nocturnal emission were reported. 
 
                     Fig 6.43: Observation of patients based on Clinical Symptoms 
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IV] Observation of patients based on Siddha clinical parameters  
 
1) Kaalam [Patients age] (n-37) 
 
                       Fig 6.44A: Observation of patients based on Kaalam 
                      
Among 37 cases, 54% of cases came under vatha kaalam the age group between 1-33 
years and 46 % of cases came under pitha kaalam the group between 34-66 years.  
 
2) Thinai  (Habitat) (n-37) 
 
Majority of 15 (89 %) patients were reported from neithal thinai (costal tract), 3 (8 %) 
patients reported from kurinchi thinai [hilly tract] and 1 (3%) patient reported from mullai 
thinai [sylvan tract]. 
                         
                      Fig 6.44 B: Observation of patients based on Thinai 
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3) Noi utra kaalam  ( Season) (n-37) 
Among 37 cases, 15 ( 40%) patients reported during Kaar kaalam[ rainy season - mid 
august to mid october], 4 (11%) patients reported during pinpanikalam [early winter-mid 
february tomid april ], 11 ( 30%) patients reported during Ilavenirkaalam [early summer-mid 
april to mid june], 7 (19%) patients reported during Muthuveneerkaalam [late summer-mid 
june to mid august] and no patients ( 0%) reported during Koothirkaalam [late rainy season-
mid october to mid december] munpanikalam [latter winter-mid december to mid february]. 
   Fig 6.44 C: Observation of patients based on Noiutra Kaalam 
                     
 
4) Thega ilakkanam (bio type) (n-37) 
 
Majority of the patients were of kabha pitham biotype with the proportion of 30%, 
24% of vathapitham, 16% of pitha kabham, 14 % of pitha vatham, 8% of vatham, 5% of 
vatha kabham and 3 % of kabham biotype 
                       Fig 6.44 E: Observation of patients based on Thega ilakkanam 
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5) Udal Thathukkal (Physical constituents) (n-37) 
Before treatment all the (100%) patients had deranged saaram ( chyle) and sukkilam 
(semen), 76%  patients had deranged senneer (blood). 32% patients had deranged oon 
(muscle), 27%  patients had deranged kozhuppu (fat), 41%patients had deranged enbu (bone), 
30% patients had deranged  moolai (bone marrow)  and after treatment it was reduced to 22% 
of saram and sukkilam, 8% of senneer, 5% of oon and kozhuppu, 11% of enbu, 3% of moolai  
                 Fig 6.44 F: Observation of patients based on Udal Thathukkal 
                   
 
6) Envagai thervu (Eight fold examinations ) (n-37) 
 
i) Naa Thervu (Tongue examination) 
 
Among 37 cases BT 25 ( 68% ) patients had normal taste in their tongue, 6 ( 16 % ) patients  
had bitter taste in their in tongue, 3 patients (8%)  with  sour taste and sweet taste in their 
tongue, and  AT 34 ( 92%) patients had normal taste, 2 ( 5%) patients with bitter taste, no 
patients (0%) with  sour taste and 1 ( 3 % ) patient with sweet taste in the tongue.   
                            Fig 6.45 A: Observation of patients based on Suvai 
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ii) Niram [ Colour], Mozhi ( Voice ), Vizhi  ( Eye), Malam ( Faeces), Meikuri ( Touch ) 
 
Among 37 cases BT 35 (95%) patients had normal skin colour and 2 (5%) with 
affected skin colour (pallor) and AT all the 37(100%) patients were with normal skin colour. 
BT 34  (92%) patients with normal voice, 3 (8%) patients with affected voice (Thantha oli) 
and AT the same proportion was reported. BT 32 (86%) patients had normal eye, 5 (14%) 
patients with affected eye (pallor, burning sensation) and AT all the patient reported with 
normal eye. BT 30 (81%) patients faeces were normal, 7 (19%) patients faeces were affected 
(constipation ) and AT 36 ( 97%) patients faeces were normal, 1 (3%) patient faeces was 
affected. BT and AT all the 37 (100 %) patients were with normal meikuri (normal body 
temperature, no tenderness) 
  
Fig 6.45 B: Observation of patients based on Niram, Mozhi, Vizhi , Malam, Meikuri  
 
iii)Neerkuri  ( Urine examination ) 
 
Before treatment 76 % of patients had normal colour, 89% of normal smell, 86 % of 
normal specific gravity and volume, froth was present in 43 % of patients, deposits was 
present in 46 % of patients and after treatment patients had 89 % of normal urine colour, 97 
% of normal smell, specific gravity and volume, froth was present in 19% of patients, 
deposits (pus cells) was present in 11% of patients. 
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                      Fig 6.45 C: Observation of patients based on Neerkuri 
    
 
 
iv) Neikkuri ( Oil-on-Urine Examination ) 
                 
              Fig 6.45 D: Observation of patients based on Neikuri shapes 
 
               
In nei kuri urine samples on observation to shapes of the oil on urine, BT most of the 
19 (51%) patients had ring shape, serpentine being 7 (19% ) ,pearl being 2 ( 5%), mixed 
being 9 ( 24%) saladai being no patients (0%) and AT it was ring being 20 ( 54%), serpentine 
being 8 (21%), pearl being 1 (3%) , mixed being 7 (19%) and saladai being 1( 3%). On 
observation to the spreading pattern of the oil on urine BT 35 ( 95 % ) cases showed slow 
spreading pattern no patients (0%) showed fast spreading, 2 (3 %) patients showed no 
spreading and AT 35 (94%) patients showed slow spreading, 1 (3%) patient showed fast 
spreading and 1 ( 3%) patient showed no spreading pattern. 
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       Fig 6.45 E: Observation of patients based on Neikuri spreading pattern 
                     
 
7)  Naadi nadai (Pulse play ) 
 
Before treatment the naadi nadai of 18 (48%) of cases was pitha vatham, 14 (38%) of 
vatha pitham, 1 (3%) patient of pitha kabham and vatha kabham and  3 (8 %) patients were 
kabhapitham. After treatment 19 (51 %) of cases had vatha pitham, 14 (38%) of pitha 
vatham, 2(5%) patients of kabhapitham and 1 (3 %) patients of pitha kabham and vatha 
kabham naadi.  
                        Fig 6.46: Observation of patients based on Naadi Nadai 
                        
 
8) Uyir thathukkal (Functional constitution of the body)  (n-37) 
 
i) Deranged Vali  (Bio energy movement) 
 
Before treatment among 37 cases 30% of cases had deranged pranan (life air), 70% of 
abanan (downd ward air), 3 % of uthanan (upward air), 54% of viyanan (centrifugal air) , 49 
% of samanan ( digestive air) and 5% of devathathan ( tiresome air) and after treatment  it 
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was reduced to 5 % of pranan, 11 % of abanan, 16 % of viyanan, 5 % of  samanan and 0% 
of uthanan and devathathan 
               
                    Fig 6.47 A: Observation of patients based on deranged Vali 
                       
 
ii)Deranged Azhal (Bio energy fire) 
 
Before treatment 6 % of cases had deranged anar pitham (digestive fire) and prasaga 
pitham (complexion fire), 11 % of ranjaka pitham (haematinic fire) and 100% of sathaga 
pitham ( accompishment fire) and after treatment it was reduced to 0% of anarpitham, 
ranjaka pitahm, prasaga pitham and 22 % of sathaga pitham. 
 
                   Fig 6.47 B: Observation of patients based on deranged Pitham 
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iii) Deranged Iyyam (Bio energy water)  
  
                 Fig 6.47 C: Observation of patients based on deranged Iyyam 
                    
Before treatment 43% of cases had deranged kilethegam (digestive iyyam), 32% had 
pothakam (gustatory iyyam) , 41% had santhikam ( articular iyyam) and after treatment it 
was reduced to 5 % of kilethegam, 8% of pothakam and 11% of santhikam. 
 
 
9) Pachakagni (Basal metabolic heat ) (n-37) 
 
        Fig 6.48: Observation of patients based on deranged Agni 
                       
 
In the present study among 37 patients, BT majority of the patients, 19 ( 51%) 
belongs to samagni, 11 ( 30 %  ) patients belong to mandagni, 5 ( 14%) patients belongs to 
vishamagni and remaining 2 ( 5%)  patients were found with teekshagni and AT 35 ( 95 % ) 
patients belongs to samagni, 2 ( 5% ) patients belongs to vishamagni. 
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V] Statistical Results 
 
1) Safety parameters 
 
i) Haematology 
The mean value of Hb (15.33, 15.11) and T.WBC ( 7775.68, 7797.30 ) showed 
significant increase (P<0.001) both AT and AFU. ESR ( 6.22, 6.16 ) showed significant 
decrease (P<0.001) both AT and AFU. Platelets showed significant increase AT (2.89, 2.88, 
P<0.01**) and non significant changes (2.883, p >  0.05) AFU. RBC (5.28, 5.270, p > 0.05) 
showed non significant changes AT and AFU. All were within normal ranges. 
 
Table 6.40A: Effect of CKC on haematological parameters in main clinical trial (AT) 
 
 
 
 
 
 
 
 
 
 
 
Table 6.40 B: Effect of CKC on haematological parameters in main clinical trial (AFU) 
 
Biochemical 
The mean value of blood sugar ( 98.27,100.03 ), total cholesterol ( 174.57, 173.30) , 
LDL ( 77.89,76,81 ) VLDL ( 30.73,29.76 ), T.protein ( 6.10, 6.16 ), uric acid ( 4.03, 4.30 ), 
SGOT (24.73, 27.54 ) SGPT ( 25.43, 26.57 ) and SAP (147.46 ) showed significant decrease 
(P<0.001) both AT and AFU. HDL (41.65, 42.08) and TGL (123.70, 122.95) showed 
significant increase (P<0.001) both AT and AFU. Urea (22.22, 22.05), creatinine (0.819, 
0.803 ) and total bilirubin ( 0.770, 0.768 ) showed non significant changes ( p >  0.05 ) ATand 
AFU. All the parameters were within normal range. 
Haematology           Mean Mean 
diff 
S.D S.E t p 
BT              AT 
HB 14.797 15.33 0.5351 0.5017 0.0824 6.487  
P<0.001*** ESR 9.62 6.22 3.405 3.158 0.519 6.560 
T.WBC 7451.35 7775.68 324.32 233.81 38.439 8.437 
RBC 5.233 5.281 0.0475 0.1911 0.0314 1.514 p < 0.05* 
Platelets 2.840 2.894 0.0537 0.1287 0.02117 2.540 P<0.01** 
Values are expressed as mean ±S.E.M, n=5,  **P<0.01, **P<0.01, ***P<0.001 
Haematology           Mean Mean 
diff 
S.D S.E t p 
BT             AFU 
HB 14.797 15.110 0.3135 0.33513 0.0550 5.690  
P<0.001*** ESR 9.62 6.16 3.459 2.968 0.488 7.089 
T.WBC 7451.35 7797.30 345.94 353.23 58.071 5.957 
RBC 5.233 5.270 0.0367 0.15280 0.0251 1.463 p >  0.05 
Platelets 2.840 2.883 0.0432 0.2034 0.0334 1.293 
                       Values are expressed as mean ±S.E.M, n=5,  ***P<0.001 
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  Table 6.41A: Effect of CKC on biochemical parameters in main clinical trial (AT) 
 
Biochemical 
Parameters 
        Mean Mean 
diff 
S.D S.E t p 
BT           AT 
R.Sugar 102.03 98.27 3.757 5.361 0.881 4.262  
 
 
P<0.001*** 
 
S.Cholesterol 179.65 174.57 5.081 1.164 0.191 26.558 
HDL 39.54 41.65 2.108 2.331 0.383 5.502 
LDL 88.57 77.89 10.676 1.733 0.285 37.473 
VLDL 41.27 30.73 10.541 2.641 0.434 24.273 
TGL 175.43 123.70 51.730 23.035 3.787 13.660 
B.Urea 21.65 22.22 0.568 2.620 0.431 1.318 p >  0.05* 
 S.Creatinine 0.819 0.819 0.000 0.0707 0.0116 0.000 
Uric acid 4.929 4.035 0.8945 0.3415 0.0561 15.933 P<0.001*** 
T.Bilirubin 0.7675 0.770 0.0027 0.0897 0.0147 0.183 p >  0.05 
T.Protein 6.838 6.100 0.8380 0.4983 0.0819 11.810  
P<0.001*** 
 
SGOT 32.78 24.73 8.054 1.794 0.295 27.305 
SGPT 33.84 25.43 5.243 2.712 0.446 11.759 
SAP 151.24 147.46 3.784 2.795 0.460 4.940 
               Values are expressed as mean ±S.E.M, n=37 ; ***P<0.001 
 
 
Table 6.41 B: Effect of CKC on biochemical parameters in main clinical trial (AFU) 
 
Biochemical 
Parameters 
        Mean Mean 
diff 
S.D S.E t p 
BT          AFU 
R.Sugar 102.03 100.03 2.0 3.464 0.569 3.512  
 
 
p<0.001*** 
 
S.Cholesterol 179.65 173.30 6.35 3.946 0.649 9.792 
HDL 39.54 42.08 2.54 3.015 0.496 5.126 
LDL 88.57 76.81 11.75 3.328 0.547 21.486 
VLDL 41.27 29.76 11.54 6.615 1.087 10.587 
TGL 175.43 122.95 52.48 32.510 5.345 9.820 
B.Urea 21.65 22.05 0.40 2.576 0.424 0.957 p >  0.05 
 S.Creatinine 0.819 0.803 0.00 0.070 0.011 0.000 
Uric acid 4.929 4.30 0.89 0.3415 0.056 15.933 p<0.001*** 
T.Bilirubin 0.7675 0.768 0.00 0.0897 0.015 0.000 p >  0.05 
T.Protein 6.838 6.168 0.96 0.498 0.081 11.810  
P<0.001*** 
 
SGOT 32.78 27.54 8.05 1.794 0.295 27.305 
SGPT 33.84 26.57 8.405 9.441 1.552 5.415 
SAP 151.24 148.97 3.784 3.334 0.548 6.902 
                    Values are expressed as mean ±S.E.M, n=37 ; ***P<0.001 
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Semen parameters 
The mean value of sperm count BT is 8.46 and significant (P<0.001) increase in the 
mean value of count (38.97, 28.97) was observed AT and AFU. The mean value of 
progressive motility BT is 10.19 and significant (P<0.001) increase was observed in the mean 
value of PR (36.03) AT and (34.59) AFU. The mean value of total motility BT is 24.05 and 
significant (P<0.001) increase was observed in the mean value of TM (54.54) AT and (48.43) 
AFU. The mean value of normal sperm BT is 23.70 and significant (P<0.001) increase was 
observed in the mean value of  normal sperm (41.0) AT and (36.86) AFU. The mean value in 
the volume of semen BT is 1.31 and significant (P<0.001) increase in the mean value of 
volume (1.86) AT and (1.71) AFU was observed. The mean value in the liquification time of 
semen BT is 25.14 and non significant changes ( p >  0.05 ) was observed in the liquification 
time both AT (23.65) and AFU (23.92). 
 
      Table 6.42 A: Effect of CKC on semen parameters in main clinical trial (AT) 
 
 
 
 
 
 
 
   Table 6.42 B: Effect of CKC on semen parameters in main clinical trial (AFU) 
 
 
 
 
 
 
 
 
 
 
 
Harmone parameters 
The mean value of testosterone, FSH and LH, BT were 4.57, 7.86 and 7.14 
respectively.The mean value of testosterone (6.09, 5.90), FSH (9.18, 8.87) and LH (8.0, 7.86) 
showed significant increase (P<0.001) AT and AFU. 
 
Semen Analysis         Mean Mean 
diff 
S.D S.E t p 
BT          AT 
Count 8.46 38.97 30.514 20.917 3.439 8.873  
 
P<0.001*** 
 
Pr.Motility 10.19 36.03 25.838 11.656 1.916 13.484 
T.Motility 24.05 54.54 30.486 17.084 2.809 10.855 
Normal sperms 23.70 41.00 17.297 10.344 1.700 10.172 
Volume 1.311 1.865 0.5541 0.5108 0.0840 6.598 
Liquification 25.14 23.65 1.486 7.534 1.239 1.200 p >  0.05 
                Values are expressed as mean ±S.E.M, n=37 ; ***P<0.001 
Semen 
Analysis 
      Mean Mean 
diff 
S.D S.E t p 
BT         AFU 
Count 8.46 28.97 20.514 15.648 2.573 7.974  
 
P<0.001*** 
Pr.Motility 10.19 34.59 24.405 11.725 1.928 12.661 
T.Motility 24.05 48.43 24.378 16.008 2.632 9.264 
Morphology 23.70 36.86 13.162 9.311 1.531 8.599 
Volume 1.311 1.716 0.4054 0.5249 0.0863 4.698 
Liquification 25.14 23.92 1.216 6.709 1.103 1.103 p >  0.05 
                 Values are expressed as mean ±S.E.M, n=37 ; ***P<0.001 
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     Table 6.43A: Effect of CKC on harmone parameters in main clinical trial (AT) 
 
Harmone        Mean Mean 
diff 
S.D S.E t p 
BT          AT 
Testosterone 4.57 6.09 1.51 0.281 0.046 32.68  
P<0.001*** FSH 7.86 9.18 1.31 0.532 0.087 15.04 
LH 7.14 8.00 0.86 0.599 0.098 8.768 
         Values are expressed as mean ±S.E.M, n=37 ; ***P<0.001 
 
    
       Table 6.43 B: Effect of CKC on harmone parameters in main clinical trial (AFU) 
 
 
 
Outcome measures 
 
I] Primary Outcome measure 
 
                                      Table 6.44: Primary outcome measures 
 Response 
 
       Count         
       n=37   
  AT       AFU 
     
p 
  
% 
 
AFU 
  Total Motility  
           n=37      
   AT       AFU 
ProgressiveMotility 
           n=37  
   AT         AFU 
              
   AT             AFU 
 
   Normal Sperms   
           n=21                      
    AT        AFU 
 Good                 19 
  
(60%) 
   23    23     18    20     16     12       8 
Moderate         9     7     7     10     9     10      4       7 
 Mild                    6     5     5      7     6      9      3       4 
 Poor            3     2     2      2    2      2      2       2 
  
1) Sperm Count 
 
On the basis of the criteria meant for the assessment of the sperm count it was 
observed that out of 37 patients, good response was observed in 19 patients AT and 15 
patients AFU. 9 patients AT and 10 patients AFU showed moderate response, 6 patients AT 
and 8 patients AFU showed mild response and 3 patients AT and 2 patients AFU showed 
poor changes.  
 
                          
Harmone       Mean Mean 
diff 
S.D S.E t p 
BT          AT 
Testosterone 4.57 5.90 1.32 0.385 0.063 20.92  
P<0.001*** FSH 7.86 8.87 1.00 0.445 0.073 13.78 
LH 7.14 7.86 0.71 0.626 0.103 6.96 
                       Values are expressed as mean ±S.E.M, n=37 ; ***P<0.001 
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                      Figure 6.49A:  Outcome measures of Sperm Count 
                         
2) Total Motility 
For assessment of total motility, among 37 patients good response was observed in 23 
patients AT and 18 patients AFU. 7 patients AT and 10 patients AFU showed moderate 
response, 5 patients AT and 7 patients AFU showed mild response and  2 patients both AT 
and AFU showed poor changes.  
                           Figure 6.49B:  Outcome measures of Total Motility 
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3) Progressive Motility 
 
Among 37 patients, progressive motility showed good response in 20 patients AT and 
in 16 patients AFU. Moderate response was observed in 9 patients AT and 10 patients 
AFU.Mild response was observed in 6 patients AT and 9 patients AFU. 2 patients  both AT 
and AFU showed poor changes. 
 
                       Figure 6.49 C:  Outcome measures of Progressive Motility 
                           
 
4) Normal form of sperms 
 
Among 21 patients, 12 patients showed normal form of sperm AT and 8 patients  
AFU. Moderate response was showed in 4 patients AT and 7 patients AFU. Mild response 
was obeserved in 3 patients AT and 4 patients AFU. In 2 patients poor response was showed 
both AT and AFU. 
 
 
 
 
 
 
 
20 
9 
6 
2 
16 
10 
9 
2 
Progressive Motility 
AT AFU 
147 
 
                 Figure 6.49 D:  Outcome measures of Normal form of sperms 
                           
 
2] Secondary outcome measure 
 
Testosterone, FSH and LH harmone showed significant increase (P < 0.001) after the 
treatment and at the end of the followup  
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7. DISCUSSION 
 
Identification and Authentication of the Ingredients 
Herbal drugs were identified and authenticated through visual inspection, organoleptic 
characters, morphology, micromorphology, taxonomical, microscopical and chemical 
methods elucidated by J.S.Gamble 2008 and Theodore cooke 2006. 
221, 222
   
Mineral drug (Gomutra silasathu) was identified and authenticated with reference to 
the microscopic characteristics. 
 
Pharmacognostical study  
 
According to World Health Organization the establishment of the 
macroscopic/microscopic characters of plant is the primary step in the direction to ascertain 
its identity and also the purity.
223 
Literature review has exposed that seeds of A.vasica and 
Alternanthera sessilis have no description regarding the pharmacognostical studies and 
therefore the study was carried out on the samples (fresh seed).  
Seed of the Alternanthera sessilis was 400µm-long;  250 µm- wide and 10µm-thick. 
Seed coat has well-known wings. Sclerotic- outer and the inner-seed coats; endosperm was 
large, polyhedral and thin walled.  
A.vasica seed has inner- sarcotesta with outer-sclerotesta (40mm-thickness). 
Parenchymatous zone was thin at lateral part of seed which was developed into wider; many-
layered at chalazal end. Radicle was circular in the sectional and the diameter is 550 µm. In 
powder microscopy study, oil bodies, starch grains, cotyledons, sarcotesta, and sclerotesta 
(ameboid within the outline) were observed. Physico chemical study in A.vasica seeds 
demonstrated loss on drying ( at 105⁰C)  to be 6.80 percent, which might be due to the 
presence of fixed oil ( in the seed ) and moisture might be negligible. Total ash was observed 
to be 4.07 percent, which indicates the existence of inorganic content to be in lower amount. 
The extractive values (water soluble/ alcohol soluble) were evaluated to be 27.73 percent and 
19.45 percent which indicates the existence of the high polar compounds.  
In TLC study, three spots at UV 254 nm, four spots at  366 nm and four spots after 
derivatization were identified and in HPTLC study, eight peaks under 254 nm, two peaks 
under 366 nm and seven  peaks at 540-nm were resolved. Spot in the Rf value - 0.89 was 
present in every conditions that might be due to the movement of the lower polar compounds 
which is near to solvent front. The anatomical characters demonstrated in Adhatoda vasica 
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and Alternanthera sessilis (seeds) may be used for the right botanical identification and 
authentication of the herbal materials and may be differentiated from its related species.  
 
Gomutra Silasathu parpam [One of the 25 ingredients] 
Gomutra Silasathu parpam was indicated for nocturnal emission [sopana skalitham], 
veneral disease [ megam], gonorrhoea [premegam], contagious ulcers [ koruku] and glandular 
swelling [kiranthi]. In the preparation of the parpam (silasathu parpam) fermented rice water 
(Kazhuneer kaadi ) was used for trituration 
25
. Kazhuneer kaadi- rice water being kept for 
three hours and which taste sour since because of fermentation. 
17
 Rice has antioxidants like 
phenols-tocotrienols, tocopherols and γ-oryzanol. 224 Cow’s urine was used for purification of 
silasathu. 
82
 Cow’s urine is related to the nectar and it impedes the free radical formation. 225 
It is rich in calcium, sodium, iron, potassium, phosphorus, copper, sulphur, chloride, nitrogen, 
lactose, phenols, gonadotropin, urinary proteins and vitamins like A;B;C; D and E.
226
 It 
promotes and enhances the bioavailability of the drugs in combination treatment.
227 Cow’s 
urine is able to cure diabetes, prostate, AIDS, cancer, and thyroid.
228
 It has hypoglycemic, 
immunomodulatory and cardio respiratory effects. 
229 
Siddha specifications on parpam were carried out to demonstrate the appropriate 
processing of the mineral asphaltum to the final parpam. In general the colour of the parpam 
must be white but occasionally will change according to the principal drug (Gomutra 
silasathu). Colour of the Gomutra silasathu parpam was found to be dark due to being as the 
principal ingredient.
205
 It was odorless, tastless, lusterless, entered in to the crevices of the 
finger, not washed out from the crevices and floated on the surface of water. All these 
inferences showed that the parpam was well processed and have been prepared. GSP showed 
lower moisture percentage which is evident from the value of loss on drying being 2.50 
percent. In Siddha text, the shelf life for parpam was refered to as 100 years 
82
 and GSP also 
might have the comparable shelf life. The total ash of GSP was evaluated as 77.45 percent 
which indicates that it includes 22.55 percent total combustible- organic matters. 23.75 % 
water soluble ash and 20.45 % acid insoluble ash reveals that 30.7 percent of total inorganic 
substance of GSP is water soluble and 26.4 percent of total-inorganic substance is acid 
insoluble in character. pH of GSP (10 % solution ) was established to be 6.04 which denotes 
the slight acidic charater of the parpam .  
 
ICP-OES study of GSP exposed that K (potassium) was identified to be high, 
calcium, Iron, sodium and magnesium were relatively in moderate quantity. Presence of 
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copper, zinc, manganese, chromium and nickel were revealed to be in less in quantity. 
Cadmium, Selenium, and tellurium were below the detection limit. For the achievement of 
reproduction selenium, zinc, nickel, copper, manganese and chromium are required. Ca, Mg 
and Cu are concerned in sperm motility. 
50
 Iron takes a vital part in spermatogenesis and in 
the normal role of testis. 
230 
Cadmium poison (acute) creates testicle injury and spermio-
toxicity.
231
    
The particle size study demonstrated that GSP accomplish its fineness. At higher 
temperature throughout the course in parpam processing, the possibility of the organic 
compounds are uncommon. 
232
 Regarding CHN analysis, the substance carbon in GSP was 
found to be 12.31 percent which showed that the organic particles derived from raw 
asphaltum remains in GSP. Nitrogen in GSP might indicate the presence of the amino acids 
in GSP. Organic constituents of asphaltum play in transporting the various mineral matters in 
to their cellular targets.
189
 The presence of carbon in GSP might play an considerable place in 
increasing efficacy and making the drug biologically assimilable.
232 
 
Quality of the prepared Chandrakanthi choornam 
All the purified drugs (herbal) and GSP (Gomutra silasathu parpam) was powdered 
then par boiled in milk (final purification process of chooranam) and dried under sunlight. 
Particle size study demonstrated that the drug CKC passes through mesh size of 100 which 
indicated its finess. The bacterial count and the fungal count were observed to be within the 
specified limits. The specific pathogens (Salmonella spp, E. coli, Pseudomonas aeruginosa 
and Staphylococcus aureus) were known to be absent.  The herbomineral formulation was 
established to be free from microbial contamination. Aflatoxins / mycotoxins (B1; B2; G1& 
G2) were observed to be BDL (below detection limit). Pesticide residues (organo chlorine / 
organo phosphorus) were found to be not detected in CKC. Heavy metals (mercury, lead, 
cadmium and arsenic) were found to be BDL (below detection level - 0.05 ppm). The results 
indicate that the drug CKC is of standard quality.  
 
Preliminary phytochemicals of CKC 
Phytochemical study showed the presence of steroids, amino acids, phenols, tannins, 
flavonoids, saponins, anthraquinones, glycosides and triterpenoids. Aminoacids are required 
in sperm activity.
.82 
Steroidal constituents (saponin, sterol) enhance the steroidogenesis and 
increase the androgen levels
. 233, 234
 Phenol,
 234
 flavonoid,
 235,21
and tannin
 235
 has antioxidant 
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activity. Presence of triterpenoids may be derived from asphaltum and showed to increase the 
testosterone and sperm count. 
236
 Anthraquinones is reported to have antioxidant activity
 .237 
 
Physico-chemical parameters of CKC 
8.45 percent of loss on drying (at 105°C) signifies that the drug CKC might have 
better shelf-life. 13.04 percent of total-ash may indicate that the CKC contains more 
inorganic substance, 3.39 percent of water soluble-ash may indicate that CKC contains 
significant quantity of the water soluble-inorganic substance. 5.61 percent of acid insoluble-
ash in CKC might be due to Gomutra silasathu. The extraxtive values (19.25 percent of water 
soluble and 16.8 percent of alcohol soluble) demonstrate that CKC contains more polar 
compounds (tannins, glycosides, phenols, saponins and flavonoids) which is already proved 
from the phytochemical results. The pH value of 6.37 indicates that CKC is slightly acidic. 
 
Heavy metal analysis of CKC (ICP-OES)   
Metal contamination in pharmaceutical inventions creates serious hazard to human. 
Monitoring of metals in process intermediates and final products is an important activity in 
food and pharmaceutical industry. Metals act as the catalysts in disintegrating the 
pharmaceutical products. Sources for metal-impurities consist of i) those are added in the 
process ii) those are carried in the process iii) those comes from the process iv) occurs 
naturally (derived form plant or minerals). 
238
 Heavy metals (mercury, lead, cadmium and 
arsenic) were found to be below detection level in CKC. 
 
Elemental analysis of CKC (ICP OES) 
The quantities (ppm) of the elements are, calcium (6482.9), magnesium (1870), iron 
(988.6), zinc (21.98) and copper (8.09). Zinc improves sperm maturation and activation, 
preserves the germinative epithelium, regulates the enzyme activity and mediates the 
metabolic regulation (sperm), extremely concentrated in the tail (mature sperm) and is 
concerned in motility. Magnesium, calcium and copper are in ionic form in semen and 
abnormal levels might affect the spermatogenesis, maturation and motility of the sperm and 
fertilizing capacity.
239
 Presence of Fe, Ca, Mg, Zn and Cu may possibly be responsible for the 
spermatogenic activity of CKC. 
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Chromatography techniques 
In view of the fact that the herbal formulations are in complex nature, 
chromatographic techniques were generally employed to create fingerprint which is the 
profile of the mixture of constituents present in the herbal product. Finger-printing might be 
applied to recognize the plant, measure the active ingredients/ markers, and identify the 
impurities/ contaminants like herbicides. 
240  
 
Thin Layer Chromatography of CKC 
Thin Layer Chromatography has been mainly applied in the qualitative study of the 
herbal medicines, help to characterize and furthermore track the constituents visually (initial 
separation technique). This chromatographic technique offers the option of presenting the 
outcome as an image. Different colours of the corresponding individual bands perform an 
additional dimension. 
240
 Photo-documentation (TLC) of CKC at UV 254 nm revealed 5 
visible green spots, with the major spots at Rf 0.24. At UV 366 nm showed 8 spots with 
major spots at Rf 0.41; 0.48 and 0.54. At 540 nm revealed seven spots with the major spots at 
Rf  0.17; 0.38; 0.44 and 0.58.  
 
High Performance Thin Layer Chromatography  
HPTLC study is uncomplicated to run, multiple-samples could be examined and 
compared on the similar plate. These features of HPTLC create it as a valuable analytical 
method for the quality control requirements and chiefly at the initial stage in testing. 
Previously was used for identification by American Herbal Pharmacopoeia. In adding with 
the visual estimation it may offer extreme rapid screening process of the complex samples. 
240 
The HPTLC - finger printing of the extract (choloroform) of CKC at UV 254nm revealed 7 
peaks with major peak at Rf -0.24 and at UV-366nm  revealed 9 peaks with major at Rf 0.48 
and  at 540 nm revealed 11 peaks with major peak at Rf -0.36. 
 
Thermo gravimetric analysis  
TGA curve provide information about the weight lost during heating a drug sample at 
a known temperature 
241 
and it is utilized to find out the total-weight change in a drug sample 
during the thermal treatments.  5.14% of the drug was decomposed at 120⁰C, which might be 
due to the loss of moisture content present in the sample.   
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Toxicity study 
Safety and the efficacy study depend on the methods adopted in the drug preparation 
and variation from the traditional knowledge (method) may not give the desired outcome.
242 
Acute toxicity studies (initial assessment in toxic studies) present fast, significant information 
and may specify whether additional toxicity studies must be conducted. It gives  information 
on the health risk that is possible to occur from the short-term experience to a drugs and is 
performed in all compounds. 
243
 Even drugs used in a longer period may produce chronic 
toxicological hazards but not have been known. WHO guidelines intends to specify the 
standard system in toxicological studies (non-clinical) associated in assessing the herbal 
medicine safety.  
As per WHO- long term toxicity guidelines, groups must be given at least 3 dissimilar 
dose levels. One dose level (no effect dose) must not cause any toxic; one dose level which 
can produce over- toxic effects must be included and within this dose range additional dose 
should be added which may develop the possibility to observe the dose response-relationship 
for the toxic manifestations.  Vehicle control group of the experimental animals should be 
included. As stated by WHO rules the period of test drug administration to animals depends 
on the estimated period of the clinical use. In case of repeated administration (clinical), 
between 1 to 6 months the administration time for toxicity study is from three to six months 
in rats 
209 
and
 
hence 3 months [90days] duration was selected as long term toxicity treatment 
schedule.  
Dose calculation 
210  
                         Table 6.45: Dose calculation for rats in toxicity study  
Dose for a rat weighing 200gm = Human absolute dose X conversion factor (Human to clinical ) 
 
Dose for a rat weighing 200gm  =  12  X 0.018  = 0.216gm/200gm b.wt 
 
Dose for a rat weighing 1kg = 1.08 gm/kg b.wt 
 
 For acute toxicity study the higher dose selected was 10 TD (10.8 gm/kg b.wt). It was 
administerd two times to the rat (single dose) 
 For longterm toxicity study three doses were selceted.  
                      Table 6.46: Three dose levels in long term toxicity study 
 
 
 
1 x Therapeutic dose = 1.08 gm/kg b.wt ( 1TD ) 
3 x Therapeutic dose = 3.24 gm/kg b.wt ( 3 TD ) 
5x Therapeutic dose  = 5.4 gm/kg b.wt  ( 5 TD ) 
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In long term toxicity 5TD was selected as higher dose instead of 10 TD, to avoid 
stress that will be caused due to two times administration of the dose per day for 90 days. 
 
Acute Toxicity Study 
CKC was orally given at dose of 10 times the therapeutic dose (10 TD ). Rats were 
observed for general conditions, signs of toxic symptoms and mortality for every hour during 
the first day with particular concentration given during the first 4 h and thereafter every day 
for 14 days. 10 TD dose level did not show any death, behavioural changes, toxic signs 
during 14 days and showed non significant changes in body weight when compared to that of 
the control group.On necropsy, no gross pathological abnormalities were observed in the vital 
organs and hence the acute toxicity study indicates that the drug is well tolerated up to 10 
times [10.8gm/kg b.wt] the therapeutic dose in tested wistar rats. 
 
Long term toxicity study  
Three dose levels of 1.08gm/kg b.wt (TD); 3.24g/kg b.wt (3 TD) and 5.4 g / kg b.wt. 
(5TD)  were administered to rats for duration of 90 days to determine whether CKC is toxic 
in long term use. The toxicity was assessed by estimating physiological, biochemical, 
hematological and histopathological effects of CKC on rats. 
 
Feed and water intake 
Diseases related with kidney, frequently are evident as water imbalance with the 
change in fluid intake subsequent to polyuria or oliguria. 
244
 Non significant changes were 
observed in the feed and water intake of animals between control and treated groups. 
 
Weight   
Body weight signifies the health status of the living beings. Increase in the body 
weight in rats specifies the normal health status of the animals and also about the information 
that no-degenerative alterations occur during the drug administration.
245
 Vehicle control, 3 
TD and 5TD group showed significant increase (weight) than the control group and TD group 
showed non significant changes in the body weight gain.  
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Organ weight 
Absolute weights of brain, liver, stomach, kidney and thymus were found to be 
comparable with those of the control group rats. Increase in absolute weight of testis the main 
target organ (drug target) was noted in animals of 3 TD group which may indicate the 
androgenic effect. 
246 
Absolute weight of heart of 5TD group and lungs of vehicle and 5TD 
group was found to be significantly decreased (p < 0.05) however no cytoarchitectural 
changes of heart and lung tissues were observed in the histopathological studies of these 
group animals. All these finding implies the dose level of TD and 3TD does not have caused 
any toxic effect on all the vital organs 
 
Blood examination 
Blood examination is the excellent way in evaluating the health condition of animals 
since it plays an important role in the nutritional, physiological and pathological status of the 
organism.
247
  
 
Hematology 
Hematological index gives the blood status indication of the animals and are 
evaluated to assess the protein quality and the utilization. CBC (complete blood count) gives 
the information concerning the kinds/numbers of the cells in blood, chiefly RBC (red blood 
cells), WBC (white blood cells) and platelets. Complete blood count also assists in checking 
the fatique, bruising and weakness that might be present in the organism. Unusual high/ low 
counts might signify the presence of diseases like infection, anemia and other disorders. 
Changes in the qualitative/quantitative composition with the biochemistry of blood cells 
might be the warning and indication of a damaged function. 
247 
Haematological parameters 
might be used to find out the extent of harmful effect of the foreign compounds on blood. 
Thes investigations are reliable, accurate, highly sensitive and remains as the bedrock in 
ethical research, diagnosis, disease prevention and in treatment. 
248
   
MCV determines cell size (erythrocytes) and the capability of the rats to endure 
prolonged oxygen-starvation. Hgb (Haemoglobin) and haematocrit are the basic standards 
that reveals anemia (degree). MCHC is the index of average Hgb concentration of red cells. 
Low-RDW indicates the uniformity in the size of RBCs. Low- RBC indicates anemia which 
is caused by nutritional deficiency (iron deficiency, vit B12/ folate deficiency). Increase in 
the RBC indicates thallasaemia and increase in RBC with Hgb level is the inidicative of 
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polycythemia, generally caused by smoking, dehydration or genetic causes (changed oxygen 
sensing, deviation in Hgb oxygen release). 
247 
 
White blood cells - Granulocytes (neutrophils; eosinophils; basophils), lymphocytes 
and the monocytes are concerned in protection of body against the foerign bodies and in the 
production of antibodies.
249
 Increase in white blood cells indicates inflammation, hemorrhage 
and decrease in WBC indicates viral infection and bone marrow failure. Decrease in white 
blood cells indicates the decline in proportion of defense mechanism to fight againt 
infections. Increase in hemoglobin indicates lung diseases. Increased MCHC might be the 
end result in the prolonged-dehydration and decrease may indicate iron deficiency. Increase 
in Nu (neutrophil) indicates inflammation, hemorrhage and decrease indicates viral infection 
and bone marrow failure. Increase in lymphocytes might indicate viral infection, leukaemia 
and decrease might indicate bone marrow infiltration and lupus. Increased monocytes 
indicate leukemia, protozoan diseases or malignant diseases. Increased monocytes and WBC 
attributes to immune system of rats which attempts to detoxify the toxicity. Low platelets 
might cause the risk of excess bleeding/bruising. Increased platelet value might act as a 
marker in vascular diseases like micro-angiopathy. Increased lymphocytes indicate viral 
infection. 
247   
Blood was evaluated for hematological toxicity of CKC and hemogram was estimated 
and results showed non significant changes in the haematological parameters like Hb, RBC, 
WBC, differential count ,MCH ,MCHC, Platelets, MPV, PCT , HCT,RDW and PDW of male 
rats of all doses levels ( TD, 3TD, 5TD) of CKC.  MCV value of vehicle control group -
showed significant increase (p < 0.05) but within normal limits. The results do not indicate 
any serious pathological conditions.  
 
Clinical Chemistry 
The clinical blood chemistry values were used to analyze renal function (BUN and 
creatinine), liver function (total protein, albumin, globulin, AST and ALT), pancreas function 
(glucose), lipid assesment (Total cholesterol and triglycerides), serum electrolytes (Na, K, Cl) 
 
Renal function test 
Increase in blood urea and in non-protein level is observed in impaired renal 
function/acute renal fail-ure. 
250 
Serum creatinine indicates the condition of kidneys and it is 
the major catabolic result of muscles/ protein respectively. 
247 
Blood urea- was found to be 
significantly decreased (P< 0.05) in TD group which was comparable to the normal control 
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groups and serum creatinine found to be significantly increased (P< 0.05) in vehicle and TD 
group (within normal biological range). In 3TD and 5 TD it showed non sinificant changes. 
The renal parameters were within normal limits which rule out the renal function impairment. 
 
Serum electrolytes 
Serum electrolytes plays an vital role in controlling fluid levels, pH (acid-base 
balance), blood clotting, nerve conduction and muscle contraction. 
246 
Kidneys take part an 
vital role in the electrolyte regulation. 
251
 Electrolytes occur in extra and intra cellular fluids 
(serum sodium, chloride). Decrease in serum sodium and chloride below the accepted values 
indicates dehydration/shock. Low potassium values (below 3 mmol) are related to 
arrhythmia, tachycardia and cardiac arrest and high potassium indicates cardiac arrhythmia.  
247    
The values of sodium of rats treated with all three dose levels were found to be 
comparable with those of the control group. Potassium showed significant decrease (P< 0.01) 
in 5TD group and non significant changes in the vehicle control, 1TD and 3TD groups. 
Chloride showed significant decrease (P< 0.01) in vehicle group, significant decrease (P< 
0.05) in 3TD and 5TD group and nonsignificant changes in 1 TD group. All the serum 
electrolytes were within the clinical range. 
 
Lipid Assessment 
High cholesterol in blood is the main cause for cardiovascular disorders. High 
triglycerides and low lipoproteins are related to coronary artery disease. 
252
 Total cholesterol 
showed non significant changes in 5TD group, significant increase (P< 0.05) in vehicle and 
3TD group, more significantly increased (P< 0.01) in TD group (within normal biological 
range). The values of trigycerides in rats treated with three dose levels (TD, 3TD and 5TD) 
were found to be comparable with those of the control group. The normal limits of 
cholesterol and trigycerides rule out the cardio vascular disorder and coronary artery diseases.  
 
Blood Glucose 
Diabetes mellitus (DM) is the disorder in which the body doesn’t have the ability to 
metabolize CHO (carbohydrates) properly. The disease is described by the excess quantity of 
sugar in blood and urine. 
253
 The present study showed non significant changes in blood sugar 
level of vehicle and in all three dose level groups. 
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Liver function test 
Liver is the important organs which is responsible in breaking all the ‘poisons’ which 
enters the body. Liver function test describes its function. The enzyme ALT (sensitive marker 
in liver cell damage) produced in the liver cells, increases in the condition when liver cells 
are inflamed/ death. When the cells are damaged, ALT escapes in to the blood and rises in the 
serum levels. AST is the state that can be related with the cellular necrosis of many tissues.
248  
 
AST- [Aspartate amino transferase] was increased significantly (P< 0.05) in 3TD and 
(P< 0.01) in vehicle group and showed non significat changes in 1 TD and 5TD groups. ALT 
[ Alanine amino transferase] showed significant decrease (P< 0.05) in 3TD group and non 
significant changes in vehicle, 1TD and 5TD group. Albumin was increased significantly (P< 
0.05) in 5TD and showed nonsignificant changes in rest of the dose levels. Globulin showed 
non significant changes in all the dose level groups. (Within normal limits) 
 
Hyper-bilirubinaemia with no abnormalities in other LFT might result from increase 
in bilirubin formation, as in ineffective erythropoiesis or haemolysis and may be due to the 
inability in transporting bilirubin across liver (as in Gilbert’s syndrome). 251 The values of 
bilirubin of rats treated with three dose levels (TD, 3TD and 5TD) and vehicle control were 
found to be comparable with those of the control group. 
 
Total protein showed non significant changes in vehicle, 1 TD and 3TD groups and 
was increased significantly in (P< 0.05) 5TD group which doesn’t fall under normal limits. 
The protein level in 5TD group can be substantiated by the results of the histopathological 
study of the liver and by further corroboration with abnormalities found in the organ weight 
of liver which revealed the non toxicological significance when compared to that of the 
control group. The cause for increase in total protein level is not known with assurance but 
might be due to the increase in hepatic protein synthesis/ decreased degradation. 
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Taking these values in to consideration it may be inferred that the biochemical results 
of the therapeutic dose and three times the therapeutic dose was found to be safe. 
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Histopathology study 
Histopathological examination of vital organs like brain, heart, liver, kidney, spleen, 
lungs, stomach, intestine, thymus and testis from both treated (1TD, 3TD, 5TD) and control 
(normal and vehicle) group animals showed normal architecture. Mild chronic gastritis was 
found in glandular part of the stomach in one animal of 5TD group (1/6). Psychological stress 
induces modifications of motility, secretion, visceral sensitivity, and local inflammatory 
responses in the GI tract. 
254 
 The pathological change observed in one wistar rat in the higher 
dose group may be due to the psychological stress and it may be due to an individual 
variation.since such pathological changes was not found in other animals of that group, in 
which higher dose was given. Thus histopathological studies also conﬁrmed the safety data, 
along with other physiological, biochemical and heamatological parameters after CKC 
treatment. 
 
Together, these data suggest that the 90 days longterm toxicity study of CKC in rats at 
the 1TD and 3 TD dose level showed no-observed-adverse-effect-level (NOAEL) since all 
the animals survived till the end of the study and gross necropsy and histopathological results 
did not reveal any major findings. 5TD dose level showed adverse effect with reference to 
significant increase in total protein and significant decrease in the organ weight of heart and 
lungs. 
 
SPERMATOGENIC ACTIVITY 
Generally in male wistar rats spermatocytogenesis occurs at the age of 30 days while 
spermiogenesis begins at 50 days.
190
 Spermatogenesis is the complex interplay which 
connects the structural components of testis and endocrine system.
234
 Alcohol abuse is 
familiar in damaging the reproductive function in the experimental animals and as well as in  
human beings. Testis is extremely vulnerable to ethanol since it traverses the blood testis -
barrier and lower the spermatogenesis. Alcohol abuse causes reduction in the production of 
testosterone, testis shrinkage, decrease sperm counts, abnormal shapes (sperm) and reduced 
sperm motility.Chronic ethanol abuse causes testicular atrophy and male infertility in 
alcoholic men. 
98
 To provide the scientific information on the androgenic and spermatogenic 
potentials of Chandrakanthi chooranam the study was carried out. Sperm parameters such as 
count, motility, viability, morphology, serum testosterone-levels, biochemical parameters like 
cholesterol, protein, glycogen, effect on body weight, ascessory sexual organ weight and 
histopathological studies on the tissues of testis, semniferius tubules and epididymis were 
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evaluated in CKC treated rats and compared with the control group rats and etnanol induced 
testicular injured rats.  
 
Weight 
Ethanol treated group showed significant decrease in the mean body weight changes 
of the rats when compared to that of the control group. Significant increase in the mean body 
weight changes was observed in study drug group when compared to ethanol induced group. 
Although ethanol supply above 50 percent of dietary energy (calories) it cannot be stored, 
and can not be used to preserve body weight.
98
 Steroidogenesis (androgenic properties - 
androgens has anabolic effect) is one of the causes in the improved body and organ (sexual ) 
weight in the treated groups. 
138, 255
  
 
Reproductive organ weight  
Male reproductive development is synchronized by the mechanism of hypothalamus-
pituitary-testis axis and the accessory sex organs. The increase in the weight of the accessory 
sexual organs (seminal vesicle/prostate gland) may be due the levels of the circulating 
androgen. 
230 
The weight of testis is related with the spermatogenic function and mainly 
depends on the number of undifferentiated sperm cells. 
255
 Generally in rats the number of 
leydig cells per testis increases parallely with the weight of the testis following the birth, 
which is accompanied with increase in the level of testosterone. 
256
 Androgens [testosterone] 
level is positively associated with the weight of testis, seminal vesicle, epididymis and 
prostate glands. 
257  
 
The reduction in testicular weight of ethanol treated rats may be due to reduced tubule 
size, spermatogenic arrest and inhibition in steroid biosynthesis. Significant increase in the 
weight of the testis  in the treated group  (CKC) when compared to the induced group may be 
due to the restoration in the number of germ cells with respect to spermatogonia (which also 
includes spermatid and sperm) which is evident from the histopathalogical study [fig 6.34 A, 
B] Significant increase in the weight of the testis, seminal vesicle and prostate may be 
attributed to the increase in the testosterone level.  
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Serum testosterone 
Testicular-Leydig cells are the chief site in the syntesis of testosterone. Steroid 
hormones play the main role in the continuation of spermatogenesis as well as fertility. 
Gonadotropins and TT (testosterone) are the principal regulators in germ cell maturity. 
Successful and entire male germ cell maturity depends on the endocrine interplay (balanced) 
of hypothalamus, pituitary and testis.
258 
Ethanol considerably increase the lipid peroxidation 
in testis and reduces the conversion of dehydroepiandrosterone and also androstendione in to 
testosterone through decreasing the activity of 3b hydroxyl steroid dehydrogenase. 
230
  
 
High significant decrease in the testosterone was observed in ethanol groups when 
compared to the control group animals. Significant increase in the levels of testosterone in 
CKC treated  group when compared with ethanol group may demonstrate the protection of 
germ cells and the sertoli cells [fig 6.34 A, B] and hence prevents the sperms and maintains 
its quality and quantity. 
230  
 
Biochemical parameters 
 
Protein 
Ethanol inhibits the speed of hepatic protein metabolism [catabolism]. And which 
may be correlated to the amount of ethanol-induced oxidative stress.
259,260
 In the 
spermatogenic study, in ethanol induced group the mean value of protein is  increased which 
might be due to the oxidative stress (ethanol induced). The protein level in CKC group is 
comparable with the control group and lower than that of the indcued group which might be 
due to the presence of steroids and other antioxidants [flavonoids, phenol] in CKC which 
favours the protein metabolism by means of depressing the oxidative damage.
259 
   
 
Glycogen 
Fructose is produced by seminal vesicle in the influence of TT (testosterone) and 
provides energy for the metabolism of sperm and its motility.
261
 Fructose arises from glucose 
through glycogen-phosphohexose pathway (in the presence of phosphohexoisomerase / 
alkaline phosphatase).
262
 Full-grown mammalian sperm have complete functional glycogen 
metabolism which results in the existence of glycogen/glycogen-like deposits in 
head/midpiece and will facilitate to maintain the energy and viability of sperm and increases 
the reproduction potential in mammals.
263
 Testicular atrophy diminishes the androgen 
formation and causes decrease in level of fructose in the testis and epidydmis.
262
 Significant 
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decrease (p < 0.001) in the mean values of glycogen was observed in the induced group 
(ethanol) than the control group may be due to the inhibition in the glycogen metabolism. 
Significant increase in the mean value of glycogen of the study group (CKC) when compared 
to the both ethanol and control group demonstrate the normal regulation in the glycogen 
metabolism which provides energy to sperm motility. 
 
Cholesterol 
Cholesterol is physiologically significant since it inhibits or stimulates the 
spermatogenesis and proceed as the precursor in the synthesis of androgen.
262
 Study drug 
group (CKC) showed significant decrease (p < 0.001) in the mean value of cholesterol when 
compared to the ethanol induced group and control group which may be due to the utilization 
of cholesterol in the production of androgens and thereby in the stimulation of 
spermatogenesis. 
 
Sperm parameters 
Rats exposed to ethanol (25%) group showed significant decrease (P<0.001) in the 
sperm count, motility, normal forms of sperm and viabilty and significant increase (P<0.001) 
in abnormal forms of sperm; treatment group showed significant increase (P<0.001) in sperm 
count, motility, viability, normal form of sperm and significant decrease (P<0.001) in 
abnormal form of sperm when compared to that of the ethanol induced group.  
 
In ethanol group, the sperm count was observed to be reduced significantly with 
reduction in the testicular weight and sperm motility which is an indication that ethanol had 
reduced/ inhibited spermatogenesis.
264
 Low sperm count and reduction in the weight of testis 
signifies that the effect might be due to the leydig cell dysfunction and which results in the 
reduction in the secretion of testosterone which is responsible for diminished 
spermatogenesis and sperm counts.
265 
Chronic consumption of ethanol reduces the motility 
and increases abnormal sperms (morphology) due to the injury / destruction in germ cells due 
to the free radical injury to the sperm cells.
230 
 Increase in the serum testosterone level, 
reproductive organ weights ( testis, seminal vesicles, prostate gland ), biochemical paramters 
( glycogen, protein, cholesterol) all demonstrate positive changes (increase) in the sperm 
count in the CKC treated group. Main function of epididymis is the maturation of sperm, that 
leads to the attainment of reproduction ability and sperm viability. 
257 
Animals treated with 
test drug showed normal morphology of epididymis [fig 6.36A, B] which may be responsible 
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for the increase in motility and viabilty of sperms. Administration of CKC attenuated the 
ethanol-induced decrease of sperm count, motility and viability. 
 
Histopathology Study  
Male infertility is greatly associated with certain histo-pathological characters of 
testes which include loss in sperm/spermatids, disarray/absence in germ cell layers
266
 and 
hence histometric analysis of testis, epididymis and semniferous tubules and histogram of 
testis and semniferous tubules were evaluated. 
 
Inside the testis, the most important target cells meant for toxicants which disrupt 
spermatogenesis are somatic-cells, (leydig/sertoli cells) and germ cells.
267
 Histocytology of 
testicular tissue of the control group animals showed well differentiated germ cells with 
respect to spermatogonia. It was observed that the presence of mature somatic cells projects 
the perfect histomorphology of the testicular cells in this group. Normal sertoli cell was 
aligned properly on the basement membrane with oval dome shaped nucleus which 
demonstrates the normal morphology of the seminiferous tubule.  
 
The Primary spermatocytes of the sample belonging to ethanol group showed 
condensed chromatin similarly the number of leptotenes and zygotenes are very minimal in 
this group. Leydig cell dysfunction occurs with testicular steroidogenic disorder
230
 This is 
correlated with the decrease in the testosterone level and unclear leydig cells [fig 6.34 A, B] 
in the ethanol group rats. Decreased number of normal Sertoli cells with irregular 
cytoarchitecture and decrease in the number of spermatogenic cells into the lumen of 
seminiferous tubule was showed in the ethanol group [fig 6.34 B]. This observations may 
demonstrate the direct - toxic effect of ethanol on sertoli cells (which plays a vital role in 
spermatogenesis).  
 
In CKC treated group primary spermatocytes with large centered nucleus and dense 
chromatin were observed. Leptotene and zygotene spermatocytes appeared rich in number. 
Preserverance of mature somatic cells were observed [fig 6.34 B]. CKC treated group showed 
many seminiferous tubules encircled by prominent membrane and also proper distribution of 
collagen fibers along with the seminiferous tubule. Tubules appeared to be uniform in size 
and shape. The seminiferous tubules showed normal spermatogenesis and spermiation [fig 
6.34 A, B, 6.35 A,B, 6.36 ] This showed the steroidogenic activity of the test drug. Plenty of 
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sperms in seminiferous tubule evidently indicates the spermatogenesis regulated by hormone 
. 
234
 Leydig cells with clear-structure were observed. Presence of normal leydigs cells in this 
group is also suggestive of normal steroids synthesis which is evident from the comparable 
testosterone level with the control group. Sertoli cells provides nutritional support to 
spermatozoa.
267 
Seminiferous tubules of CKC treated group showed plenty of sertoli cells 
with normal histology and also increased spermatogenic cells into the lumen of seminiferous 
tubule. Sertoli cells with apparent triangular nucleus was observed. Epididymis is the place 
where sperm maturation (morphology) takes place, which also provides the store house for 
matured sperms. 
267
 Animals treated with test drug showed numerous number of spermatid 
cells in the epididymis and also showed normal presence of epididymal lobule. Size and 
shape of the sperms appear normal in this group. Diameter of testis and semniferous tubules 
in the treated group was increased when compared with the control group and it showed 
prevention from the shrunken pattern when compared to the ethanol group.   
 
Increase of sperm count and normal sperms (morphology) in the drug treated animals 
demonstrate positive changes in spermatogenesis and increase in sperm motility demonstrate 
positive changes of sperm maturation in epididymis. 
257, 258
   
 
Probable Mechanism 
Antioxidant defense mechanism is of most important since peroxidative damage is 
considered as the significant cause for impaired-testicular function which results in wide 
range of pathological consequences (from testicular torsion- alcoholism). Normally the 
antioxidant system in the reproductive-tissues and the secretions are probable to quench ROS 
(reactive oxygen species) and defend against the oxidative injure to mature sperm and 
gonadal cells. 
98 
  
 
In the present study rats treated with ethanol showed sertoli cells with irregular 
cytoarchitecture, decreased spermatogenic cells ( in the lumen of seminiferous tubule), 
presence of high number of abnormal size and shape of the spermatozoa, reduction in the 
diameter of testis and semniferous tubules which may indicate the cytotoxicity. Reduction in 
count, motility increase in the abnormal sperms percentage is directly associated to infertility 
153 
Sperm membranes are mainly vulnerable to oxidative stress because of elevated poly-
unsaturated fatty acids and have need of sertoli cell - barrier protection. 
153
 High cholesterol ( 
high poly unsaturated fatty acids) level in the ethanol group might have damaged the sperm 
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membranes. And also the presence of sertoli cells with irregular cytoarchitecture in this 
ethanol group rats may indicate the impairment of sertoli cell barrier protection. These factors 
might results in the initiation of oxidative stress and reduces the spermconcentration, motility 
, viability and  normal form of sperm in the ethanol group. 
 
Sertoli cells plays an significant role in spermatogenesis.
267
 The histopathology study 
results of CKC treated rats showed plenty of sertoli cells with normal histology, apparent 
triangular nucleus which might evidently indicate that the drug (CKC) has positive effect on 
spermatogenesis in rats which is also evident from the increased sperm concentration in CKC 
treated group. The androgenic activity of CKC is reflected by the increase in testis weight and 
serum testosterone levels.  
 
Spermatogenic and androgenic effects of CKC is possibly due to the combined effects 
of the phytochemicals [amino acids, steroid, flavonoids, phenols, tannins, and saponins] and 
the nutritional elements [iron, calcium, magnesium, zinc, copper] present in CKC. Zinc 
enhances sperm maturation and motility, calcium, copper and magnesium on 
spermatogenesis
239 
aminoacids in sperm activity
, 
saponins and sterols in steroidogenesis; 
phenols, flavonoids and tannis
 
shows antioxidative property. 
234,235,21
 The Antioxidants 
present in CKC might have ameliorated the oxidative stress induced by ethanol and had 
improved the androgenesis and spermatogenesis.  
 
Clinical study 
Environment, diet or lifestyle modification in current decades interfer with man’s 
capability to produce sperm,
268
 smoking and alcoholism directs to low semen quality.
9
  
Reproductive organs are extremely at risk to free radicals due to toxins (pesticides, 
insecticides lead, radiation, heavy metals) from environment.
268 
 Sperm count has been 
declining at two percent / annum for the last twenty years. This is due to increase of global 
temperature/ environmental pollution.
19
 Oligozoospermia is the main cause for infertility in 
most of the couples. It is commonly treated by assisted reproductive techniques. Generally in 
these methods male with oligozoospermia are untreated, while the female partners are treated. 
Although various empirical treatments are in existence to cure oligozoospermia, it is hard to 
make out a therapy which is expected to help out a man with oligozoospermia. This lead to 
the trial of various therapies resultant in different success rates. 
269 
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 Clinical study was carried out in to two phases  
 
1] Pilot study and  
2] Main clinical trial 
 
The safety aspect of CKC was assessed on the basis of biochemical, haematological 
parameters and urinary parameters.In hematological analysis the parameters evaluated were 
Hb (gm/dl), Total RBC ( cells/µl), Total WBC count (million/µl)), Erythrocyte sedimentation 
rate (ESR), Platelets (lakhs /µl). In biochemical analysis the parameters evaluated were blood 
glucose (mg/dl), serum total cholesterol (mg/dl), HDL (mg/dl), LDL( md/dl), VLDL ( mg/dl), 
serum triglycerides (mg/dl), blood urea (mg/dl), serum creatinine (mg/dl), uric acid (mg/dl), 
serum total bilirubin (mg/dl),serum total protein (gm/dl), AST (IU/ml), ALT (IU/ml) and 
alkaline phosphatase (IU/L). In urine routine, the parameters evaluated were albumin, sugar, 
bile salts, bile pigments, Urobilinogen, Acetone and occult blood. 
 
The efficacy aspect was assessed on the basis of semen parameters and harmone 
parameters. Semen examination was carried out at recommended standards of World Health 
Organization (WHO).The parameters evauated were semen volume [ml], liquification time 
[minutes], semen viscosity, sperm concentration [million/ml], percentage of progressive and 
total motile spermatozoa, percentage of normal forms of sperm and pus cells (per field). In 
Harmone analysis the serum samples were measured for testosterone, follicle stimulating 
hormone (FSH) by ECLIA method and luteinizing hormone (LH) by CLIA method.  
 
Parameters were assessed at baseline (Day 0), at the end of the trial (Day 91) and at 
the end of the follow up (day 181).  
 
Pilot study 
This study was designed to assess the feasibility, safety and tolerability of 
administration of study in Oligozoospermic patients prior to conducting phase II main clinical 
trial. Study was conducted in 5 patients in the out patient department of National Institute of 
Siddha, Chennai, India. The trial drug provided high significant (P<0.001) increase in the 
sperm count, progressive motility, total motility and normal form of sperm both after 
treatment AT and AFU. The mean value of the safety parameters were within normal range 
both AT and AFU. 
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Main Clinical Trial 
The study was conducted in accordance with the guidelines of the Indian Council for 
Medical Research (ICMR) and GCP adapted from ICH and accepted by Ayush. The study 
was conducted for one year in between April 2013 and April 2014 in the out patient 
department of National Institute of Siddha, Chennai, India.The Selected patients had been 
given Agasthiar Kuzhambu at the dose of 130 mg with ginger juice in the early morning in 
empty stomach to bring the mukutram to equilibrium. After that patients were put on 90 days 
of interventional Medicine 12 gm of CKC chooranam at night with milk. After the 
completion of treatment also the patients were kept under follow up for 3 months to asess the 
total overall effect of the treatment. Total number of patient’s registered for study was 40. As 
per ICMR guidelines, Phase II is a therapeutic exploratory trials and normally 20 - 25 patients 
should be studied for assessment of each dosage. In this study 37 patients have completed the 
trial out of estimated 40 registered patients and their data were analyzed. No clinically 
significant adverse effect neither reported by the patients nor observed by the investigator 
through out the study period.  
 
General status 
According to previous illness the causes for spermatogenic arrest in 2 ( 5%)  patients 
may be due to the history of mumps.
19 
Socio economic status being the confounding factor 
also affect semen quality. 27 (73 %) patients comes under middle economic status and 7 
(19% ) patients of low economic status and 3 (8%) patients of high economic status.
4 
Sleep 
disturbances is associated with the androgen deficiency 
270
 16 ( 43% ) had disturbed sleep and 
12 ( 32%) patients were having delayed sleep. Increase in BMI is associated to low semen 
quality, diminished sperm couts and motility and increase in DNA fragmentation index. 
Obesity and overweight are normally associated with reduced testosterone levels. 
271
  BMI 
report of the main clinical trial signifies 2 (5 %) patients were underweight, 4 (11%) patients 
were over weight, 4 (11%) patients were obese and 27 (73%) comes under normal 
category.Majority of the patients 34 (92 %) were of mixed type and remaining 3 ( 8% ) 
patients were vegetarian. Vegetarian diets may cause vitamin deficiencies (B12, A, B, C, E, 
Omega-3 fatty Acids, Se and Zn) and that might promote hinderance in the spermatogenesis 
process. Non- Vegetarian diet may cause Oligozoospermia since because of hormonal 
injections applied on poultries and cattles for the better yield. 
88
 Fish, meat, poultry, 
vegetables, various prepared and processed foods include considerable levels of MSG (free 
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glutamate). MSG (monosodium glutamate) has toxic effect on testes and causes 
oligozoospermia in rats. It causes testicular degeneration, hemorrhage and alteration. 
272  
 
6 patients (16%) were addicted to smoking, 9 (24 %) patients to alcohol, 2 patients (6 
%) to tobacco, 4 patients (11 %) both to smoking and alcohol. Smoking and alcohol are 
observed to cause testicular toxins/leyding toxins and causes oligozoospermia.
88
 
Gonadotoxins like chemotherapeutic agents; radiation exposure and various pharmaceutical 
agents (nitrofurantoin, cimetidine, ethanol, sulfasalazine, androgenic steroids and cannabis) 
acts as an direct spermato-toxins or via steroidal pathway. 
48
 In the clinical trial 10 (27 %) 
patients had history of exposure to gonadotoxic agents such as anti-bacterial drugs, drugs 
used for treatment of gastric problems, antidepressant drugs and steroids. 
4, 55
 It was observed 
that the maximum of 22 ( 59%) patients were found between the age group of 31 to 40 years , 
11 ( 30 %) patients were between 21-30 years and 4 ( 11 %) patients were between 41-45 
years. Highest proportion of duration of infertility was observed between 1-5 years in 23 
(62%) patients, 8(22%) patients showed duration between 6-10 years, 5(13%) patients 
showed between 11-14yrs and in 1 (3%) patient the duration was found above 15 years. Other 
previous studies have mentioned highest percentage of male infertile age group between 30-
39 years and duration between 1-5years. 
273 
36 (97%) patients were presented with primary 
infertility and 1 (3%) patient complained of secondary infertility.In men rate of promiscuity 
increases when their partners are pregnant/breastfeeding and this describes the increased rate 
of secondary infertility through change in sperm quality with time. Causes may be fever, 
malignancy, testicular disease, stress, drug intake, environmental pollutants, surgical 
conditions and tobacco relating the reproductive tract.
48 
 
 
Rise in cortisol levels in reaction to stress reduce testosterone level
274
 and may inhibit  
spermatogenesis.
4
 In present study 5 (13%) patients were in depression and 10 ( 27%) were 
under stress. Excessive masturbation may lead to Oligospermia. 
88  
Antisperm antibodies 
might result as an exposure to sperm antigens in rectal mucosa and have been identified in the 
serum of homosexual men.
274 
21 ( 57% ) patients comes under normal, 2 cases ( 5 % ) were 
having perversion and  history of masturbation before marriage in 14 cases (38 %) were 
reported. In this clinical study only 3 (8%) of the patients had the family history of delayed 
conception in mother or siblings, 1 (3%) patients had history of infertility in siblings and 33 ( 
89% ) patients had no family history. Majority of the patients 19 (51 %) were doing physical 
exertional work, 12 (32 %) patients were doing intellectual work, 02 (5 %) patients were 
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doing chemical /radiation work and 04 (11%) patients comes under thermal nature of work. 
Various occupational factors show deleterious result on male reproductive function. Welders, 
dyers, furnance and steel workers at their work place are exposed to the high temperatures 
and stated to have impaired spermatogenesis.
19
 Ozone radiation and radio frequency 
electromagnetic waves emmited from the cell phones may lead to oxidative stress. Lead 
workers, professional drivers, agricultural workers and pesticide manufacturer are reported to 
have toxic effect on fertility. 
4, 55, 57,58
 Prevalence of infertility in male with blood group-O is 
higher than other blood groups (ABO), which shows the correlation between male inferility 
and blood group O. 
275
  This clinical study showed maximum of 15 ( 40%) patients reported 
in O+ group, 11 ( 30% )  patients reported  A+ group, 4 ( 11%) patients reported AB+ group 
and 7 (19%) patients reported B+ group. 15 (41% ) patients were having the habit of hot 
water bath and 22 ( 59% ) patients were having the habit of normal water bath. Sertoli cells 
and germ cells are highly susceptible to increased temperature which may cause 
partial/complete-spermatogenic arrest.
19
 High summer temperatures, fever, saunas and 
frequent hot-baths results in destruction of germinal epithelium. Elevated testicular 
temperature (1°C beyond baseline) diminsh spermatogenesis (by 14%) and elevated testiculo-
epididymal temperature diminish the sperm membrane coating protein synthesis. 
19 
10 (27%) 
patients had primary education, 6 (16%) had secondary education, 18 (49%) had graduation  
and 3 ( 8% ) were illliterate. Highest frequency of patients had done their graduations. 
 
Safety study 
 
Biochemical 
Modification in liver function, exocrine pancreas and biliary system are common in 
DM (Diabetes Mellitus).
251
 The mean value of blood sugar (98.27, 100.03) was significantly 
decreased (P<0.001) both AT and AFU. Significant decrease in bood sugar after treatment 
may be due to glucose which may be converted in to glycogen to provide energy for the 
sperm movement 
263
 which is evident from the significant increase ( P<0.001 )  in the motility 
of the sperm and additionally the drug CKC is also given in polyuria. 
25 
  
 
The mean value of total cholesterol (174.57, 173.30), LDL (77.89,76,81) VLDL 
(30.73,29.76) showed significant decrease (P<0.001) and HDL (41.65,42.08), TGL (123.70, 
122.95) showed significant increase (P<0.001) both AT and AFU. The mean value showed 
no lipotoxicity.T.protein (6.10, 6.16), AST (24.73, 27.54 ), ALT (25.43, 26.57), SAP (147.46 
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) showed significant decrease (P<0.001), total bilirubin ( 0.770, 0.768 ) showed non 
significant changes ( p >  0.05 ) both ATand AFU. The mean value showed no liver toxicity. 
Sterols reduces serum cholesterol by inhibiting the intestinal cholesterol-absorption; and 
polyphenols (ﬂavonoids, tannins) lowers blood lipids.250 The drug CKC has revealed the 
presence of sterol, flavonoids and tannins which may be the cause for the reduced cholesterol 
level after treatment and additionally the drug CKC is also given in biliousness 
25
(the 
composition of the bile is cholesterol; bileacids and phospholipids 
251 
). Urea (22.22, 22.05 ) 
and creatinine (0.819,0.803 ) showed non significant changes ( p >  0.05 ) and uric acid 
(4.03,4.30) showed significant decrease (P<0.001) both AT and AFU. The mean value 
showed no renal toxicity.  
 
Haematology 
The mean value of Hb and T.WBC showed significant increase (P<0.001) in both AT 
and AFU. ESR showed significant decrease (P<0.001) both AT and AFU. Platelets showed 
significant increase AT (P<0.01) and non significant changes (p > 0.05 ) AFU. RBC (p > 
 0.05) showed non significant changes AT and AFU. All were within normal ranges. The 
evaluation showed absence of hematological toxicity .Copper along with iron is essential for 
the synthesis of haemoglobin. 
276
 CKC showed the presence of iron and copper ( ICP-OES) 
which may be the cause for the increased Hb level after treatment.The increase in the WBC 
level may indicate the CKC in enhancing the immune system (immunopotentiating effect) 
after treatment. 
250 
  
 
Efficacy study 
 
Harmone parameters 
Deficiency of testosterone and FSH (marker components) may cause 
oligozoospermia.
11
 FSH is the main endocrine parameter to assess testicular function.
19
 
Testosterone will stimulate sertoli cells which will produce paracrine agent that stimulate 
sperm- proliferation/differentiation.
277
 Plant testosterone are safer than the artificial form. 
278  
 
BT 2 (5%) patients were having testosterone below 2.8 ng/ml, 34 (92%) were in 
normal range between 2.8 to 8 ng/ml, 1(3%) patients were having above 8 ng/ml. AT 
36(97%) patients were improved to the normal range between  2.8 to 8ng/ml  and 1 (3%) 
patient  was having above 8ng/ml value.  
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BT FSH of 25(68%) patients were in the normal range between 1.7 to 8.6 mIu/ml and 
12 ( 32%) patients were above 8.6 mIu/ml, AT same proportion was reported. BT LH of 34 
(92%) patients were in the normal range between 1.5-12.4mIu/ml, 3(8%) patients were 
having LH above 12.4 mIu/ml. AT same proportion was reported.  
 
The mean value of testosterone, FSH and LH, BT were 4.57, 7.86 and 7.14 
respectively.The mean value of testosterone ( 6.09), FSH ( 9.18 ) and LH ( 8.0 ) showed 
significant increase (P<0.001) AT. Thus, it is proposed that the possible explanations for the 
increased sperm concentration and motility in the present study might be due to the 
significant increase (P<0.001) in the mean level of testosterone, FSH and LH . 
 
Semen Parameters 
Testosterone controls functional ability of accessory sex organs because sufficient 
seminal fluid is essential for sperm survival and motility. 
19
 Significant increase in the mean 
value of semen volume was observed after treatment which may be due to significant 
increase in testosterone level (AT) and in addition due to the presence of ingredients like 
Tribulus terrestris and Madhuca longifolia in CKC which has the property in increasing the 
semen seminal fluids. 
72,109] 
 
Non significant changes (p >  0.05) was observed in the liquification time after 
treatment. BT 6 (16 %) patients showed high viscous semen, 2 (5 %) patients of low visous 
semen and AT the values decreased to 1 (3%) patient in high viscous semen, no patients (0%) 
in low viscous semen.The CKC has the ingredient Moringa oleifera which is given in high 
and low viscous semen and Bombax ceiba which keeps the semen in suspension 
40,17
 which 
may be the cause for the improvement of normal viscous. BT 5 (13%)  patients showed pus 
cells of more than value of 5, 4 (11%) patients  showed  less than 5 and AT the values 
decreased to 1 (3%) in more than 5, 4 (11%) patients in less than 5. The pus cell values 
decreased after treatment states the clinical improvement in observation of infection.  
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Sperm Parameters 
 
Sperm count 
Normal fertility needs normal spermatogenesis, epididymal storage and sperm 
transport. Partial/complete disruption to spermatogenesis effects in spermatogenic arrest and 
leads to oligozoospermia. Sertoli cells ( functional/fully differentiated ) are vital for 
spermatogenesis process and also offer structural/functional support to the 
growth/differentiate of germ cells.
19
 The mean value of sperm count before treatment is 8.46 
and significant (P<0.001) increase in the mean value of 38.97 was observed after treating 
with CKC.  
 
Sperm motility 
Male fertility depends on sperm motility and morphology.Yearly decline (2.6%; 
0.3%; 0.7%) in sperm count, motility and morphology have been reported in earlier studies.
19
 
Sperm motility is the main factor used in evaluvating the sperm quality and this is obtained 
by the transist of sperm through epididymal duct. 
271  
  
The mean value of PR (progressive motility) before treatmnet is 10.19 and significant 
(P<0.001) increase was observed in the mean value (36.03) of PR after treatment. The mean 
value of TM (total motility) before treatment is 24.05 and significant (P<0.001) increase was 
observed in the mean value (54) of TM after treatment. The observed result demonstrate the 
improvement in the quality of the sperm 
 
Sperm morphology 
Normal sperm morphology is required for progressive motility (linear) of sperm. 
Sperm morphology and motility are the excellent predictor for fertility potential.
19 
The mean 
value of normal sperm before treatment is 23.70 and significant (P<0.001) increase was 
observed in the mean value (41 ) of sperm after treatment. 
 
The significant increase in sperm count after treatment demonstrates Chandrakanthi 
chooranam have positive effect on spermatogenesis. Though the study mainly concern about 
sperm count, but still it was found that CKC has significant effect on motility and 
morphology of sperm. Histophysiology of epididymis and achievement of sperm motility 
depends in the presence of testosterone.
271
 In the present study the percentage of progressive 
and total motility was significantly increased which is also comparable with significant 
increase in testosterone level. Viscosity interfer’s with motility and sperm antibody coating.44 
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In this clinical study the observation in the improvement of viscosity, significant increase in 
motility and significant increase in WBC level (boosting the immune system) are 
interconnected with one another. Antisperm antibodies formation is an immune mediated 
system and steroids can suppress it.
279
  CKC has steroids, ingredient like Tribulus terrestris ( 
effective in anti-sperm antibodies) and has ingredients posessing immuno-modulatory 
activities like Curculigo orchioides, Asphaltum punjabinum, Cinnamomum tamala,Vitis 
vinifera, Glycyrrhiza glabra, Phoenix dactilifera, Alternanthera sessilis 
98,189,118,148,179,157,194
 
which may be the cause for the improvement of motility and viscosity.This suggestion should 
be further explored through the interventional medicine in combating with the antisperm 
antibodies. 
 
Clinical symptoms 
Gonadal and the sexual dysfunction are linked with increased circulating-cortisol 
levels. Cortisol levels rises in stress response and cause drop in testosterone.
273
 Nicotine 
causes negative impact on erectile function. Studies showed relationship between erectile 
dysfunction and BMI (increased in obesity) with hormone dysfunction.
48
 Depression is 
connected with erectile dysfunction. Antibiotics, drugs used in treating blood pressure,gastric 
problems and CNS depressant interfere with production of sperm and ejaculation.
4  
 
Pitham is affected in nocturnal emmision. Abanan [vatham] is affected in premature 
ejaculation and viyanan [vatham] is affected in erectyle dysfunction. 
32,41
 Before treatment 20 
(54%) patients with erectyle dysfunction, 26 (70%) patients with premature ejaculation and 
11(30%) patients with nocturnal emission were reported and after treatment 6 (16%) patients 
with erectyle dysfunction, 4 (11%) patients with premature ejaculation and 2 (5%) patients 
with nocturnal emission were reported which bring about the study drug showed 
improvement in the clinical symptoms. The improvement in the symptoms after treatment 
may be due to the presence of Tribulus terrestris, Moringa oleifera, Syzygium aromaticum 
given in premature ejaculation; Mucuna prurita, Tribulus terrestris, Curculigo orchioides, 
Glycyrrhiza glabra and cuminum cyminum given in erectile dysfunction; Mucuna prurita, 
Bombax ceiba ,Gomutra Silasathu parpam given in nocturnal emission. [as stated earlier in 
drug review]. 
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Follow up 
After the completion of treatment also the patients were kept under follow up to 
observe further for 3 months, so that the total overall effect of treatment could be assessed. 
Investigations on safety study revealed that there was no alteration in any of the 
haematological and biochemical parameters related to any systemic toxicity AFU. The same 
significance P<0.001 persisted in the mean value of the count, total motility, progressive 
motility, normal form of sperms, semen volume  and same non significant changes  persisted 
in the the mean value of the liquification time of semen after follow up.   
 
Probable Mechanism 
 
Spermatogenesis pathway 
Testosterone and FSH are hormones which act on Sertoli cells directly and promote 
spermatogenesis.
11
 Hence, the probable reasons of the increased spermia, normal sperm count 
and motility in the present findings may be due the higher levels of testosterone which acts on 
the sertoli cells. 
11 
The drugs postive effect on spermatogenesis may be due to the presence of 
amino acids, iron, calcium, magnesium, zinc and copper. Aminoacids in sperm activity, Zinc 
in sperm maturation and motility, Ca, Cu, Mg and Fe in spermatogenesis. Additionally the 
ingredients like Curculigo orchioides; Tribulus terrestris; Mucuna prurita; Asphaltum 
punjabinum;  Moringa oleifera; Cinnamomum verum and Phoenix dactilifera in CKC are 
reported to have spermatogenic activity and Maerua arenaria; Cinnamomum tamala; Vitis 
vinifera; Bombax; Costus speciosus; Mesua ferrea; Glycyrrhiza glabra; Myristica fragrans; 
Ilicium verum; Cyperus rotundus were therapeutically given in to increase sperm. [as stated 
earlier in drug review] 
 
Steriodogenesis pathway 
Luteinizing hormone and FSH (gonadotropins) acts on gonads which secretes 
testosterone. 
280 
LH stimulates leydig cells (in testis) to produce testosterone, while FSH acts 
on Sertoli cells to regulate the spermatogenesis. 
280 
Synthesis of ABP (androgen-binding 
protein) is FSH- dependent process. ABP binds testosterone with dihydrotestosterone and 
makes the availability of local androgenic-pool which supports gametogenesis.
278
 In the 
present study there is significant increase in the concentration of testosterone, FSH and LH. 
The increase in LH concentration observed in this study may confer an increase in 
testosterone concentration. 
280 
The effect on the harmone parameters may be due to the 
presence of the steroid, glycoside and saponins in CKC which increase the steroidogenesis 
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and elevate androgen levels. Furthermore the androgenic effect of the drug may also be due 
to the androgenic activity reported in the ingredients like Curculigo orchioides; Tribulus 
terrestris; Asphaltum punjabinum; Syzygium aromaticum; Costus speciosus and Ilicium 
verum. [as stated earlier in drug review] 
 
Endocrine pathway 
Hormonal activity is completely an integrated process and hence it is essential to 
establish any probable endocrine impact. 
281
 Spermatogenesis is the complex-interplay 
connecting structural elements of testis with the endocrine system.
234
 Psychological stress 
(chronic exposure) is known to produce various patho-physiological alterations in 
neuroendrocrine structure, resulting in changes in steroidogenesis. 
210
 The significant increase 
in serum LH and FSH levels may suggest stimulatory effect on pituitary gland which may 
demonstrate that the drug may act directly on hypothalamic– pituitary–gonadal axis. 280 This 
statement is supported by the action of the ingredients Mucuna prurita; Asphaltum 
punjabinum; Curculigo  present in CKC on endocrine system. [as stated earlier in drug 
review] 
 
Antioxidant  pathway 
Increased reactive oxygen species causes an imbalance between the ratio of oxidant 
and anti-oxidant, which in turn causes increased lipid peroxidation which damage sperm 
membrane and causes dysfunction. 
210
 Psychological stress is be associated with oxidant 
production 
277 
Smoking/passive inhalation of smoke cause seminal oxidative stress. Ethanol 
considerably enhances lipid peroxidation in testis and reduces the conversion of 
dehydroepiandrosterone/androstendione to testosterone.
259
 Obesity increases sperm intra 
cellular reactive oxygen species 
271
 Antioxidants alters androgen level and increases the 
spermatogenesis.
234
 CKC demonstrated to have  phenols, flavonoids
 
and tannis (antioxidants) 
and moreover the ingredients like Curculigo orchioides; Tribulus terrestris; Mucuna prurita; 
Asphaltum punjabinum; Madhuca longifolia; Cuminum cyminum; Cinnamomum verum; Vitis 
vinifera; Bombax ceiba; Costus speciosus; Mesua ferrea; Glycyrrhiza glabra; Phoenix 
dactilifera; Myristica fragrans; Ilicium verum; Cyperus rotundus and Coscinium fenestratum 
are reported to have antioxidant activities. [as stated earlier in drug review] 
 
The mechanism by which the drug Chandrakanthi chooranam results in the 
improvement of spermatogenesis in human subjects should be further elucidated. 
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Outcome measures 
On the basis of the criteria meant for the assessment of the sperm parameters it was 
observed that Good response was observed in 19 patients (count; n=37), 23 patients (total 
motility; n=37), 20 patients (progressive motility; n=27) and 12 patients (normal form of 
sperm; n=21). Moderate response was observed in 9 patients (count; n=37), 7 patients (total 
motility; n=37), 9 patients (progressive motility;n=27 ) and 4 patients  ( normal form of 
sperm; n=21). Mild response was observed in 6 patients (count; n=37), 5 patients ( total 
motility; n=37), 6 patients (progressive motility; n=27 ) and 3 patients (normal form of 
sperm; n=21). Poor changes was observed in 3 patients (count;n=37), 2 patients (total 
motility and progressive motility; n=27 and normal form of sperm;n=21). 
Sperm count, progressive motility, total motility and normal sperms showed 
significant increase (P<0.001) after treatment and the mean value differences (increase) after 
treatment were 30.51, 25.83, 30.48 and 17.29 respectively.Testosterone,FSH and LH showed 
significant increase (P<0.001) after treatment and the mean value differences (increase) after 
treatment were 1.51,1.31 and 0.86 respectively. 
 
Siddha system of clincal study 
 
Kaalam (Age) 
Among 37 cases, 54% of cases came under vatha kaalam, and 46 % of cases came 
under pitha kaalam. According to siddha text, vathakalam constitutes 1-33 years of age, 
pitham kalam 34-66 and kaba kalam from 67-99yrs.
32
 In the present study male infertile 
patients with age between 21-45 years were included in the clinical trial. Hence all the cases 
selected for this study came under Vatham and pitham kaalam.  
 
Paruva Kaalam (Season)  
Majority of 40% patients were reported during Kaar kaalam [ rainy season - mid 
august to mid october] and followingly 30% of patients were reported during Ilavenirkaalam 
[early summer-mid april to mid june] 
 
Thinai (Land) 
Majority of 15 (89 %) patients were reported from neithal thinai (costal tract) and 1 
(3%) patient reported from mullai thinai [sylvan tract] in both of which pitham will be 
vitiated 
32 
which is opposite to the nature of sperm and 3 (8 %) patients reported from 
kurinchi thinai [hilly tract] which may causes disease regarding blood
32
 which is the second 
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body constituent and the precursor in the formation of sperm. Study can be merely 
determined after a multicentric study.  
 
Thega ilakkanam ( Bio type) 
Vali bio type groups are prone to Thatu nashtam (Oligozoospermia), iyyam bio type 
groups are prone to Inthriya kuraivu (Oligozoospermia), Pitham bio type groups  are prone to 
arpa sukilam (Oligozoospermia)
32,36
 This states that all the bio type are prone to 
oligozoospermia.In this clinical study majority of the patients were of kabha pitham biotype 
with the proportion of 30% , 24% of vathapitham,16% of pitha kabham, 14 % of pitha 
vatham, 8% of vatham, 5% of vatha kabham and 3 % of kabham biotype. 
 
Envagai Thervu (Eight fold Examination) 
In vali derangement, tongue will exhibit sour taste, in azhal kaipu taste and in iyyam 
sweet taste will be exhibited. 
32
  Among 37 cases, before treatmnet 68% patients had normal 
taste 16 % patients had bitter taste, 8% patients with sour and sweet taste in their tongue 
which states pitham is affected maximum and after treatment 92% patients had normal taste, 
5% patients with bitter taste, 0% with sour taste and 3 % patient with sweet taste in the 
tongue.  
 
Before treatment 5% of patients were with affected skin colour (pallor) indicates 
pitham affected and after treatment all the patients were with normal skin colour.Pitham lies 
in blood and chyle. Excess chyme resulting in paleness of the body and decreased blood 
resulting in discoloration of the skin.
32
  
 
Before treatment 14% patients had affected eye (pallor, burning sensation) which 
indicates the vitiation of iyyam and pitham and after treatment it was normal.Before treatment 
in 19% of patients faeces were affected (constipation) which indicates the vitiation of vatham 
and after treatment 3% of patient faeces were affected and 97% patient’s faeces were normal. 
As per sathaga naadi, pulse perceived in thatunashtam [oligozoospermia] are vali naadi, vali 
azhal naadi, azhal vali naadi and pithathil vayu.
32
 Before treatment the naadi nadai  of 48% 
cases was pitha vatham, 38% of vatha pitham, 3% patient of pitha kabham and vatha kabham 
and 8 % patients were kabhapitham. After treatment 51 % of cases had vatha pitham, 14 38% 
of pitha vatham, 5% of patients were kabhapitham and 3 % of patients with pitha kabham 
and vatha kabham naadi were reported. 
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BT 34 (92%) patients with normal voice, 3 (8%) patients with affected voice (Thantha 
oli) and AT the same proportion was reported. Both before and after treatment all the patients 
were with normal meikuri (normal body temperature, no tenderness). In the present clinical 
study datas of mozhi and meikuri does not have research significance as majority of them are 
normal. 
 
Before treatment 76 % of patients had normal urine colour, 89% of normal smell, 
43% of frothy urine, 46% of deposits, 86 % of normal specific gravity and volume and after 
treatment 89 % of normal urine colour, 97 % of normal smell, 19% frothy urine, 11% of 
deposists, 97% of specific gravity and volume were reported. Frothy micturation is one of the 
features of aan maladu. As per siddha science frothiness is due to kabam derangement. 
32 
  
 
In nei kuri urine samples on observation with regard to shapes of the oil on urine, 
before treatment 51% patients had ring shape, serpentine being 19% ,pearl being  5%, mixed 
being 24%, 0% of case with saladai and after treatment ring being 54%, serpentine being 
21%, pearl being 3%, mixed being 19% and saladai being 3%. Pearl and saladai are 
incurable signs. Ring, serpentine and mixed are curable signs. 
32
 On observation to the 
spreading pattern, before treatment 95% cases showed slow spreading pattern, 0% of patient 
showed fast spreading pattern, 3 % of patients showed no spreading and after treatment 94% 
of patients showed slow spreading, 3% of patient showed fast spreading and 3% of patient 
showed no spreading pattern. Slow spreading is curable; fast and no spreading are incurable 
signs. 
32
 The results shows the clinical improvement. 
 
Uyir thathukkal (Functional constitution of the body) 
 
Deranged Vali (Bio energy movement) 
Pranan [life force] is responsible for respiration and digestion. Abanan [downward 
air] responsible for absorption, assimilation of essence, excretion of urine, faeces, ejection of 
semen, contracts and relaxes the sphincters. Uthanan [upward air] responsible for speech, 
stations the essence of food at appropriate place (nutrition). Helps in the digestion of food. 
Viyanan [centrifugal air] disseminates all over the body through vessels and nerves causing 
voluntary and involuntary functions, takes the essence of food to all the parts of the body. 
Samanan [digestive/homeostatic air] balances other components, responsible for assimilation, 
equalizes six tastes, water, food etc. Devathathan [Tiresome air] responsible for lassitude, 
laziness and lethargy. 
32
 Before treatment among 37 cases 30% of cases had deranged 
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pranan, 70% of abanan, 3 % of uthanan, 54% of viyanan, 49 % of samanan and 5% of 
devathathan and after treatment  it was reduced to 5 % of pranan, 11 % of abanan, 16 % of 
viyanan, 5 % of  samanan and 0% of uthanan and devathathan 
 
Deranged Azhal (Bio energy fire ) 
Before treatment 5 % of cases had deranged anar pitham and prasaga pitham, 11 % 
of ranjaka pitham and 100% of sathaga pitham and after treatment it was reduced to 0% of 
anarpitham, ranjaka pitahm, prasaga pitham and 22 % of sathaga pitham. Ranjaka pitham 
(Haematinic fire) exists in the stomach, stains red the essence of the digested food. Anar 
pitham (digestive fire) exists in stomach and intestines possess the quality of increased fire 
dries up water contents of the food stuffs and digests all the ingested foods. Prasaga pitham 
(complexion fire) existing in the skin, it gives lustre to it. Sathaga pitham (accomplishment 
fire) existing in the heart, with the help of knowledge, intellect and affinity performs the 
desired act.
32,27  
 
Deranged Iyyam (Bio energy water )  
Before treatment 43% of cases had deranged kilethegam, 32% had pothakam, 41% 
had santhikam and after treatment it was reduced to 5 % of kilethegam, 8% of pothakam and 
11% of santhikam. Kilethegam (digestive iyyam) exist in the stomach, break down the 
ingested hard food stuffs and liquifies them. Pothakam (gustatory iyyam) exists in the tongue, 
intimates the taste of the food. 
32,27
  
 
Udal Thathukkal (Physical constituents ) 
  Excess chyme results in diminished digestive fire, fatigue, excessive sleep, slackening 
of all the joints, heaviness of the body, paleness and coldness,excess salivation and decreased 
chyme results in skin roughness, body pain,leanness. Blood excess results in dyspepsia, 
reddening of eyes and skinand decreased blood causes liking of cold and sour foods, nervine 
debility, dryness and skin discoloration. Excess muscle causes increases of flesh in cheeks, 
stomach, thigh, penis and neck and decreased muscle causes five sense organs weakness, 
joint pain, shrinking of chin, buttocks, penis and thighs. Excess fat causes symptoms similar 
to that of muscle excess, along with fatigue, dyspnoea on exertion, associated with excess 
muscle formation in buttocks, genitals, chest, abdomen and thighs and decreased fat causes 
the weakness of hip with pain, emaciation of the body, enlarged spleen. Excess bone causes 
increased bone growth, teeth and decreased bone causes painful joints, loosening of teeth, 
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fissures and falling of nails, splitting and falling of hairs. Excess marrow causes obesity, 
heaviness in the eyes, swelling in finger and toe joints, decreased urination, gradually healing 
ulcers and decreased marrow casues perforation in bones, shock and diminished vision. 
Increased semen causes increased libido and fromation of renal calculi and decreased semen 
causes dropy ejaculation of semen or blood during copulation, pricking pain in the testis, 
inflammation and blackening of the genitalia. 
32,27
  
 
Before treatment 100% patients had deranged saaram (chyle) and sukkilam (semen), 
76%  patients had deranged senneer (blood), 32% patients had deranged oon (muscle), 27%  
patients had deranged kozhuppu (fat), 41% patients had deranged enbu (bone), 30% patients 
had deranged moolai (bone marrow)  and after treatment  it was reduced to 22% of saaram 
and sukkilam, 8% of senneer, 5% of oon and kozhuppu, 11% of enbu, 3% of moolai . 
 
Status of Pachakagni 
Samagni (optimal digestive fire) is constituted by samanan, analam and kilethakam. 
It is the digestive fire which ensures proper and timely digestion of all the solid and liquid 
food materials taken by an individual. Vishamagni  (Toxic digestive fire) is delayed digestion 
due to deranged and dispalced samanan leading to toxic digestion. Teekshagni ( Fiery 
digestion) is due to increased digestive fire intake of even improperly cooked/under cooked 
food gets digested along with essence. Mandagni (Sluggish/delayed digestion) in which 
without digesting immediately the food items taken eagerly, it produces rumbling noise in the 
abdomen along with abdominal distension and heaviness of body. 
32, 27
 
 
In the present study among 37 patients, before treatment majority of the patients (51% 
) belongs to samagni, 30% patients belongs to mandagni, 14%  patients belongs to 
vishamagni and 5% patients were found with teekshagni and after treatment 95 % patients 
belongs to samagni, 5% patients belongs to vishamagni. Irregular pattern in taking food, 
starvation, poor eating, over eating, incompatible food and taking unwholesome diet finally 
will results in mandagni, teekshagni, vishamagni which will actually results in incomplete 
nourishment of saaram (precursor in the formation of sperm). 
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Siddha – Probable mode of actions of Chandrakanthi chooranam 
 
Suvai (Taste )  
30,32,36,39 
 
Sweet Strengthens semen/sperm [ Inthirya balam] 
Bitter Toxin removal [nanju neekum - ROS, free radicals ] 
Astringent Purifies the blood, and reduce cholesterol 
 
Viriyam (Potency)  
 
Viriyam of CKC is cold [thatpam] and will reduce heat (pitham)  
 
 
 
 
 
 
 
 
Sweet 
Earth+Water 
Bitter 
Air + Space 
Astringent 
Earth + Air 
Thatpam 
(Cold) 
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Vipakam (Post digestive transformation of tastes)   
A concept explaining the disintegration/assimilation of six taste in the digestive tract 
in to three primary taste. Sweet and salt becomes sweet; sour becomes sour; bitter, pungent 
and astringent becomes pungent. Chooranam will be digested in 12 naligai [288mts]. 
Vipakam of CKC is sweet and pungent.  
 
Prabhavam (Specific action) 
Opposite action to the original character of the drug’s taste, action, potency, post 
digestive transformation. 
Astringent / bitter / sweet taste of CKC will balance Pitham  
 
General action of the drug 
Asphaltum punjabinum will act as a synergistic enhancer of other drugs and enhances 
the bioavailability in the body, tonifies the action of the seven body constiuents ( plasma, 
blood, muscle, fat, bone, marrow and semen). Removes body toxins, transports mineral 
substances to their target cell and  nutrients into the deeper tissues. 
185 
Madhuca longifolia 
will promote active components extraction from herbs and absorbs active components from 
gastrointestinal tract.
112 
 
By correcting vatham, pitham and kabam, nourishing the seven body constituents, the 
drug  may improve the sperm parameters [ count, motility and normal form of sperms].  
 
Siddha treatment Method 
45  
 
`Sweet taste and seetham veeriyam will reduce pitham, bitter will subside pitham which 
comes under ethirurai. Sweet will increase sperm production which comes under 
oppurai.And hence the treatment method of  Chandrakanthi chooranam comes under 
kalapurai.   
 
 
 
Oppurai A cure employed by the drugs which stimulate the symptoms similar 
to those of the disease. Heat to heat and cold to cold. 
Ethirurai A cure by those drugs which acts against and supress the symptoms 
of the disease. 
Kalapurai Combined action of oppurai and ethirurai 
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Siddha interpretation in three-humour 
 51% patient were doing  physical exertional work which causes vitiation of Vatham 
since Vayu [air element] governs the activities like running, sitting,walking, lying and 
standing.
32,27
 16% patients were getting a continuous exposure to Pitham vitiating 
causes like working under thermal exposure, chemical, radiation work. Theyu [fire 
element] has the phenomena with qualities of heat, burning 
32,27
 Pitham is directly 
opposite to the quality of sperm.  
 
 Iyyam lies in sperm, adipose tissue, blood, bone and bone marrow. Vali lies in muscle. 
Pitham lies in blood and chyle.
32
 In observation of udal thatu in all the patients 
Pitham and iyyam is vitiated and 32% of patients vatham is vitiated. 
 
  43% of patients had unhealthy sexual habits, 75% of the people had sleep 
disturbances, 15 (41%) patients were having the habit of hot water bath which comes 
under the vitiation of pitham since because of the qualities of fire element.
32
 
 
 57% of patients were addicted to smoking, alcohol and tobacco. Alcohol is thamo 
gunam (Vatha) food articles
30
 and hence causes derangment of vali. Nicotiana 
tabacum ( Tobacco, smoking) vitiate pitham 
40
 and destroys sperm. 
 
 5 (13%) patients were in depression, 8 (22%) patients were in anxious state, 4 ( 11% ) 
patients were in fear and anger state each and 10 (27%) were under stress. These 
factors vitiate vatham which has the quality of mental agony and pitham which has 
the quality of fear. 
32,27
   
 
 Among 37 cases BT 6 ( 16 % ) patients  had bitter taste in their tongue which states 
pitham is affected, 3 patients ( 8%)  with  sour taste  which states vatham is affected 
and sweet taste in their tongue which states iyyam is affected. 
32 
 
 
 BT 2 ( 5%) patients with affected skin colour ( pallor ) and 5 (14%) patients with 
affected eye (pallor, burning sensation) which states pitham is affected and 7 (19%) 
patients faeces were affected (constipation ) which states vatham is vitiated. 
32
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 BT most of the 19 (51%) patients had ring shape with pitham being vitiated, 7 (19%) 
patients with serpentine with vatham being vitiated, pearl being 2 ( 5%) with iyyam 
being vitiated, mixed being 9 ( 24%) thontham kutram is reported. 
32 
 
 
 Before treatment the naadi nadai of 18 (48%) of cases was pitha vatham, 1 (3%) 
patient of pitha kabham in which pitham is being dominant.14 (38%) patients of vatha 
pitham, 1 (3%) patient of vatha kabham  in which vatham being dominant and  3 (8 
%) patients were kabhapitham in which kabam being dominantly vitiated. 
32 
 
 
 On the basis of observation, it may be concluded that pitham and vatham are the 
prime predisposing factor and iyyam being minor factor for causing Oligozoospermia 
and after treatment improvement in the sperm parameters were observed due to 
alleviation of the vitiated humours by the trial drug.  
 
Siddha interpretation in body constituent 
As stated by siddha physiology seven body constituents has realtion with one another 
Ingested food will be transformed to chyle which is proposed to develop into blood. The 
RBC’S in blood will carry oxygen and will supply to muscle cells which make use of the 
oxygen in breaking the glycogen in muscle and will produce ATP to provide energy. Pyurvic 
acid will be the end product of this glycolysis and acetyl coA formed from pyurvic acid will 
supply carbon atoms for synthesis of cholesterol. Cholesterol is the precursor in producing 
steroid harmones. Steroid harmones will procced on the osteoblast/osteoclast and modifies 
bone resorption/formation. Inside the inner region of bones, bone-marrow is situated which 
consist of fat cells, fluid, fibrous tissue, blood vessels and hematopoeietic cells. And from this 
bone marrow semen is formed. Recent research had showed early-stage sperm cells created 
from human bone marrow. 
77 
 
 
Saaram [ First precursor in the formation of sperm ] 
Saaram gives mental and physical perseverance. Samagni is the optimal digestive fire 
constituted by samanan, anila pitham and kilethakam. It is the digestive fire which ensures 
proper and timely digestion and it is the heat required for nourishment of life. Any imbalance 
in samagni will cause toxic, fiery or delayed digestion and will cause improper nourishment 
of saaram. Pitham which has the quality of fear will be vitiated in psychological stress and 
affects saaram which gives mental perseverance. Emotional stress will reduce testosterone 
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levels and will interrupt spermatogenesis. 
274
 The autonomic nervous system and adrenal 
hormones plays role in stress response, which will also affect steroidogenesis / 
spermatogenesis .The sweet taste in CKC will pacify the pitham thodam and will balance the 
samagni and thus will noursih saaram. The ingredients like Cuminum cyminum; Vitis 
vinifera; Costus speciosus; Glycyrrhiza glabra; Lawsonia inermis; Mucuna pruriens; 
Shilajith which is reported to have antistress and antidepressant activity [as stated earlier in 
drug review] reduces stress and will nourish saaram.  
 
Blood [Second precursor in the formation of sperm] 
Significant increase in the Hb level after treatment is reported and which may be due 
to the presence of iron and copper in CKC. 
276
 Moreover the ingredients like Madhuca 
longifolia; Cuminum cyminum; Vitis vinifera; Myristica fragrans [as refered in drug review] 
will enrich the blood and thuvarpu taste in CKC helps in the formation of-blood
39 
Altogether 
may demonstrate that the second physical constituent blood is well nourished. 
 
Muscle [ Third precursor in the formation of sperm] 
Glycogen is stored in muscles & liver. Sweet taste has the action of strengthening 
semen/sperm and according to modern science metabolism of carbohydrates [sweet taste] 
particularly glucose, is essential for male reproductive health. Maintenance of testicular-
glucose metabolism homeodynamics is important; if not spermatogenesis will be arrested. 
Glycogen plays essential role in testis. Sertoli cells use extracellular-glucose through GLUT-
5 the specific glucose transporters.
282 
GLUT-5 facilitates the transporting of glucose into 
sperm cell, which is used as substrate in the production of energy.
283
 Presence of energetic-
reservoir in glycogen form will sustain the energy and therefore viability of sperm from 
ejaculation to fecundation and increases the reproduction potential. 
263
 Significant decrease in 
the glucose level and significant increase (P<0.001) in the motility of the sperm after 
treatment may state that the drug may act on glycogen phosphohexose pathway, by which 
frutose may arises from glucose which is needed for sperm motility.
262
 Tribulus terrestris; 
Mucuna prurita; Asphaltum punjabinum; Cuminum cyminum; Maerua arenaria; 
Cinnamomum tamala; Vitis vinifera; Bombax ceiba; Costus speciosus; Phoenix dactilifera; 
Cyperus rotundus; Coscinium fenestratum are the ingredients present in CKC with 
antihypergycemic activity [as refered in drug review] and due to which the glucose level 
might be decreased significantly after treatment and utilized for energy.  
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Cholesterol [Fourth precursor in the formation of sperm] 
Increased BMI is related to poor quality of semen, decreased sperm count and normal-
sperm motility.
259
 Significant decrease in cholesterol level after treatment (CKC ) may be due 
to anti hyperlipidemic effect of Cuminum cyminum; Glycyrrhiza glabra; Cinnamomum 
tamala; Cyperus rotundus; Phoenix dactlifera; Costus specious; Coscinium fenestratum; 
Mucuna pruriens; Myristica fragrans; Cumin cyminum; Asphaltum punjabinum; Syzgium 
aromaticum [as refered in drug review]  and additionally due to the astringent taste present in 
CKC which reduces cholesterol level.
39
 Thus the drug balances the cholesterol level the 
fourth body constituent and fourth precursor in the formation of sperm. 
 
Bone [Fifth precursor in sperm formation] 
The significant increase in the testosterone [steroid harmone] reported after treatment 
may proceed on osteoblast/osteoclast and modify the bone formation.  
 
Bone marrow [Sixth precursor in the formation of sperm] 
Element iron is present in CKC. Asphaltum punjabinum the ingredient present in CKC 
helps in the absorption of iron into the body and makes it bioavailable to bone marrow stem 
cells and additionally Phoenix dactilifera have stimulatory effect on the bone marrow tissue 
185,158
  
 
Semen/Sperm 
In the present study spermatogenesis is enhanced which is evident from the significant 
increase in sperm parameters after the treatment which may be due to the presence of steroid, 
amino acids, iron, calcium, magnesium, zinc and copper with respect to sperm production, 
maturation and motility.On the basis of observation it may be concluded the drug nourishes 
the body constituents and improves the sperm parameters [ count, motility and normal form 
of sperms].  
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8. SUMMARYAND CONCLUSION 
 
 The study was conducted to explore and establish the safety and efficacy of the siddha 
herbo-mineral formulation Chandrakanthi chooranam in the treatment of 
oligospermia through clinical and preclinical studies and to ensure the quality of the 
drug through analytical studies. 
 
 Heavy metals and aflatoxins were found to be below detection level. Bacterial and 
fungal count [microbial contamination] was found to be within the prescribed limits. 
Specific pathogens and pesticide residues were found to be absent. The results 
propose that the prepared drug study is of standard quality. 
 
 Acute toxicity study of the drug Chandrakanthi chooranam revealed that it didn’t 
produce any signs of toxicity sign and is well tolerated up to 10 times [10.8gm/kg 
b.wt] the therapeutic dose in tested wistar rats. Long term toxicity study for 90 days in 
wistar rats revealed that the no-observed-adverse-effect-level of Chandrakanthi 
chooranam was found to be 1 TD and 3TD dose level with respect to animal survival, 
haemotological, biochemical and histopathological findings and low adverse effect 
was found to be  in 5TD dose level with reference to significant increase in total 
protein and significant decrease in the organ weight of heart and lungs. 
 
 The findings of this study bring forth the spermatogenic activity of Chandrakanthi 
chooranam and showed protctive effect on sperm count, motility, viability and normal 
forms of sperm in rats treated with ethanol.  The combined androgenic and 
antioxidant activity may be the cause for its positive results on spermatogenesis. 
 
 Pilot study in clinical was found to be feasible, no safety issues occurred and the trial 
drug showed significant increase in the sperm parameters. The main clinical trial 
showed significant increase in sperm count, motility and morphology and it may be 
due to the presence of the steroidal constituent of Chandrakanthi chooranam and its 
meiosis inducing effect during the Spermatogenesis. This proposition is further 
comparable with the significant increase in testosterone level which stimulate 
spermatogenesis. 
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 The Trial conclude and set forth the drug  Chandrakanthi chooranam  was proved  to 
be safety and efficacy in preclincal studies and clinical trial and the outcome obtained 
present it as standard treatment for patients with oligospermia by improving sperm 
parameters. 
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9. RECOMMENDATION  
 
 The study states Chandrakanthi chooranam had showed significant increase in sperm 
parameters and testosterone level and it is recommended for the treatment of 
oligospermia leading to infertility 
 
 Animal experimentation which requires further research works to elucidate the 
antioxidant activity and effect of the trial drug on antisperm antibodies. 
 
 It is recommended that Phase III -Therapeutic Confirmatory Trials should be done in 
a larger number of patients in comparison with a standard/ placebo  drugs to validate 
the  safety and efficacy that is established in the present Phase II trial. 
 
 The limitation of the present study comprise the asessment of the fertility potential of 
Chandrakanti chooranam in oligospermic patients and hence the drug should be 
further directed to asess the fertility potential. 
 
 The drug improves the sperm quality and is recommended to be harmonized with 
assisted fertility treatments. The oligozoospermic patients should be treated with 
Chandrakanti chooranam to improve sperm quality before performing retrieval of 
sperm. 
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                           National Institute of Siddha, Chennai, Tamilnadu, India 
                     Safety and Efficacy of Chandrakanthi Choornam in Oligospermia –  
                                                 A  Preclinical and Clinical study 
                               FORM-I - SCREENING AND SELECTION PROFORMA 
                              
1. Name:                                                                      
 
2. S.I. No                                                                     3.O.P.D No 
 
            4.  Age:                                                                          5. Sex                                                                   
 
                                             
            6. Address & Phone No  
 
 
SELECTION CRITERIA  
 
Inclusion criteria 
Male infertile patients with age between 21-45 years 
Marriage history  for >1 year  
Sperm count 1-15 million/ml [ below one million is excluded] 
Patients with normal liver & renal function test 
Willing to give specimen of semen  before & at the end of the clinical trial 
Informed patients giving written consent 
 
Exclusion criteria 
Azoospermia-complete absence of sperm in the ejaculate 
Aspermia-complete lack of semen 
Necrospermia- spermatozoa in semen are dead 
Clinical diagnosis of varicocele & hydrocele 
History of undescended testis 
Inguinal hernia on physical examination 
Male accessory gland infection 
History of DM, Hypertension and Cardiac Disease 
Any recent medical or surgical illness 
Underwent treatment for promoting spermatogenetic fertility in last 3 months 
Other systemic disease requiring specific therapies 
Known Thyroid disease 
Past history of  renal, hepatic or any other chronic illness in the patient  
      
 
 
            Patient is included in the Trial                      YES  /  NO 
 
 
 Date:                                                                       Signature of the Investigator: 
 
                                     
                                    
                                National Institute of Siddha, Chennai, Tamilnadu, India 
                             Safety and Efficacy of Chandrakanthi Choornam in  Oligospermia –  
                                                      A  Preclinical and Clinical study 
                                                 FORM-II - HISTORY PROFORMA 
                              
1. Name:                                                                      
 
2. S.I. No                                                                    3. O.P.D No 
 
            4. Age:                                                                           5.  Sex                                                                   
 
                                             
            6. Permanent Address & Phone No  
 
            7. Education :     Illiterate / Primary / Secondary / Graduate / Post graduate 
 
8. Occupation :  Labour  / Intelectual / Sedentary   
 
 Nature of Work: Physical / Intelectual / Chemical or radiation / Thermal or night shift 
 
            9.Socio economical status:    L / M / U 
 
 
            10. COMPLAINTS AND DURATION  :   
 
No issues since                        years 
 
 
                Primary Infertility                       Secondary Infertility   
 
             
            11. HISTORY OF PRESENT ILLNESS 
 
           
                                                                                                          
            12. HISTORY OF PREVIOUS ILLNESS   
 
            Mumps / orchitis / Prostatitis / STD / Hypertension / Cardiac disease / DM /    
           
            Scrotalinjuries / TB / Filariasis / others  
                     
            
            13. SURGICAL INTERVENTION 
 
Hydrocele  /  Varicocele / Blockage of Vas / Vasectomy / Hernia /  
 
Obstruction of  ejaculatory duct /  Trauma 
 
                            
            
         14. PERSONAL  HISTORY 
 
          15. DRUG HISTORY 
        
                Addiction /  Steroids / Antidepressant / Opiod / Chemotherpeutic agents /    
 
                Cyclophosphamide / others 
                                                                                               
               
          16. MARITAL HISTORY 
 
Duration of Marriage               years               Consanguineous  - Yes  /  No 
 
 
          17. SEXUAL HISTORY 
 
           Sexual desire:     Lack / Normal / Excess 
 
              Coitus :                Pain / Weakness / Burning / normal     
  
              Pervertion           Yes  / No   
                             
    Mastrubation -    Yes  / No 
 
 
18. PSYCHOLOGICAL HISTORY 
 
Normal / Depressed / Anxious / Stress / Anger / Fear   
 
            19. FAMILY HISTORY 
 
Congenital anomalies / Crypto-orchidism / Hypospadias / issueless / delayed  
                                                                                                             conception 
 
History of  conception ( Wife’s) -      Abortion                    Miscarriage 
                                                                       
 
              
            Date :                                                            Signature of the investigator 
                              
Diet                   Veg / Mixed  
Food habits  Irregular pattern  / starvation / poor eating / over eating /  
         incompatabile food / unwholesome diet / normal  
Sleep        Sound / disturbed / delayed 
Exercise     Heavy / Moderate / less / no 
Addiction Smoking / Alcohol / Tobacco / Smoking & Alcohol / No addiction 
Undergarments    Synthetic Tight / Synthetic Loose / Cotton Tight / Cotton Loose 
Bath       Hot water / Normal water 
                        National Institute of Siddha, Chennai, Tamilnadu, India 
                       Safety and Efficacy of Chandrakanthi Choornam in  Oligospermia –  
                                              A  Preclinical and Clinical study 
                                   FORM-III – CLINICAL ASSESSSMENT PROFORMA              
             1.Name:                                                                      
 
2. S.I. No                                                                        3.OPD No 
 
            4.  Age:                                                                           5.  Sex                                                                   
 
A] SIDDHA ASPECT 
I] Nilam ( Land ): Kurinji / Mulai / Maruthuam / Neithal / Palai 
 
II] Paruvakalam ( Season) : Kaar / Koothir / Munpani / Pinpani / Elavenil / Muthuvenil 
 
III]  Thega Nilai (Bio Type) :  Vatham / Pitham / Kabam / Thontham 
 
IV] Gunam (Character) : Sathuvam / Rasatham / Thamasam 
 
V] Vanmai (Bulit) : Iyalbu (Normal) / Valivu ( Heavy) / Melivu (Lean) 
 
VI] Poripulangal  (Sensory Organs)  
 
 
 
 
 
 
 
 
 
VII]Kanmendriyam ( Motor Organs) 
 
 
 
 
 
 
 
     
 
VIII Kosangal (Sheath)    
 
 
                          
 
 
 
 
Parameters Assessment 
Kai (Upper limb) Normal / Affected 
 Kaal (Lower limb) Normal / Affected 
Vai (Buccal Cavity) Normal / Affected 
Eruvai (Excretory organs Normal / Affected 
Karuvai ( Reproductive organ) Normal / Affected 
Parameters Assessmet 
Mei (Skin) Normal / Affected 
 Vai ( Buccal cavity) Normal / Affected 
Kann ( Eye) Normal / Affected 
Mooku( Nose) Normal / Affected 
Sevi ( Ear) Normal / Affected 
Parameters Assessment 
Annamayakosam Normal / Affected 
 Pranamayakosam Normal / Affected 
Manomayakosam Normal / Affected 
Vignanamayakosam Normal / Affected 
Anandhamayakosam Normal / Affected 
IX] Seven Thathus ( Seven somatic components) 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
X] Mukkutram : [Affection of Three Humors] 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Parameters 0th  Day 91st Day 
Saaram Normal / Affected Normal /Affected 
Senneer Normal / Affected Normal /Affected 
Oon Normal / Affected Normal /Affected 
Kozhupu Normal / Affected Normal /Affected 
Enbu Normal / Affected Normal /Affected 
Moolai Normal / Affected Normal /Affected 
Sukkilam Normal / Affected Normal /Affected 
Parameters 
 
0th Day 91st Day 
VATHAM 
Pranan 
 
Normal / Affected Normal /Affected 
Abanan Normal / Affected Normal /Affected 
Uthanan Normal / Affected Normal /Affected 
Viyanan 
 
Normal / Affected Normal /Affected 
Samanan Normal / Affected Normal /Affected 
Koorman 
 
Normal / Affected Normal /Affected 
Naagan Normal / Affected Normal /Affected 
Kirukaran Normal / Affected Normal /Affected 
Devathathan Normal / Affected Normal /Affected 
Dhanjeyan 
 
Normal / Affected Normal /Affected 
PITHAM 
Aakkanal Normal / Affected Normal /Affected 
Vanna eri Normal / Affected Normal /Affected 
Alosakam 
 
Normal / Affected Normal /Affected 
Prasagam Normal / Affected Normal /Affected 
Aarralanki 
 
Normal / Affected Normal /Affected 
KABAM 
Avalampakam Normal / Affected Normal /Affected 
Kilethegam Normal / Affected Normal /Affected 
Pothakam Normal / Affected Normal /Affected 
Tharpakam 
 
Normal / Affected Normal /Affected 
Santhikam Normal / Affected Normal /Affected 
XI] Envagai Thervu : [ Eight- fold examination ] 
------- 
S.NO Envagai Thervu Parameters 0th  Day 91st Day 
1. Naa (Tongue) Thanmai (Character) Normal / Affected 
 
 
Normal / Affected 
Niram (Colour) Normal / Affected Normal / Affected 
Suvai (Taste) Normal / Affected Normal / Affected 
2. Niram 
(Complexion) 
Examination of 
colour 
Normal / Affected Normal / Affected 
3. Mozhi (Voice) Thanmai ( Character) Normal / Affected Normal / Affected 
4. Vizhi (Eye) Niram ( Colour) Normal / Affected Normal / Affected 
Thanmai ( Character) Normal / Affected Normal / Affected 
5. Malam (Stools) Thanmai (Character) Normal / Affected Normal / Affected 
Niram (Colour) Normal / Affected Normal / Affected 
Vemmai (Warmth) Present / Absent Present / Absent 
6. Sparisam 
(Palpatory 
perception) 
Veppam ( Warmth) 
 
Normal / Affected Normal / Affected 
Thoduvali  (Pain) Present / Absent Present / Absent 
     7.----
-------. 
Naadi (Pulse) Thanmai (Pattern)   
8. Moothiram 
(Urine) 
 
i)Neerkuri 
( Urine 
examination) 
 
 
 
 
 
 
 
ii)Neikuri  (Oil 
on urine sign) 
Niram (Colour) Normal / Affected Normal / Affected 
Manam (Odour) Normal / Affected Normal / Affected 
Nurai ( Froth) Present / Absent Present / Absent 
Edai (Specific 
gravity) 
Normal / Affected Normal / Affected 
Kalapu ( Deposits) Present / Absent Present / Absent 
Enjal (Volume) Normal / Affected Normal / Affected 
 
  
 
         
 
 XII]  Status of Panchagni ( Basal metabolic heat) 
 
 
 
 
 
 
 
 
 
 
XIII] Food Affinity:  
 
Taste:      Innipu(sweet)/ Pulipu(sour)/ Karpu(acrid)/ Kaipu(bitter) 
 
                / Uppu(salt)/ Thuvarpu(astringent) 
 
Hot / Cold 
 
B] MODERN ASPECT 
 
I] General Examination 
 
Height                                  Respiratory rate  Cyanosis   
Weight                                 Blood pressure               Clubbing 
BMI Temperature Lymphadenopathy 
Pulse rate                     Pallor Pedal edema 
Heart rate                      Jaundice Jugular Vein Pulsation 
 
II] Systemic Examination 
 
1. Respiratory system 
 
2.  Cardio vascular system 
 
3. Digestive system 
 
4. Nervous system 
 
 
 
 
 
 
 
 
 
 
 
 
Parameters 0th  Day 91st Day 
Samagni Normal / Affected Normal /Affected 
Mandagni Normal / Affected Normal /Affected 
Teekshagni Normal / Affected Normal /Affected 
Vishamagni Normal / Affected Normal /Affected 
 5.Male genital system 
 
III] Clinical Symptoms 
 
Date :                                              Signature of the investigator 
                              
S.No Parameters Assessment 
1. Pubic hair Distribution No / light / dark / small / extends to thigh & 
umblicus 
2. Inguinal lymph node Palpation Palpable / Non palpable 
3. Penis Skin Normal / Redness / Swelling / Scar / Ulcer 
Body /shaft : Normal / Curved / shrunken / wound 
Prepuce Normal / Phimosis / Paraphimosis / Circumcessed 
Glans Normal / Ulcer / Scars / Balanitis / Balanoasthitis 
Urethral meatus Normal / Hypospadis / Epispadis / Discharge 
4. Scrotum Skin Normal / less fold / Nodules / Redness / Ulceration 
Pigmentation Normal / Hyper / Hypo 
Sac Normal / Sagging / Hydrocele 
Hernia Right – direct / Indirect ; Left – direct / Indirect 
Cremastic reflex Present / Absent 
5. Testis Position Normal / Retracted / Criptoorchid 
Surface Smooth / Nodular 
Consistency Firm / Soft 
Borders Regular / Irregular 
6. Epididymis Palpation Tender / Nontender 
7. Spermatic cord Palpation Normal / Thickened / Varicocele 
8. Vasa Palpation Tender / Nontender 
9. Rectal examination 
(Prostate gland) 
Consistency Normal / Hard / Boggy 
Palpation Tender / Nontender 
Surface Smooth / Nodular / Other impression 
Clinical Symptoms 0th 
day 
16th 
day 
31st 
day 
46st 
day 
61th 
day 
76th 
day 
91st 
day 
Premature 
ejaculation 
Present / 
Absent 
Present 
/Absent 
Present 
/ Absent 
Present 
/ Absent 
Present / 
Absent 
Present 
Absent 
Present 
/Absent 
Nocturnal 
emission 
Present / 
Absent 
Present / 
Absent 
Present 
/ Absent 
Present 
/ Absent 
Present / 
Absent 
Present / 
Absent 
Present 
/Absent 
Erectile 
dysfunction 
Present / 
Absent 
Present / 
Absent 
Present 
/ Absent 
Present 
/ Absent 
Present / 
Absent 
Present / 
Absent 
Present 
/Absent 
                                National Institute of Siddha, Chennai, Tamilnadu, India 
                             Safety and Efficacy of Chandrakanthi Choornam in  Oligospermia –  
                                                      A  Preclinical and Clinical study 
                                             FORM-IV – LABORATORY PARAMETER 
 
1. Name:                                                                      
 
2.  S.I. No                                                                    3.OPD No 
 
            4. Age:                                                                           5.  Sex                                                                   
 
            5.Date of Assessment 
 
Blood Investigation  0th Day 
 
  91st Day   121st Day 151st Day 181st Day 
HB (gms %)      
RBC (milli/cu.mm)      
ESR (mm)                                1/2hr 
                                                   1hr 
      
     
T.WBC (cu.mm)      
Differential count (%)       Polymorphs  
                                             Lymphocytes 
                                             Monocytes 
                                             Esnophils 
                                             Basophils 
     
     
     
     
     
Blood Glucose (mg/dl ) (R)      
Lipid Profile (mg/dl)          Cholesterol 
                                             HDL 
                                             LDL 
                                             VLDL 
                                             TGL 
     
     
     
     
     
RFT (mg/dl)                     Blood urea 
                                         Serum creatinine 
                                         Serum uric acid 
     
     
     
LFT (mg/dl)                    Total bilirubin 
                                        Direct bilirubin 
                                        Indirect bilirubin             
                                        Serum total protein 
                                        Serum Albumin 
                                        Serum globulin 
                                        Fibrinogen (g/dl) 
                                        Serum calcium 
                                        Serum phosphorus 
                                        SGOT (IU/L) 
                                        SGPT (IU/L) 
                        Alkaline phosphatase (IU/L)  
  
   
  
   
  
   
  
   
  
   
  
   
  
   
  
   
  
   
  
   
  
   
  
   
  VDRL 
  
   
  HBsAg 
  
   
 Urine Investigation 0th Day 
 
91st Day 121st Day 151st Day 181st Day 
Albumin 
     
Random sugar 
     
Deposits 
     
Bile salts 
     
Bile pigments 
     
Urobilinogen 
     
 
              
Semen Analysis 0th Day 91st Day 121st Day 151st Day 181st Day 
Collection 
     
Abstinence Period 
     
Method of collection 
     
Time of collection 
     
Time of examination 
     
Colour 
     
Appearance 
     
Volume (ml) 
     
Liquefication time (mt) 
     
Viscosity 
     
Pus cells 
     
Sperm count (million/ml) 
     
Motility(%)  Total Motility 
            Progressive Motility 
                       Immotile 
     
     
     
Morphology (%) Normal 
    Abnormal - Head Defect 
                        Tail Defect 
     
     
     
 
Harmone Analysis 0th Day 
 
91st Day 181st Day 
TSH 
   
LH 
   
Testosterone 
   
 
 
Blood group 
 
ECG  
 
Others:  
 
 
 
Date :                            Signature of the Investigator 
 
                          National Institute of Siddha, Chennai, Tamilnadu, India 
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                                     FORM-V – ADVERSE REACTION  FORM 
 
1. Name:                                                                      
 
2. S.I. No                                                                      3.OPD No 
 
            4.  Age:                                                                           5.  Sex                                                                   
 
             
 
           To be filled by the investigator 
 
12 Did the event require to stop 
the study drug 
 
13 Out come of the event  
14 Date and time of report  
15 Signature of the investigator  
 
          The Adverse Effects will be intimated to the Institution Ethical Committee within 48    
          hours of time. 
 
 
 
                             National Institute of Siddha, Chennai, Tamilnadu, India 
Sl.no   Particulars                            Details 
1  Study site  
2 Brief description of the event  
3 Date of onset  
4 Time of onset  
5 Date of administration of 
1stdose of study drug 
 
6 Time of administration of 1st 
dose of study drug 
 
7 Date of administration of last 
dose of study drug 
 
8 Time of administration of last 
dose of study drug 
 
9 Severity of the AE  
10 Did the subject hospitalized  
11 Relationship to the study drug  
                       Safety and Efficacy of Chandrakanthi Choornam in Oligospermia –  
                                              A  Preclinical and Clinical study 
                                            FORM-V A– WITHDRAWAL FORM 
 
1. Name:                                                                      
 
2.  S.I. No                                                                     3.OPD No 
 
            4. Age:                                                                           5.  Sex                                                                   
 
            
 
Date of Trial Commencement: 
 
Date of Withdrawal from Trial: 
 
Reasons for Withdrawal: 
 
Long absence at reporting                                                         Yes / No 
Irregular treatment                                                                     Yes / No 
Shift of locality                                                                          Yes / No 
Increase in severity of symptoms                                              Yes / No 
Development of severe adverse drug reactions                         Yes / No 
 
 
 
Date:                                                                                               Signature of the Investigator  
 
 
                                                                                                            Signature of the  Guide 
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                                    FORM-VI –DRUG COMPLIANCE FORM    
 
 
 
 
Name Of The Drug :CHANDRAKANTHI CHOORNAM 
Drugs issued:  (Grams) 
Drugs returned:    (Grams)    
                                
 
 
 
                                                                                                             Signature of the Patient                          
                                        
                             National Institute of Siddha, Chennai, Tamilnadu, India 
Name S.I.No OPD No 
Day Date Time 
    1   
    2     
    3   
    4   
    5   
    6   
    7   
    8   
    9   
   10   
   11   
   12   
   13   
   14   
   15   
   16   
   17   
   18   
   19   
   20   
   21   
   22   
   23   
   24   
   25   
   26   
   27   
   28   
   29   
   30   
Day Date Time 
    31   
    32     
    33   
    34   
    35   
    36   
    37   
    38   
    39   
   40   
   41   
   42   
   43   
   44   
   45   
   46   
   47   
   48   
   49   
   50   
   51   
   52   
   53   
   54   
   55   
   56   
   57   
   58   
   59   
   60   
Day Date Time 
    61   
    62     
    63   
    64   
    65   
    66   
    67   
    68   
    69   
   70   
   71   
   72   
   73   
   74   
   75   
   76   
   77   
   78   
   79   
   80   
   81   
   82   
   83   
   84   
   85   
   86   
   87   
   88   
   89   
   90   
                       Safety and Efficacy of Chandrakanthi Choornam in  Oligospermia –  
                                              A  Preclinical and Clinical study 
                                      FORM-VI A – DIETARY ADVICE FORM                                
 
 
I] Pathiyam  (Diet and Behaviors to Follow)  
 
Diet:  
Greens of Drumstick, Climbing brinjal, Spinach and Amaranthus tritis 
Goat meat; Emperor and Eel fish 
Plantain flower, Drumstick 
Mango fruit, Black grapes, Black plum and Pomegranate 
Cow’s Milk  
Cashew, Almond and Walnut   
     
Behaviour:  
Patients were adviced to take oil bath twice in a week  
Avoid intercourse on the day of the oil bath 
 
II] Apathiyam  (Diet and Behaviors to Avoid)  
 
Diet:  
Horse gram  
Mango, Bitter guord  
Sesban leaves 
 
Behaviour:  
Avoid intercourse in day time and during digestion of the food 
 
Other Advices  
Tobacco, Smoking, Alcohol, Drug abuse  
Hot baths 
Strenuous activities 
Occupation in hot environment, 
Wear loose under wear  
Control obesity 
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                                 FORM-VII  –  PATIENTS INFORMATION SHEET  
 
You are asked to participate in this study. Therefore, the following information is given for 
better understanding of how the research study is being done and to know about your rights to 
decide to participate/ not to participate in this study. 
Purpose of the study: To provide effective treatment in the oligospermia through siddha 
formulation. 
 
Total number of participants and duration of the study: 40 participants and  90 Days 
 
Treatment procedure: For every 15 days once the participants should come to OPD for 
consultation, and collection of medicine. Blood, urine and semen test will be conducted 
before and after  and during the follow up period. 
 
Laboratory investigations to be done: Initially screening of the semen, blood & urine will 
be done to know the eligibility criteria for participating in the study. You will be involved to 
undergo for semen test in the beginning, at the end of the treatment period and follow up 
period to assess the control of disease. Siddha parameters like Naadi, neikuri and neerkuri 
will be done on 1st day and also in end of the trial. 
 
Benefits to the participants: Medicines, semen, urine, blood test will be carried out at free 
of cost during the study period. It is hoped that the treatment you receive will help to increase 
the sperm count.  
   
Withdrawal criteria:  If you are uncomfortable in any situation during the study period, you 
have the right to withdraw from the study at any time. You will be provided regular health 
service. 
 
Adverse effects:  In case of any adverse effects occur during the study period, it should be 
informed to investigator. Necessary arrangements will be made for immediate treatment. 
 
Benefit for the society: Results of this study may be useful to decide oligospermia therapy 
with siddha formulations for the larger population. 
 
Remuneration: You will not be paid any remuneration for participating in this study. 
 
Confidentiality:  The information provided by you will be kept in strict confidence. Under 
no circumstance shall I reveal the identity of the participant or their family to anyone.  
 
Publications of the research results: The information that I collect shall be used for 
approved research purposes with ID number. 
 
Contact person: Whenever you have any doubt regarding disease/medicine/treatment, you 
have rights to ask any questions to the investigator.  
 
                Dr.Akila.M.D(S), PhD Scholar, Department of Maruthuvam,  
               National institute ofSiddha, Chennai-47; Cell no: 9444645833  
                            National Institute of Siddha, Chennai, Tamilnadu, India 
                       Safety and Efficacy of Chandrakanthi Choornam in  Oligospermia –  
                                              A  Preclinical and Clinical study 
                                           FORM-VII A – CONSENT FORM 
 
 
 
    I______________S/o________________________________________ 
 
Study Participant ID No:__________  have  received the verbal information regarding the 
above study. The above information have been read by me / read to me, and have been 
explained to me by the investigator. I was informed that I may withdraw myself from the 
study at any time without any reason and I ensure that I will take medicines as recommended 
by the investigator. I agree to use my research data as described in the informed consent 
form.  Having understood the same, I hereby give my consent to participate. I affixing my 
signature/ left thumb impression to indicate my consent and willingness to cooperate in this 
research study. 
  
 
 
 
  
 
 
 
 
 
 
 
 
 
          Name Signature 
Participant   
Investigator       Dr.B.Akila  
Witness  
Relation ship 
                                                                                                                              
                       Figure 5.1.1: Ingredients present in Chandrakanthi choornam 
      Tribulus terrestris           Curculigo orchioides        Moringa oleifera             Mucuna prurita                            
    
 
    Madhuca longifolia        Maerua arenaria          Cuminum cyminum         Cinnamomum tamala                  
   
 
         Cinnamomum verum    Syzygium aromaticum          Bombax ceiba                     Vitis vinifera 
    
 
Costus speciosus           Glycyrrhiza glabra               Mesua ferrea               Phoenix dactilifera   
    
 
 
 
 
 
 
Bambusa aurundinaceae    Myristica fragrans         Cyperus rotundus                 Ilicium verum                    
    
 
 Coscinium fenestratum       Adhatoda vasica            Lawsonia inermis          Alternanthera sessilis        
    
 
  
     
                                               
 
 
 
 
 
 
                           
 
 
 
 
 
 
 
 
 
 
 
 
 
 
   Asphaltum punjabinum   
 
  
 
                         Figure 5.1.2: Prepartion of Gomutra Silasathu Parpam
 
   5.1.2A Layer formation                        
 
      
 
                                                
 
 
 
 
   
 
                                                         
     
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 5.1.2B Pellets 
  
Figure 5.1.3 Chandrakanthi choornam 
 
 
 
 
                    Figure  6.1 (a) : Alternanthera sessilis flower with seed 
  
 
 
 
                                                              
                                        
 
   
 
        
                                            
 
 
 
 
 
 
 
 
 
 
 
 
 
 
                                        
                                                  
 
 
 
 
              Figure  6.1 (b):  External feature of Alternanthera sessilis  seeds  
   
Figure 6.2: LS of Alternanthera sessilis  seed (entire view -16x 
 
                       (En- Endosperm; Sc- Seed coat) 
Figure 6.3: Alternanthera sessilis seed coat with    Figure 6.4:TS of Alternanthera sessilis seed (10x)                                
sclerotic testa and outer outgrowing wing - 40x   
         
      (ISC:Innerseedcoat;OSC:outerseedcoat;W:Wing) 
 
 
    Figure 6.5: A. sessilis seed coat with                         Figure 6.6: Cellular endosperm of  
         outer wing - 40x                                                                  A.sessilis seed – 40x 
   
             (En- Endosperm; Sc- Seed coat)                                         (En- Endosperm)      
 
 
 
 
 
 
                         Figure 6.7: Adhatoda vasica seeds external features showing  
                                          median ridge and  rugose surface (1x, 5x) 
 
 
Figure 6.8: Vertical tangential longitudinal section      Figure 6.9: LS of Adhatoda vasica seed upper  
     of Adhatoda vasica seed  reconstructed -4x                              chalazal position-10x 
              
(CO: Cotyledons,  RA: Radicle, TE: Testa)                    (SAT: Sarcotesta, ST: Sclerotesta) 
 
Figure 6.10:Lower portion of the seed shows                Figure 6.11: Sectional view of the  
a part of the  cotyledons and seed coat-10x                      Adhatoda vasica seed coat 10x 
        
                    (CO: Cotyledons)                                                (CO: Cotyledon, ST: Sclerotesta) 
 
 
 Figure 6.12:A portion of the cotyledons-40x    Figure 6.13: A.vasica seed coat epidermis       
                                                                                          sclerotesta in surface view-16x 
          
(SAT: Sarcotesta; RW: Radial wall-thick and lignified) 
                                             
  Figure 6.14:Epidermal cells-enlarged-40x    Figure 6.15: Inner part of the seeds coat sarco- 
                                                                                           testa in surface view -40x 
  
                  CW: Cell wall  
 
 
   Figure 6.16:cells of cotyledons with                       Figure 6.17:  Isolated cotyledon-40x 
            starch grains-40x 
     
                 (SG: Starch grain) 
                                    
 
            Figure 6.18: Oil-bodies-40x                                      Figure 6.19. Starch grain-40x 
         
 
 
 
 
 
  A.Under UV 254 nm           B.UV 366 nm      C.After Derivatization 
                         Figure 6.20: TLC profile of chloroform extract of A. vasica seed 
                                        Track 1. 5µl; Track 2. 10 µl; Track 3. 15 µl. 
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Figure 6.21A: HPTLC Finger print 
CHCL3extract of A.vasica 
 
Figure 6.22A: HPTLC Finge
CHCL3extract of A. vasica seed at uv 366 nm         
 
Figure 6.23A: HPTLC Finger print profile of 
CHCL3 extract of A.vasica 
 
profile    Figure 6.21B: 3D of Chromatogram of CHCL
seed at uv 254 nm       extract of A.vasica seed at uv 254 nm
 
r Print profile of      Figure 6.22B: 3D Chromatogram of CHCL
 extract of a. vasica seed at uv 366 nm   
 
   Figure 6.23B:3D Chromatogram of all 
seed at 540 nm             CHCL3 extract of A
 
3  
   
 
3  
 
 
tracks of  
.vasica seed at 540 nm 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
                  Figure 6.24  Siddha specification for Gomutra Silasathu Parpam 
                    Floats on water                                              Lines of the thumb finger    
           
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
A.Under UV254 nm B.UV 366 nm C.Derivatized 
Figure 6.25: TLC profile of CHCl3 extract of Chandrakanthi chooranam.  
Track 1. 7µl; Track 2. 10 µl; Track 3. 12 µl. 
                    Figure 6.26: HPTLC  finger print of CHCl3  
                                extract of  CKCat UV 254 nm                                                                        
 
    1     2        3 1       2       3 
       1         2      
  
 
 
 
 
                              Figure 6.28 HPTLC  finger printing  
                            of CHCl3 extract of CKC at UV 540 nm                                          
 
 
 
 
 
 
 
                                      Figure 6.27. HPTLC  finger print of     
                                      CHCl3 extract of CKCat UV 366 nm                               
                         
  
  
 
 
 
                            
                              Figure  6.29. TGA spectra of Chandrakanthi choornam 
 
 
 
 
 
 
 
 
 
 
 
 
            Figure 6.30A: Gross necropsy of the vital organs in acute toxicity study
        
              Normal Control                         Vehicle Control                          10 TD
 
 
Figure  6.30B: Gross necropsy of the vital organs in acute toxicity study ( 10 TD Group)
A- Lungs;  B- Spleen; C
  
- Kidney; D- Heart; E- Liver; F- Testis; G
 
 
 
 
 
- Caecum 
  
  Figure 6.33: Histopathological photomicrographs of rats in longterm toxicity study
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